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Abstract
The risk of diabetes is increasing and it is anticipated that people with diabetes
will double by 2030 with about 90% of patients having type-2 diabetes. The use
of herbal remedies in the treatment of diabetes has increased because of the side
effects (flatulence, diarrhoea, tiredness and upset stomach) of some common
drugs. To prevent or delay type-2 diabetes, the blood glucose level needs to be
controlled. The objective of this research was to make a preliminary assessment
of the capacity of PFS (Plant Food Supplement) extracts to reduce glucose,
fructose and sucrose transport (acarbose-like activity) across the Caco-2 cell
monolayers and inhibit digestive enzymes by PFS extracts. Sucrase activity is
responsible for the hydrolysis of sucrose to fructose and glucose in the brush
border membrane of the small intestine. Accordingly, inhibiting glucose uptake
in the intestine may be beneficial for diabetic patients in controlling their blood
glucose level. The initial steps of the in vitro tests development involved
determining the activities of sucrase, maltase, isomaltase and human salivary α-
amylase in an acetone-extract of rat intestinal tissues, improving on a previously
published method by analysing glucose concentration via the hexokinase assay,
and analysing the effect of PFS on sugar transporters using a previously
published method using the Caco-2 cell monolayer. The literature evidence for
the inhibition of cellular glucose uptake and transport by polyphenols across
Caco-2 cells is limited. Also, to the best of our knowledge, this research is the
first report regarding the analysis of cellular uptake and transport of 14C-sucrose
and 14C-fructose using the Caco-2 cell monolayer with polyphenol-containing
extracts. Additionally, 14C radioactivity was used due to its easy detection and
allowed high sensitivity. Glucose, fructose and sucrose transport across the
Caco-2 cell monolayer was significantly attenuated in the presence of PFS.
Green tea, German chamomile and Vitis Viniferae extracts inhibited the transport
of glucose, fructose and sucrose when tested independently. However, the Vitis
Viniferae extracts were not able to achieve 50% inhibition for the sucrose and
fructose transport. While the cellular uptake of glucose and fructose was
inhibited by the PFS extracts, they were effective on the cellular uptake of
sucrose. By contrast, Pelargonium and Echinacea were ineffective for both the
transport and cellular uptake of sugars. Purified German chamomile and green
vtea extracts were found to be moderate inhibitors of α-amylase digestion of 
amylopectin and α-glucosidase enzymes. 
Due to the acarbose-like activity of the PFS extracts, they may have a potential
role to reduce the risk of diabetes by inhibiting the hydrolysis of starches and
reducing post-prandial blood glucose spikes. PFS may be seen as beneficial for
use by diabetics as part of a nutritional intervention and in combination with
exercise and drug treatment.
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CHAPTER 1 LITERATURE REVIEW
High intake of sugars may have negative effects on health and this situation
could feed metabolic abnormalities, such as type-2 diabetes (Johnson et al.,
2009). Type-2 diabetes, cardiovascular disease and metabolic syndrome risk is
increased with repeated high post-prandial glucose spikes (Liu et al., 1999; Liese
et al., 2005; Flynn, et al., 2005; Manzano and Williamson, 2010; Hauner et al.,
2012). There are some in vitro animal and human intervention studies, which
reported the effect of various dietary polyphenols on carbohydrate metabolism.
The possible mechanisms are inhibition of digestive enzymes for glucose
production, inhibition of glucose transporters in the intestine, stimulation of
insulin secretion from the pancreatic β-cells, activation of insulin receptors and 
glucose uptake in the insulin-sensitive tissues, modulation of glucose release
from the liver and modulation of intracellular signalling pathways and gene
expression (Hanhineva et al., 2010).
The highest concentration of post-prandial polyphenols is in the gut lumen
compared to any other site in the body (Williamson, 2012). After consumption of
high-polyphenol beverages, such as coffee, tea and orange juice, the amount of
polyphenols reach millimolar concentrations in the gut lumen (Williamson,
2012). Therefore, glucose metabolism may be affected in the gut lumen. In this
study, the Caco-2 cell line was used as it has been extensively employed as a
model of the intestinal barrier in the literature. The Caco-2 cell line is the best
choice to assess the inhibition of sugar transport because several morphological
and functional characteristics of the mature enterocyte are able to be expressed
by Caco-2 cells (Sambuy et al., 2005; Angelis and Turco, 2011). However there
is also a limitation in the use of Caco-2 cells because it is not possible to mimic
all biological activity of the human intestine.
1.1 Overview of Polyphenols
Polyphenols are plant metabolites and they are found in most plants or plant-
derived foods and beverages (Bravo, 1998). Polyphenols protect plants from
stress and excessive ultraviolet light exposure (Williamson, 2004). In addition,
- 2 -
they contribute organoleptic properties, taste and flavour of food products, such
as red wine, tea, coffee and they have health benefits (Tomas Barberan & Espin,
2001; Williamson, 2004). There are numerous studies that have shed light on the
effects of polyphenols, and reached the conclusions that these dietary
antioxidants may protect against free radical damage (Tamara et al., 2004), and
promote health by preventing cardiovascular disease, cancer, osteoporosis,
neurodegenerative diseases, diabetes and inflammatory disorders (Carughi, 2008;
Kaliora et al., 2009). In addition, polyphenols affect the sensory and nutritional
qualities of plant foods. Anthocyanins are present in plants as major polyphenol
pigments, and these pigments give the red, purple or blue colour (yellow is less
frequent) to plants (Cheynier, 2005). The content of the phenolic compounds
affects the astringency and bitterness of foods and beverages (Cheynier, 2005).
Also, during processing or storage the degree of oxidation of polyphenols may
cause either beneficial or undesirable characteristics in food products (Bravo,
1998). Flavonoids are the major plant phenolics and are classified into groups,
such as the flavonols, flavanols, flavanones, flavones, anthocyanidins and
isoflavones (Wacha et al, 2007) (Table 1).
Table 1 Classes of phenolic compounds in plants (Balasundram, et al., 2006).
Class Structure
Simple phenolics, benzoquinones C6
Hydroxybenzoic acids C6–C1
Acethophenones, phenylacetic acid C6-C2
Hydroxycinnamic acids, phenylpropanoids (coumarins,
isocoumarins, chromones, chromenes)
C6-C3
Napthoquinones C6-C4
Xanthone C6-C1-C6
Stilbenes, anthraquinone C6-C2-C6
Flavonoids, isoﬂavonoid C6-C3-C6
Lignans, neolignan (C6-C3)2
Biﬂavonoids (C6-C3-C6)2
Lignins (C6-C3)n
Condensed tannins (proanthocyanidins or ﬂavolans) (C6-C3-C6)n
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Table 1 indicates the natural polyphenols that consist of simple molecules (as
phenolic acids) and highly polymerised compounds (tannis). Mainly, they are
conjugated with one or more sugar units linked with hydroxyl groups. The linked
sugars can be formed of monosaccharides, disaccharides or oligosacharrides
(Bravo, 1998). Glucose is the most common sugar residue (Bravo, 1998).
Flavonoids are the largest class of polyphenols and are identified by the
diphenylpropanes (C6-C3-C6) structure. Diphenylpropanes consist of two
aromatic rings linked through three carbons that usually form an oxygenated
heterocycle (A, B and C ring) (Bravo, 1998). Figure 1 presents the structure and
structural variations.
Figure 1 Flavonoids (C6-C3-C6); basic structure and structural variations.
Generally, flavonoids are most commonly found as glycoside derivatives (Bravo,
1998). Figure 1 indicates the two kinds of rings (A and B). The A ring is
generated from a molecule of resorcinol (phloroglucinol) and the shikimate
pathway derives the B ring (Henning et al., 2004). Heterocyclic C-ring
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flavonoids can be subdivided into six groups, including flavones (e.g. apigenin,
luteolin, diosmetin), flavonols (e.g. quercetin, myricetin, kaempferol),
flavonones, catechins, anthocyanidins and isoflavones (Henning et al., 2004).
According to their polarity and chemical structure, most of these compounds are
soluble in aqueous and organic solvents (e.g. water, acetone, and methanol) and
have relatively low molecular weights (Bravo, 1998). The B ring shows the
characteristics of catechin flavanol structures by a dihydroxyl or trihydroxyl
substitution, the A ring has the 5,7-dihyroxyl substitution and the C ring has a 3-
OH substitution. (Yang et al., 2001). The shikimate and acetate are the main two
pathways that polyphenols biogenetically arise from (Bravo, 1998). Mostly, they
are produced using intermediates of carbohydrate metabolism in the shikimate
pathway (Tomas Barberan & Espin, 2001). The content of polyphenols in food is
affected by many factors that contribute towards phenolic stability, biosynthesis
and degradation (Tomas Barberan & Espin, 2001).
The main dietary sources of flavonols and flavones are tea and onions (Tamara et
al., 2004). The intake of flavonoids is difficult to estimate, since the average
intake will vary greatly within the population. “Estimates range from 26 mg/day
of flavonols in the Dutch diet to a median intake of total flavonoids of 239
mg/day, with a very wide range of 0.6 to 3,524 mg/day, among 34,708 U.S.
women” (Williamson, 2004). One gram per day is the estimated amount of the
daily polyphenol intake (Scalbert and Williamson, 2000; Scalbert et al., 2005;
Vauzour et al., 2010). Current epidemiological studies report that consuming
polyphenol-rich foods, fruit and vegetables lowers the risk of suffering from a
stroke, Parkinson’s disease and dementia, such as Alzheimer‘s disease, in elderly
people (Bastianetto et al., 2008). Also, these findings concur with animal and in
vitro studies suggesting that polyphenols derived from either beverages, fruits or
plant extracts exhibit neuroprotective abilities or are able to reverse cognitive
deficits (Bastianetto et al., 2008). The consumption of plant foods lowered the
risk of chronic diseases including diabetes, cardiovascular diseases and cancer
(Scalbert et al., 2005; Crozier et al., 2009; Clifford et al., 2004; Knekt et al.,
2002).
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1.2 Plant Food Supplements
Due to the promising health benefits of polyphenols, their interest has increased
recently. A complex mixture of polyphenols (flavonol, flavanol, flavone,
anthocyanidin) or flavonoids alone has been used therapeutically as a dietary
supplement in European countries and in the United States (Moini et al., 2000).
Weiss et al. (2006) reported that over 85% of Americans use dietary supplements
(botanicals or herbals, vitamins, and minerals) regularly due to their promising
health benefits (CVD, type-2 diabetes, cancer, inflammation and
neurodegenerative disorders) and are a multi-billion dollar business (Weiss et al.,
2006; Seeram et al., 2006). Dragan et al, (2015) reported that about 30% of
patients with type-2 diabetes are using CAM. PFS contain concentrated sources
of plants, their extracts or derivatives and are able to deliver physiological effects.
Throughout history, plants and herbs have been part of the diet not only because
they provide nutrients, but also for their health-promoting properties. Several
reviews indicate the benefits of traditionally consumed plants for the
management of diabetes (Bailey and Day 1989; Gougen and Leiter 2001; Shane
2001; Dey et al., 2002; Liu et al., 2002; Yeh et al., 2003; Rahimi et al., 2005;
Chang et al., 2007; Rizvi and Mishra, 2013; Ezuruike and Prieto, 2013; Lao et
al., 2014; Shikov et al., 2014). It was observed that some herbal medicines and
nutritional supplements were able to decrease blood glucose levels through
various mechanisms that could be used in the management of diabetes (
Table 4). Chang et al. (2007) reviewed the extensive use of CAM (such as
nutritional supplements and herbal medicines) for diabetic people with 18 studies
from 9 countries and found that it varied between 17 and 73% between patients
(Chang et al., 2007). Also, WHO (2003) reported that 65 to 80% of the world
population uses traditional medicines for health care.
Due to the side effects (flatulence, diarrhoea, tiredness and upset stomach) of
some common drugs (such as acarbose, which prevents blood glucose levels
from increasing too much after eating a meal, metformin, which reduces the
glucose that is released from the liver to the bloodstream, sulphonylureas, which
increase insulin secretion from the pancreas, and glitazones, which increase the
sensitivity of body cells to increase) in the treatments of diabetes, the use of
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herbal remedies has increased; 2 to 3.6 million diabetic patients in the USA use
herbal remedies for the management of diabetes (Dabaghian et al., 2012).
It was reported that people prefer to use plants in the belief that plants are more
efficient, safer (as they have no side effects compared to synthetic drugs) and
cheaper (Mall and Sahani, 2013; Durmuskahya and Ozturk, 2013). Plants used
for the treatment of diabetes show differences between regions due to their
traditional uses and where they grow (e.g. variations on account of the weather).
Also, depending on the plant and region the leaf, bark, fruit, flower or the whole
plant may be used. For instance, in India the most commonly used plants are
Allium sativum, Aegle marmelos, Azadirachta indica, Curcuma longe, Emblica
officianalis, Gynema sylvestre, Magnifera indica, Trigonella foenum-graecum
and Terminelia chebula (Mall and Sahani, 2013). Punica granatum, Rosa
damascene, Plantago psyllium, Coriandrum sativum, Portulaca oleracea and
Rumex patientia are the most popular traditionally used plants used in Iran due to
their anti-diabetic effects (Dabaghian et al., 2013). In Turkey, the most
commonly used plants for diabetic improvement are reported as Zizyphus jujube
Mill., Origanum onites L., Ceracus mahaleb L. and Trigonella foenum-graecum
(Durmuskahya and Ozturk, 2013). The aim of this investigation was to determine
the effect of polyphenols from the following plant food supplements: Camellia
Sinesis (Green tea), Matricarcia Recutita (German chamomile), Vitis Viniferae
(grape leaf), Pelargonium and Echinacea on cellular glucose uptake and the
transport of glucose from the apical to the basolateral compartment using a
Caco-2 intestinal cell model. This study is a part of EU framework 7 project
PlantLIBRA – Plant food supplement: Levels of intake, benefit and risk
assessment. The project aimed to investigate science-based decision-making and
the safe use of PFS (see 2.1). PFS extracts were chosen based on the project
partner’s suggestion (see ANNEX 1 page 234), missing data reported by EFSA
experts and the results produced by the study group about the estimation of PFS
intake. There was several PFS, whose effects were analysed, such as Echinacea
purpea, Andrographis paniculata, Pelargonium sidoides, Vitis vinifera (grape
leaf), Matricaria recutita (chamomile), Camelllia sinensis (green tea) and
Bowelliae res spir. All the extracts were received from one of the project
partners: PhytoLab Co. KG.h (Vestenbergsgreuth, Germany). The water
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solubility of received extracts and the effect of 1 mg/ml of each PFS extract on
glucose transport was analysed using Caco-2 cells, and based on those results the
supplements were chosen.
1.2.1 Composition and protective health effects of Green tea
Camellia sinensis is the plant species of green tea and the leaves of the tea are
roasted at a high temperature to inhibit polyphenol oxidation. Green tea has the
highest concentration of flavanol content compared to other teas (Cai and Chow,
2004), which is given in
Table 2. Catechins, which are the major compounds of green tea, are phenolic
compounds that are contained in dietary supplements (Weiss et al., 2006). The
common catechins in all green teas are EGC, C, EGCG, EC and ECG
Table 2. Narotzki et al. (2012) reported that 59% of the total catechins in green
tea is EGCG with 19% of EGC, 13.6% of ECG and 6.4% of EC. One cup (240
ml) of brewed green tea contains up to 200 mg EGCG (Mukhtar and Ahmet,
2000).
- 8 -
Table 2. Polyphenol content of green tea (Cabrera et al., 2003).
Class Polyphenol
Flavan-3-ols (-)- epicatechin
(-)- epicatechin-3-gallate
(-)- epigallocatechin
(-)- epigallocatechin gallate
(+)- catechin
(+)- gallocatechin
theaflavin
theaflavin-3-3’-digallate
theaflavin-3’-gallate
theaflavin-3-gallate
thearubigins
Flavones apigenin
luteolin
Flavonols kaempferol
myricetin
quercetin
Others gallic acid, chlorogenic acid, caffeic acid
Polyphenols are antioxidants. In vitro studies showed that green tea polyphenols
could be direct antioxidants by scavenging reactive oxygen species or chelating
transition metals and may act directly by up-regulating phase-II antioxidant
enzymes. EGCG and ECG have the highest ROS activity (Henning et al., 2004;
Foster and Lambert, 2011). Armoskaite et al. (2011) analysed green tea from
three different regions (Japan, China and Sri Lanka). They reported that green
tea from China has the highest polyphenol content while Sri Lanka has lowest.
Green tea from Japan was reported as having the highest antioxidant capacity
while Sri Lankan tea had the lowest (Armoskaite et al., 2011). Thus,
standardization (EGCG and EGC levels) should be implemented on commercial
GTDS or GTDS should be biologically standardized according to antioxidant
capacity (Seeram et al., 2006).
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Figure 2. Chemical structures of green tea catechins.
1.2.1.1 Absorption of polyphenols and green tea catechins
Polyphenol absorption and metabolism are affected by their chemical structure,
such as conjugation with other phenolics, molecular size, degree of
polymerisation and solubility (Bravo, 2008). However, the absorption and
metabolism of all flavonoids (from the poorly absorbed anthocyanins to the well-
absorbed isoflavones) are following the same pathways (Williamson et al., 2000).
The concentration of flavonoid metabolites in the plasma is between 0 to 4 µM
with an intake of 50 mg aglycone equivalents (Manach et al., 2005), and in many
human studies it did not exceed 1 µM.
The absorption of flavonoids occurs in the small intestine; however, depending
on their ingested form it can also take place in the large intestine or stomach
(Jagannath et al., 2006). Deglycosylation is the initial step for the absorption
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process of glycosylated flavonoids, which is essential if further metabolism
exists (Williamson et al., 2000). They are conjugated by intestinal enzymes and
transported to the serosal or mucosal sides (Williamson, 2004). Deglycosylation
can potentially occur at several sites in the duodenum and jejunum:
(1) within the intestinal lumen;
(2) brush border hydrolases; or
(3) intracellular hydrolases after transport of the flavonoid into the enterocyte
(Day et al., 2003; Williamson, 2004; Farrell et al., 2013).
The absorption of flavonoids occurs in two pathways as shown in Figure 3
(Williamson, 2004).
Figure 3 Absorption and metabolism of flavonoid glucosides in the small
intestine.
The first step utilises an enzyme, lactase phlorizin hydrolase (LPH), which is
found in the brush border of the small intestine, to catalyse deglycosylation of
glycosylated flavonoids. LPH is an enzyme that hydrolyses lactose and is located
in the brush border of the small intestine (Williamson, 2004). Aglycones, which
are the product of the deglycosylation reaction, can then diffuse into epithelial
cells in two ways: passive or facilitated diffusion (Williamson, 2004).
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An alternative step is flavonoid glycoside transport into the enterocyte via the
function of a sugar transporter such as SGLT1. After deglycosylation, flavonoid
glycosides are hydrolysed by β-CBG to flavonoid aglycones (Gee et al., 2000;
Williamson, 2004; Wolffram et al., 2002). Some polyphenols, which are not
absorbed in the small intestine, will pass to the colon and will be metabolised by
gut microflora. Flavonoid aglycones are substrates for colonic bacteria forming
phenolic acids. It was estimated that about 90 to 95% of total polyphenol intake
will be accumulated in the large intestine up to the millimolar range and
metabolised by gut microflora into the low molecular weight phenolic
metabolites (Cardona et al., 2013). Flavonoids linked with rhamnose are
absorbed in the large intestine after degradation by the gut microbiota
(Bifidobacterium dentium) (Marin et al., 2015). After biliary excretion, green tea
flavonoids are further metabolised to phenolic acids by colonic bacteria.
Gonthier et al., 2003 reported that among catechin metabolites are
hydroxyphenylpropionic acid, hydroxybenzoic acid, hydroxyhippuric acid,
hippuric acid, p-coumaric acid, vanillic acid and hydroxyphenylacetic acid in the
colon. (-)- Epicatechin and procyanidin B2 are broken down into a mixture of
phenolic acids with 5-valeric acid, 3-propionic acid and phenylacetic acid as the
major catabolites (Stoupi et al., 2009). These catabolites are absorbed into the
circulation often at greater quantities compared to their parent aglycones.
Williamson (2004) reported that both free and conjugated flavonoids in the colon
can re-enter the enterohepatic cycle before being further metabolised. The
conjugated form of green tea flavonoids has been found in plasma and urine.
Henning et al. (2013) reported a human green tea intervention study. After
consumption of 6 cups of green tea daily for 3 to 6 weeks, it was found that only
phenolic acids (3,4-dihyroxyphenylacetic acid and 4-hydroxyphenylacetic acid)
significantly changed compared to baseline plasma.
Following the absorption of the aglycones or final derivatives (in the small
intestine or colon), this undergoes some degree of phase II metabolism (UGTs,
SULTs and COMT). UGTs, SULTs and COMT are the important metabolic
enzymes for the conjugation of flavonoids (Day et al., 2000; Boersma et al.,
2002). The multiple hydroxyl groups in flavonoids are the major targets for
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conjugation by human metabolic enzymes. The initial step of flavonoid
conjugation takes place in the small intestine. UGT1A1 and UGT1A8, and
SULT1A1 and SULT1A3 enzymes are responsible for the conjugation of green
tea polyphenols in the small intestine. Following the conjugation of flavonoids in
the small intestine, they are transferred to the liver by the bloodstream and may
be subjected to more metabolic enzymes before being transported to the blood
stream again until excretion takes place in the urine or bile. UGT1A9 and
SULT1A1 enzymes are involved in modifications of green tea polyphenols in the
liver (Pai et al., 2001; Williamson, 2004; Lambert et al., 2007).
The study by Williamson et al. (2005) showed that flavonoids are extensively
metabolized during absorption, resulting in the glucuronide, sulfate and methyl
conjugates being the predominant metabolites present in human plasma. The
physiochemical properties of conjugated flavonoids found in the plasma are
different to the aglycone forms. As methylation improves lipid solubility, most
flavonoids found in the plasma are also conjugated with glucuronic acid or
sulfate, which dramatically enhances hydrophilicity and molecular weight.
1.2.1.2 Protective health effects of green tea
The studies on the health benefits of green tea facilitate investigation on the
green tea extracts production (Seeram et al., 2006). There are many in vitro and
in vivo assessments reported in the literature for the consumption of green tea.
Green tea shows benefits in more than one element of metabolic syndrome and
some of these researches are summarized below.
According to studies in cell lines and animal models, tea flavanols have
antiproliferative, antiangiogenic and anticarcinogenic activities. For example,
Steffen et al. (2008) reported that the NADPH oxidase activity in HUVEC cells
is inhibited by tea catechin and epicatechin, decreases the generation of
endothelial superoxide, and potentially promotes nitric oxide longevity. The
Hooper et al. (2008) study showed that green tea consumption significantly
reduced LDL cholesterol. Also, in other researches, green tea has been shown to
have positive effects on bone health (Dew et al., 2007), arthritis (Ahmed, 2009)
and cognitive function and neuroprotection (Bastianetto et al, 2008; Nathan et
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al., 2009). The popularity of consumption and the absence of toxicity in tea may
make it a strong candidate for use in cancer prevention (Henning et al., 2004;
Sturgeon et al., 2009).
The level of obesity is increasing worldwide and it is one of the leading
preventable causes of death. Hence, to promote weight loss and maintain weight,
the use of green tea is common. Some studies show that green tea catechins with
caffeine are effective in weight loss and maintaining weight (Hursel et al., 2009;
Phung et al., 2010).
According to the in vivo and in vitro studies above, there needs to be more
research with regards to the beneficial effects of green tea consumption.
1.2.1.3 Bioavailability of green tea catechins
The FDA defines bioavailability as “the rate and extent to which the active
ingredient or active moiety is absorbed from a drug product and becomes
available at the site of action.” The biological effects of polyphenols depend on
their bioavailability. The bioavailability of polyphenols is affected by their
absorption, metabolism and excretion processes (Jagannath et al., 2006). Also,
polyphenol absorption and metabolism are affected by their chemical structure.
Bravo (2008) states that the degree of glycosylation, acylation, their basic
structure (e.g. benzene or flavones derivatives), conjugation with other phenolics,
molecular size, degree of polymerization; pH and solubility also affect the
bioavailability of polyphenols. Changes in pH affect the degradation of green tea
catechins (these are stable at low pH and degradation is rapid at neutral or above
pH). As the stomach has a low pH (1-3, gastric juice), catechin stability is
unaffected; however, in the intestine the pH is ~7-8 (pancreatic juice), and
therefore the stability of catechins is greatly reduced (Chen et al., 1998; Desesso
and Jacobson, 2001). Ferruzzi (2010) reported that when the catechins reach a
neutral pH in the intestine, there is ~ 80% of loss.
There are other studies regarding the effect of adding other food constituents to
catechins on the absorption of green tea catechins. Chen et al. (1998) reported
that the stability of green tea catechins improved in the presence of ascorbic acid
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at neutral pH. In a human intervention study it was reported that the consumption
of cocoa with bread and sugar increased the bioavailability of catechins and
epicatechins (Schramm et al., 2003). Peters et al. (2010) observed the
bioavailability of green tea in ascorbic acid- and sucrose-fed rats and found that
the bioavailability of catechins was improved. Egert et al. (2013) studied the
plasma catechins of 24 volunteers who consumed decaffeinated green tea with
the addition of protein (skimmed milk, casein or soy milk). It was observed that
the bioavailability of total catechins was reduced. Therefore, the addition of
other food constituents may influence the bioavailability of catechins.
1.2.2 Chamomile composition and protective health effects
Chamomile belongs to the daisy family called Asteraceae or Compositae (Khan
et al., 2014) and it is represented by the two most known varieties, German
chamomile (Matricaria recutita) and Roman chamomile (Chamaelum nobile).
German chamomile is the most common variety used for medical purposes
(Srivastava and Gupta, 2007). It consists of the fresh or dried flower heads of
Matricaria recutita and their preparations. Chamomile contains several bioactive
phytochemicals that could provide therapeutic effects; therefore, it is used as a
herbal medication from the ancient times till today. Srivastava et al. (2010)
reported that chamomile was traditionally used for centuries to treat ulcers,
wounds, eczema, gout, haemorrhoids, ear and eye infections, cracked nipples,
chicken pox, diaper rash and nasal inflammation.
It was reported that chamomile contains ~120 secondary metabolites including
28 terpenoids and 36 flavonoids, such as apigenin, quercetin, patuletin as
glucosides, and various acetylated derivatives (Srivastava et al., 2010). Both
species contains flavonoids (apigenin, luteolin, patuletin, and quercetin),
coumarins (herniarin, umbelliferone) and hydroxycoumarins and are considered
to be major bioactives in chamomile (Srivastava et al., 2010). Apigenin is
present in very small quantities as free apigenin, but predominantly exists in the
form of various glycosides (Srivastava et al., 2010). Other common flavonoids
are luteolin glucosides, quercetin glycosides and isohamnetin. McKay and
Blumberg (2006) reported that chamomile has high levels of polyphenol content,
such as flavonoids and coumarins. Approximately 0.1% of the total constituents
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are coumarins, umbelliferone and esculetin (McKay and Blumberg, 2006). In
another study, cinnamic acid derivatives, ferulic and caffeic acid were found in
large amounts (39%) (Mulinacci et al., 2000). Due to the equipment (GC-MS,
ESI/-MS, LC-MS2) or methods (in organic solvent or water solubility) that were
used to analyse the composition of chamomile some differences in the results
emerged (Ignat et al., 2011; Lin and Harnly 2012). However, the major
component of chamomile (flowers and plant) was reported as apigenin in many
studies except Mulinacci et al. (2000). It was reported that the major polyphenols
in chamomile are ferulic and caffecic acid (Table 3). See Table 7 for the
composition of chamomile is presented in detail.
Table 3 Polyphenol content of German chamomile (McKay and Blumberg,
2006).
Polyphenol Percentage of total polyphenols
Apigenin 16.8
Luteolin 1.9
Quercetin 9.9
Patuletin 6.5
Hydroxycoumarins 0.1
Ferulic and caffeic acid 39.1
Unidentified phenolic derivatives 25.8
The medical benefits and widespread use of chamomile enables chamomile tea
to be perceived as a popular tea, with consumed over one million tea cups
consumed per day (Srivastava and Gupta, 2007).
1.2.2.1 Absorption of chamomile flavones; apigenin-7-glucoside
Apigenin-7-O-glucoside (A7G) is deglycosylated to apigenin in the intestine
once it is absorbed (LPH or SGLT1) from the intestinal tract and then
metabolized to UGT or SULT conjugates. Also, by the gut microflora, apigenin
is further cleaved to 3-(4-hydroxyphenyl) propionic acid. Hanske et al. (2009)
analysed the bioavailability of A7G in germ-free and human microbiota-
associated (HMA) rats. They reported the main metabolites of A7G as apigenin,
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naringenin and 3-(4-hydroxyphenyl) propionic acid, detected both in urine and
faecal suspension. However, in whole blood samples, only apigenin conjugates
and phloretin were detected. Chen et al. (2002) reported that apigenin is
metabolised rapidly by UGT1A1 in the HepG2 cell line. After conjugation, the
metabolites circulate in the blood and are then excreted into the bile and urine.
Apigenin is rapidly glucuronidated in both human and mouse liver microsomes
and the rate of glucuronidation is faster than sulfation (Nielsen et al., 1999).
Chen et al. (2007) reported the urinary excretion of apigenin in rats and found
that the concentration of apigenin was low in urine. Therefore, they assumed that
more apigenin may be metabolized to simple compounds (glucuronidated and
sulphated apigenin) in the gut and absorbed, and may be further metabolised in
the liver. They also detected apigenin in plasma. Lu and colleagues (2011)
reported that apigenin in plasma, urine and bile was found mainly in conjugated
form. Zhang and colleagues (2012) reported that the absorption of apigenin
mainly occurs in the duodenum part of the intestine and the in vivo intestinal
absorption may be through either passive transport in the ileum and colon
segments or active carrier-mediated transport both in the duodenum and jejunum
segments. Hu and colleagues (2003) analysed the intestinal disposition of
apigenin metabolism in the Caco-2 cell line. They concluded that glucuronidated
apigenin and apigenin sulphate conjugates were biotransformed in the cells and
transported back to the apical compartment mainly by MRPs and possibly OATs.
Teng and colleagues (2012) analysed the absorption and initial metabolism of
apigenin using the intestinal perfusion model in situ. They found that 29% of the
administered apigenin was transported back to the vascular side. They also
reported the percentage concentration of apigenin glucoronides, sulphates and
free apigenin, as 9, 4 and 16% at the vascular side respectively.
1.2.2.2 Protective health effects of chamomile
The Srivastava et al., (2009) findings demonstrate that apigenin glucosides enter
into the cancer cells and are actively hydrolysed within the cells (Srivastava, et
al., 2009). The cancer cell growth rate is reduced by apigenin glucosides via the
deconjugation of glycosides (Srivastana et al., 2009). Using German chamomile
as a mouthwash has some benefits in plaque and gingival reduction. Pourabbasa
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and colleagues (2005) reported that compared to the control rinse (p≤0.001),
German chamomile mouthwash significantly decreased both plaque and
gingivitis without an adverse effect on teeth staining. One of the animal model
studies indicated an antipruritic effect of German chamomile (Pourabbasa et al.,
2005). In mice, the compound 48/80-induced scratching behaviour significantly
decreased after feeding them for 11 days with GC (Kobayashi et al., 2003).
German chamomile was offered as a herbal tea (vervain, liquorice, fennel, balm
mint) to children to observe the treatment of colic (Gardiner, 2007). After 7 days
of treatment (each day <150 ml/dose, no more than three times) the parents
reported that tea eliminated the colic in 57% of cases, whereas the placebo
helped only 26% without any adverse effect (Gardiner, 2007).
Rafraf and colleagues (2014) studied 64 individuals with type-2 diabetes in a
single blind randomized controlled trial. They consumed 3g chamomile/150ml
hot water three times for 8 weeks straight after meals. They reported that
chamomile tea significantly reduced serum insulin levels. Kato and colleagues
(2008) reported the inhibition of rat intestinal maltase and sucrase activities in
the presence of chamomile and some of the active components of chamomile.
Chamomile extract inhibited maltase and sucrase activity with an IC50 value of
2.6 and 0.9 mg/ml respectively. Cemek et al. (2008) observed the effect of the
chamomile ethanolic extract (70 mg/kg body weight) on hyperglycemia using
streptoztocin (STZ)-induced diabetic rats. They found that treatment with
chamomile extract significantly reduced post-prandial hyperglycemia. Emam
(2012) analysed the antidiabetic activities of the water extracts of Rosmarinus
Officinalis and Matricaria recutita (200 mg/kg for 21 days) using STZ-induced
diabetic rats. They found a significant decrease in the fasting blood glucose level.
The Ramadan et al. (2012) study also supported that the water extract of
chamomile has a potential to reduce the blood glucose level of STZ-induced
diabetic rats (100 mg/kg for 21 days). Another recent study also analysed the
hyperglycaemic effect of the ethanolic extract of chamomile using STZ-induced
diabetic rats (500 mg/kg for 4 weeks) (Al Musa and Al Hashem, 2014). They
found a reduction in blood glucose level without improving insulin levels.
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Liang and colleagues (1999) analysed the anti-inflammatory activity of apigenin
and found that COX-2, PG and nitric oxide production was inhibited by apigenin
in lipopolysaccharide-activated macrophages. McKay and Blumberg (2006) also
reported that apigenin and quercetin showed the highest inhibitory activity of
histamine release from human basophils, 89 and 96% respectively, at a
concentration of 50 µM. This study showed that chamomile’s active components
have the potential of an anti-allergenic activity by inhibiting the antigen-induced
histamine release from basophils.
Savino and colleagues (2005) investigated the effect of chamomile consumption
for the treatment of intestinal colic in breastfed infants (randomized, double-
blind, placebo-controlled trial). Infants were fed with the herbal mixture extract
containing 71 mg/kg/d chamomile or the placebo for one week and it was found
that the colic improved after consumption of the herbal extract. Another
supportive double-blind human intervention study reported that infants fed with
the herbal mixture containing chamomile had a significantly higher intestinal
colic improvement (57%) compared with the placebo (26%) (Weizman et al.,
1993).
Srivastava and Gupta (2009) analysed the anticancer properties of methanolic
and aqueous extracts of chamomile. Chamomile showed anti-proliferative and
apoptotic activity in human cancer cells. They also found that apigenin
glucosides entered the cancer cells and were effectively hydrolysed within them.
Using the BT-474 human breast cancer cell line it was reported that the ethanolic
extract of the chamomile gel capsules showed weak estrogenic and
progestational activity; however, they did not exhibit androgenic activity
(Rosenberg Zand et al., 2001).
In brief, those researches showed that German chamomile exhibits different
health benefits.
1.2.2.3 Bioavailability of chamomile flavones; apigenin-7-glucoside
The biological effects of polyphenols depend on their bioavailability. As
explained previously in chapter 1 section 1.2.1.3, polyphenol’s absorption and
metabolism are affected by their chemical structure (Bravo, 2008) and food
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matrix (Manach et al., 2004). Hanske and colleagues (2009) investigated the
influence of human intestinal microbiota on the bioavailability of A7G and they
concluded that human microbiota have a big impact on A7G metabolism. Wen
and Walle (2006) analysed the effect of structure on the bioactivity of dietary
polyphenols in comparison with methylated and unmethylated polyphenols using
the human liver S9 fraction and the Caco-2 cell line. They concluded that the
combined use of the hepatic S9 fraction and Caco-2 cells has promising results
on the oral bioavailability of dietary polyphenols. Methylated polyphenols were
more attractive than unmethylated polyphenols for intestinal absorption and
hepatic metabolic stability. Manach and colleagues (2004) reported that plant
foods generally contain both dietary fiber and polyphenols. Dietary fiber intake
improves the microbial metabolites in the intestine. Therefore, the bioavailability
of polyphenols may have an effect without a food matrix, and food that is
consumed with polyphenols affects their absorption and plasma concentration
levels.
1.2.3 Vitis Viniferae composition and protective health effects
The biological effects of polyphenols depend on their bioavailability. As
explained previously in chapter 1 section 1.2.1.3, polyphenol’s absorption and
metabolism are affected by their chemical structure (Bravo, 2008) and food
matrix (Manach et al., 2004). Hanske and colleagues (2009) investigated the
influence of human intestinal microbiota on the bioavailability of A7G and they
concluded that human microbiota have a big impact on A7G metabolism. Wen
and Walle (2006) analysed the effect of structure on the bioactivity of dietary
polyphenols in comparison with methylated and unmethylated polyphenols using
the human liver S9 fraction and the Caco-2 cell line. They concluded that the
combined use of the hepatic S9 fraction and Caco-2 cells has promising results
on the oral bioavailability of dietary polyphenols. Methylated polyphenols were
more attractive than unmethylated polyphenols for intestinal absorption and
hepatic metabolic stability. Manach and colleagues (2004) reported that plant
foods generally contain both dietary fiber and polyphenols. Dietary fiber intake
improves the microbial metabolites in the intestine. Therefore, the bioavailability
of polyphenols may have an effect without a food matrix, and food that is
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consumed with polyphenols affects their absorption and plasma concentration
levels.
1.2.4 Vitis Viniferae composition and protective health effects
One of the most widely grown fruit crops in the world is Vitis Viniferae and it
belongs to the Vitaceae family (Giribabu et al., 2014). The polyphenolic
composition of Vitis Viniferae leaves has been analysed by several researchers
and they are rich sources of anthocyanins, hydroxycinnamic acids, flavanols
(catechin, epicatechin and epigallocatechin) (Shi et al., 2003) and flavonol
glycosides and stilbenes, such as resveratrol (Monagas et al., 2006; Roopchand
et al., 2013; and Kammerer et al., 2014). Aqueous extract of leaves contains
flavonols, hyroxycinnamic acid and catechins. It was also reported that the skin,
stems and seeds of the Vitis Viniferae are an important source of PROs. While
seeds contain procyanidins polymers (catechin, epicatechin and ECG), the skin
and stems contain prodelphinidins (EGC, EGCG, gallocatechin) (Monagas et al.,
2006).
Due to the polyphenol content of Vitis Viniferae, it has several pharmacological
uses, such as an antidiabetic and antioxidant (Saada et al., 2006; Orhan et al.,
2011), antimicrobial (Delgado-Adamez et al., 2011; Oliveira et al., 2013),
anticarcinogenetic (Yi et al., 2005; Mertens-Talcott et al., 2006; Sharma et al.,
2012) and an inhibitor of platelet aggregation and low density lipoprotein (LDL)
oxidation (Castilla et al., 2006; Shanmuganayagam et al., 2012).
Giribabu and colleagues (2014) investigated the effect of Vitis Viniferae seeds on
carbohydrate-metabolizing enzymes and the other enzymes in the liver in
diabetes using STZ-diabetic male rats (fed with 250 and 500 mg/kg/day Vitis
Viniferae seed ethanolic extract for 28 days). They concluded that Vitis Viniferae
may help to protect the liver in diabetics by decreasing liver oxidative stress.
Pandey and Rizvi (2014) reviewed the effect of quercetin, myricetin and
resveratrol obtained from red grapes on diabetes and observed that under diabetic
conditions they protect against high glucose-induced oxidative stress.
Normal, glucose-hyperglycaemic and STZ-induced diabetic rats were fed with
an aqueous extract of Vitis Viniferae (250 and 500 mg/kg for 15 days) to
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investigate the extract’s acute and subacute hypoglycaemic and
antihyperglycaemic effects. They reported that the Vitis Viniferae extract has
significant antihyperglycaemic and antioxidant activity compared to the positive
control, tolbutamide, in diabetic rats (Orhan et al., 2006). Banini et al. (2006)
observed the effect of muscadine grape juice (MJ), muscadine grape wine (MW)
and dealcoholized muscadine grape wine (dMW) on the blood glucose levels of
healthy and type-2 diabetic subjects over 28 days. Daily intake of 150 ml of MW
and dMW consumption with meals decreased blood glucose levels compared to
diabetics administered with MJ.
1.2.5 Pelargonium composition and protective health effects
Pelargonium belongs to the Geraniaceae family and contains ~280 species that
are mostly grown in South Africa (Mabbereley, 1997). Pelargonium contains
essential oils, flavonoids, tannins and phenolic acids (ellagic acid, isoquercetrin,
quercetrine, kaempferols, caftaric acid and rutoside) (Lalli et al., 2006; Kokalou
and Souleles, 1988; Kolodziej et al., 1995; Contour and Louguet, 1985; Avila et
al., 2013). Pantev and colleagues (2006) also reported on myricetin, apigenin and
catechin in Pelargonium sanguineum. Due to its polyphenol content, Bown,
(1995), Brendler and Wyk (2008) and Avila and colleagues (2013) indicated that
it was traditionally used for ulcers, whooping cough, kidney pain, staunch
bleeding, heal wounds, uterine haemorrhage, diarrhea and skin disorders. The
essential oil of Pelargonium has also been used traditionally as an antiallergenic,
antioxidant, antiviral, antibacterial, antidiarrhetic, antihepatotoxic, stomachic and
antidiabetic (Brendler and Wyk, 2008; Boukhris et al., 2012). Boukhris and
colleagues analysed the effect of pelargonium leaf oil on hyperglycaemia using
alloxan-induced diabetic rats, and concluded that the essential oil of
Pelargonium may be helpful in the management of diabetes. The essential oil of
Pelargonium was traditionally used in the treatment of inflammation,
haemorrhoids, diarrhea, gastric ulcers, liver problems, diabetes and urinary
stones (Slima et al., 2013). Lizogub and colleagues (2007) conducted a
randomized, placebo-controlled double blind trial of 103 adults to observe the
effect of the Pelargonium sidoides liquid drug for the common cold and found
that the symptoms and duration of the common cold was shorter compared to the
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placebo. Koutelidakis and colleagues (2008) analysed the total antioxidant
capacity (TAC) of plasma and organs using mice that were fed with
Pelargonium purpureum (8 g/100 ml of water). It was found that this increased
the TAC in the plasma and lungs. The antioxidant effects of Pelargonium radula
were investigated by researchers (using DPPH free radical, reducing power and
LDH leakage assays) and reported that due to its promising antioxidant capacity,
the leaf extract may have a role in the management of diabetes (Latte and
Kolodziej, 2004; Lalli et al., 2008; Karagozlera et al., 2008; Petlecski et al.,
2012). The antidiabetic effect of the extract was only analysed due to its essential
oil content, not because of its polyphenol content.
1.2.6 Echinacea composition and protective health effects
Echinacea is one of the most commonly consumed plants, with nine species in
North America. For medicinal use, Echinacea angustifolia, Echinacea pallida
and Echinacea purpurea species are preferred (Mishima et al., 2004;
Vimalanathan et al., 2005; Shah et al., 2007; Georgieva et al., 2013). While the
FDA approves it as a food, the Federal Bureau of Health (Germany) recognizes
it as a medicine (Mishima et al., 2004). In the current study, Echinacea purpurea
was used to analyse the transport of carbohydrates across the Caco-2 cell
monolayer. There are ~800 products (tablets, extracts, juice and tea) present in
Europe using different parts of Echinacea purpurea or with different extraction
and formulation used as a herbal medicine (Shah et al., 2007; Georgieva et al.,
2014).
The polyphenolic composition of Echinacea has been reported as caffeic acid
derivatives (cichoric acid, caftaric acid, chlorogenic acid, caffeic acid, cynarin,
echinacoside) and ferulic acid derivatives (Perry et al., 2001; Pellati et al., 2005;
Georgieva et al., 2014). Echinacea is commonly used as a cold and flu treatment
(Barrett, 2003; Lee at al., 2006). The phenolic acid composition of Echinacea
supports immunostimulatory properties, promotes in vitro and in vivo phagocyte
activity, shows anti-inflammation activity and inhibits free radical production
and lipid peroxidation (Linde et al., 2006; Georgieva et al., 2014). Vimalanathan
et al. (2005) reported that Echinacea purpurea has antiviral activity due to its
caffeic acid content. Lee et al. (2006) reported that the Echinacea species
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inhibited P450 enzymes in vitro and, therefore, it may increase antiretroviral
drug concentrations. Aherne et al. (2007) analysed the effect of Echinacea
purpurea extracts on the viability, membrane integrity, antioxidant activity and
DNA integrity of Caco-2 cells and compared the results with rosemary, oregano
and sage extracts. The authors indicated that Echinacea had the lowest toxic
effect with an IC50 value of 1421 µg/ml.
Ryan and colleagues (2001) indicated the Echinacea, garlic, herbal mixtures and
glucosamine were the most commonly consumed alternative medicine for
diabetes. Also, Dannemann and colleagues (2008) and Villa-Caballero and
colleagues (2010) indicated that Echinacea was used as an alternative medicine
for type-1 diabetes between type-1 diabetic patients. Delorme and Miller used
non-obese diabetic (NOD) mice as a model for human type-1 diabetes and fed
them with Echinacea. Due to its immune-stimulation effect of NK cells, it may
be used in the management of type-1 diabetes (Delorme and Miller, 2005). To
our knowledge, this is the first time the potential effects of Echinacea have been
studied and reported in the literature on diabetic complications.
1.3 Carbohydrate metabolism and diabetes
1.3.1 Carbohydrates
Carbohydrates are the most important energy-containing components of the diet.
They cover 56% of the usable energy in a diet of 12,500 kJ daily (Paulev &
Zubieta, 2004). Carbohydrates are classified into 4 groups: mono-, oligo- and
poly-saccharides, and their derivatives (Lindhorst, 2003). Oligo- and poly-
saccharides are synthesised from mono-saccharides (two or more joined
together), which are catabolised during digestion to the mono-saccharide form in
order to provide energy. Nutrients occur from food degradation followed by
absorption in the small intestine or bacterial fermentation in the large intestine.
Sucrose, maltose and isomaltose are examples of disaccharides synthesised by
the reaction between glucose and fructose and two glucose units respectively.
The difference between maltose and isomaltose is the position of glycosidic links
between glucose molecules, and is shown in Figure 4. Hydrolysis of sugars
(sucrose, isomaltose and maltose) by digestive enzymes
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Sucrose, maltose and isomaltose are hydrolysed by sucrase, maltase and
isomaltase enzymes respectively located in the small intestine. One glucose and
one fructose unit (α-1,2 glycosidic bond) make up one sucrose molecule, Mw 
342.3. Two glucose units with an α-1,4 and α-1,6 linkage comprise maltose and 
isomaltose respectively.
The enzymatic hydrolysis of sucrose is catalysed by sucrase (EC 3.2.1.48) in
humans. This enzyme is located at the luminal surface of enterocytes and is
expressed by microvillus cells (Marieb, 2004; Beaulieu et al., 1989). Gasteiger
et al. (2003) reported that there are two enzymes present which catalyse sucrose
hydrolysis directly: sucrose α-glucosidase (EC 3.2.1.48) and β-
fructofuranosidase (EC 3.2.1.26). Maltose is catalysed by α-glucosidase (EC 
3.2.1.20) and sucrose α-glucosidase (EC 3.2.1.48). Oligo-1,6 glucosidase (EC 
3.2.1.10) catalyses the action of isomaltase, which is responsible for the
hydrolysis of maltose and isomaltose. The active site of sucrase hydrolyses the
α-1,2 and α-1,4 glycosidic bonds. 
Figure 4 Structure of sucrose, maltose and isomaltose.
1.3.1.1 Transport mechanism of glucose and fructose
Mono-saccharides are transported by active transport via the sodium-dependent
glucose transporter SGLT1, and by facilitated sodium-independent transport via
the glucose transporter GLUT2 (Goodman, 2010). The primary glucose carrier is
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SGLT1, which is a protein composed of 664 amino acid residues (Wright et al.,
2011; Turk et al., 1996). GLUT2, composed of 554 amino acids, can be recruited
into the apical membrane to assist SGLT1 uptake of glucose when high
concentrations of glucose are present in the intestinal lumen (Ait-Omar et al.,
2011). At low luminal concentrations, SGLT1 transports glucose against a
concentration gradient with a K0.5 (substrate concentration of half saturation-
affinity) of 0.5 mM (Wright et al., 2011). Two Na+ molecules bind to SGLT1 to
permit glucose binding to the transporter (Jiang et al., 2012). After binding to
SGLT1 on the luminal side of the intestinal brush border membrane, a
conformational charge occurs that allows glucose binding. The second
conformational charge allows glucose and Na+ to enter the enterocytes (Figure 5)
(Goodman, 2010). Glucose is released from the enterocyte via the GLUT2
passive transporter at the basal surface and enters the circulation, and the process
of uptake and expulsion is simultaneous and continues until the concentration of
glucose within the cell is <30,000 times that of the intestine (Figure 5)
(Goodman, 2010; Nelson and Cox, 2000). Fructose enters and exits the cells via
facilitated diffusion. Mono-saccharides generate adenosine triphosphate (ATP)
to provide cellular energy (Marieb, 2004). The detailed transport mechanism for
each sugar is given in the related chapters.
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Figure 5 Absorption of carbohydrate (adopted from Paulev & Zubieta, 2004).
GLUT2 trafficking from basolateral to apical is depending on glucose [G]
concentration.
1.3.2 Carbohydrate-related diseases
Carbohydrate-restricted diets are becoming popular for weight loss, while the
prevention of obesity also encourages people to consume more animal products.
However, the use of low carbohydrate diets may increase the risk of CVD due to
the high amount of saturated fat and cholesterol associated with the consumption
of animal products (Foster et al., 2003; Holton et al., 2006). Hauner and
colleagues (2012) reported that high carbohydrate consumption increased total
and LDL cholesterol but reduced HDL cholesterol.
Holton and colleagues used the data from 82,802 women in the Nurses’ Health
Study to analyse the relationship between a low carbohydrate diet and coronary
heart disease. It was found that a low carbohydrate diet, and higher protein and
fat intake were not related with increased risk of coronary heart diseases in
women. Also, the risk of coronary heart diseases in women was reduced when
the source of fat and protein was from vegetables (Holton et al., 2006). Park and
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colleagues (2008) analysed the relationship between carbohydrate intake and
CVD with the data from the third Korea National Health and Nutrition
Examination Survey (1536 men and 2235 women). It was reported that in
women, high intake of carbohydrates increased the risk of higher BMI, blood
pressure, fasting glucose, triglycerides and LDL-cholesterol levels, but high
carbohydrate intake was inversely associated only with total cholesterol for men
(Park et al., 2008). Meyer et al. (2000) conducted a cohort study with 35,988
older Iowa women who did not have diabetes. After 6 years, the report of
diabetes incident was related to 1141 women. Meyer and colleagues concluded
that a diet that includes cereal fibre, grains and dietary magnesium prevents the
development of diabetes in older women.
Barclay and colleagues (2008) observed the relationship between glycaemic
index (GI), glycaemic load (GL) and the risk of chronic diseases. The
comparison of inconsistent findings in the literature showed that low GI/GL diets
were independently related with a reduced risk of chronic diseases but high post-
prandial glycaemia was found to be related with disease progression (Barclay et
al., 2008). Liese and colleagues (2005) analysed the relation of fibre intake, GI,
GL insulin sensitivity, fasting insulin, acute insulin response, disposition index,
BMI and waist circumference from the data of 979 adults with normal and
impaired glucose tolerance from the Insulin Resistance Atherosclerosis study
between 1992 and 1994. It was found that GI and GL might not be associated
with insulin sensitivity, insulin secretion and adiposity. Fibre intake has a
beneficial effect on pancreatic functionality. Higher intake of carbohydrates with
high GI increased the acute glucose and insulin response. Therefore, GI in the
diet has an important role in glucose metabolism, insulin secretion and insulin
resistance (Liese et al., 2005).
1.3.3 Type-2 diabetes
There are 346 million people suffering from diabetes worldwide (WHO, 2008).
This number is expected to double by the year 2030. Zhang and colleagues (2010)
reported that the cost of diabetes treatment in Europe is 10% of the total
healthcare costs ($196 billion) in Europe in 2010 and it is expected to rise to
almost $235 billion in 2030. Glucose is an important carbohydrate that plays a
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role in the development of diabetes. About 95% or more of all diabetics globally
have type-2 diabetes. Type-2 diabetes develops due to insulin resistance or/and
insulin deficiency. Type-2 diabetes is manifest when there is deficient or
impaired insulin signalling for effective blood glucose absorption resulting in
high blood glucose level although the sequence of events regarding insulin
signalling dysfunction is not clear (e.g. whether insulin deficiency stimulated
from β cell failure takes place first). Following the absorption of postprandial 
glucose in the blood (see Figure 5), it is transported to body cells via the
bloodstream. The pancreas (β-cells) secretes insulin to maintenance glucose 
homeostasis in the body. Following insulin secretion into the blood, GLUT4
move from the intracellular membrane pool to the plasma membrane and
enhanced glucose uptake into the muscle and adipose tissues. (Govers, 2014;
Leney and Tavare, 2009). To prevent or delay type-2 diabetes, the blood glucose
level needs to be controlled. Reducing the glucose in blood can occur in two
ways: one is inhibiting the digestive enzymes for glucose production (α-amylase 
and/or α-glucosidase) and the second is inhibiting the glucose transporters that 
have a role in glucose absorption. Diabetes increases the risk of heart disease and
complications which damage the kidney, retina and peripheral nerves
(Williamson and Carughi, 2010). Therefore, controlling the blood glucose level
will decrease the risk of those diseases and diabetes (Table 4, Table 5 and Table
6).
The normal blood glucose level in humans is ~4 mM (72 mg/dl) but after eating
a meal this begins to increase the blood glucose level temporarily to <7.8 mM
(140 mg/dl) (National Institute for Clinical Excellence, 2011). This increase
stimulates the secretion of insulin and excess glucose is taken up by muscle cells
and stored as glycogen (Nelson and Cox, 2000). By decreasing the blood glucose
levels to normal, the insulin level begins to fall. Type-2 diabetes causes a high
blood glucose level (hyperglycaemia) due to the lack of insulin production or the
fact that the insulin produced is enough but ineffective (insulin resistance)
(Nelson and Cox, 2000). The International Diabetes Federation reported
that >382 million people around the world have diabetes and this may rise
to >592 million by 2030, and 90% of all people will have type-2 diabetes. In the
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UK, it is assumed that ~750,000 people have type-2 diabetes and have not been
diagnosed while about 2.7 million are diagnosed (Diabetes, UK, 2012).
Therefore, lowering the blood glucose level via dietary intervention may assist in
the prevention of progression to type-2 diabetes. There are several in vitro and in
vivo studies which have explored such strategies and are discussed below.
Wilson and colleagues (2008) studied twelve healthy participants fed with
sucrose (35 g) and berries (150 g of purée made of bilberries, blackcurrants,
cranberries and strawberries providing ~800 mg polyphenols). Berries are a rich
source of anthocyanins, flavonols, proanthocyanidins and phenolic acids.
Participants who were fed without berries produced a different post-prandial
glycemic response compared to the subjects who were fed with berries (Wilson
et al., 2008). Zhong and colleagues (2006) investigated whether tea extracts had
the ability to affect carbohydrate absorption. The authors fed the human adult
volunteers with 50 g white rice and a beverage containing either black, green or
mulberry tea extract or a placebo. Then they measured the concentration of
breath hydrogen and carbon dioxide at regular intervals. The ingestion of tea
extracts significantly increased the breath hydrogen concentration compared to
the placebo. Breath hydrogen concentration is indicative of the quantity and
metabolic activity of anaerobic bacteria in the intestine.
Goodman (2010) analysed the glucose transporter in the presence of polyphenols
using Caco-2 cells and intestinal brush border membrane vesicles or everted
sacs. These studies claim that several flavonoids and phenolic acids can inhibit
glucose transport. Phytochemicals are known to interact with SGLT-1 for the
absorption of nutrients across the apical membrane of enterocytes (Buddington et
al., 2003). The phytochemical phloridzin is often used as a selective inhibitor.
Buddington and colleagues (2003) reviewed some polyphenols that have the
ability to reduce glucose uptake. By decreasing SGLT-1 activity, soy isoflavones
partly affect post-prandial glucose levels; tea polyphenols were shown to lower
the rate of glucose transport by non-specific binding to proteins; catechins and
other phytochemicals were able to change brush border fluidity, which
potentially influences the function of the transporters. Gao et al. (2007) studied
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the inhibitory effect on the α-glucosidase enzymes of maltase, sucrose and 
isomaltase by the fruits of Terminalia chebula (Retz.). Phenolic compounds were
extracted from the fruits and test samples with substrate (sucrose, maltose and
isomaltose), and crude enzyme solutions were incubated. The authors found that
the extracted polyphenols inhibited rat intestinal maltase activity; however, they
did not inhibit sucrase or isomaltase activity. They concluded that phenolic
compounds extracted from the fruits of Terminalia chebula (Retz.) may be
useful as a natural source of α-glucosidase inhibitor that can be utilised in the 
suppression of post-prandial hyperglycaemia in type-2 diabetes management.
1.4 Hydrolysis of amylopectin by human salivary α-amylase 
Carbohydrate-rich foods mainly contain starch in the human diet and they are
responsible for the high level of blood glucose after intestinal digestion of a
starch-containing meal. The hydrolysis of starch starts in the mouth with α-
amylase and as the enzyme is degraded in the acidic content of the stomach, it
has a minor role in the starch digestion and progress to the small intestine (Singh
et al., 2010). Salivary α-amylase catalyses starch to maltose, maltotriose and 
limits dextrins in the mouth (Butterworth et al., 2011). The gene encoding
salivary amylase, AMY1, is located on the short arm of the chromosome and the
gene encoding the enzyme with Mws of ~56 000. The N-terminus of salivary
amylase is blocked by a pyroglutamic acid residue and the total protein content
of saliva is between 0.1 to 10 mg/ml (Butterworth et al., 2011). Starch mainly
consists of amylose (linear polymer of α-D glucose units linked together with α-
1,4 glycosidic linkages and a degree of polymerisation (DP) ~500-6000 glucose
residues) or amylopectin (branched polymer of α-D glucose units linked together 
with α-1,4 and α-1,6 glycosidic linkages and a DP ranging from 3x105 to 3x106
glucose units). Salivary amylase is an endo-amylase and it hydrolyses at the α-
1,4 glycosidic bonds of the starch molecule, and different α-limit dextrins 
containing α-1,6 bonds are formed with amylopectin (Bijttebier et al., 2009).
Bread and cereal products, which are consumed daily, are rich in starch, which is
rapidly digested and absorbed after a meal. This can cause an increase in high
blood glucose level and insulin secretion. Nantanga and colleagues (2013)
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reported that different foods with starch content have a similar amount of blood
glucose level but the insulin level shows a difference.
The moisture content of starch (e.g. in cooking) has an effect on the salivary
amylase activity. Low moisture processing starch allows amylase to show
activity on fewer polymer chains compared to high moisture processing. Lower
moisture content of starch is gelatinized primarily by helix-helix dissociation
followed by partial helix-coil dissociation. Therefore, the enzyme is able to
access the cluster chains more easily than raw starch. By contrast, a high
moisture content is gelatinized at the dissociation of helix-helix and helix-coil
and this allows salivary amylase to access and hydrolyse α-1,4 glycosidic bonds 
between unwound and cluster chains. By contrast, the enzyme more efficiently
hydrolyses molecules without a helical structure (Nantanga et al., 2013).
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Table 4 Summary of polyphenol rich food effect on glucose transport, uptake and inhibition of α-glucosidase and α-amylase enzymes (human 
intervention studies).
Analysed/ major
polyphenols
Plant Food Experimental model Type of interaction Effect Reference
Flavan-3-ols, theaflavins Black tea Healthy humans Oral glucose load black
tea
Late phase plasma glucose response
reduced but the insulin level increased.
Brayns et al.,
2007
Anthocyanins,
proanthocyanins
Bilberry,
blackcurrants,
cranberries and
strawberries
Healthy humans Randomised controlled
cross-over
Plasma glucose concentration
significantly lower than control (15 &
30 min).
Torronen et
al., 2010
Catechin, epicatechin,
procyanidin flavonoids
Chocolate Healthy subjects Oral glucose tolerance Protect against acute hyperglycaemia. Grassi et al.,
2005
Chlorogenic acid Coffee Overweight men Randomized crossover
trial
Glucose, insulin concentration reduced
significantly.
Van Dijk et
al., 2009
Catechins Green tea Type-2 diabetic
patients
Double blind control
study
Recovery of insulin secretory ability. Nagao et al.,
2009
Stilbene, quercetin,
resveratrol
Muscadine
grape
Type-2 diabetic
patients
Fasting glucose
concentration and
insulin level
Fasting blood glucose decreased blood
insulin glucose ratio increased.
Banini et al.,
2006
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Table 5 Summary of polyphenol rich food effect on glucose transport, uptake and inhibition of α-glucosidase and α-amylase enzymes (cell 
studies).
Analysed/ major
polyphenols
Plant Food Experimental model Type of interaction Effect Reference
Phloretin, quercetin,
apigenin, myricetin
- Caco-2 cells Na+-free / dependent Na+-dependent: no effect
Na+-free: glucose uptake reduced
Johnston et al.,
2005
Quercetin, myricetin,
isoquercetin
- Xenopus laevis
oocytes
GLUT2 expressed Xenopus
laevis oocytes
Complete inhibition of glucose
transport with 50 µM quercetin
Kwon et al., 2007
Apple, Strawberry Apple and
strawberry
Caco-2 cell
monolayer
Na+-free / dependent Q3R: 26%, phloridzin: 52%,
diCQA: 12%, P3G: 26%
Manzano and
Williamson 2010
C3R, P3R, quercetrin Acerola Caco-2 cells 3-O-[methyl-3H]-D-
glucose- uptake
IC50 Acerola: 0.2 mg/ml
Inhibitory effect of P3R higher than
Acerola
Hanamura et al.,
2006
Chebulagic acid Terminalia
chebula retz
Caco-2 and acetone
rat intestine extract
Glucose oxidase method Inhibited sugar digestive enzymes and
sucrose hydrolysis.
Huang et al., 2012
Catechin, EC, EGCG
,GCG, ECG
Pu-erh tea HepG2 cells Fluorescence- 485 nm Glucose uptake increased. Du et al., 2012
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Table 6 Summary of polyphenol rich food effect on glucose transport, uptake and inhibition of α-glucosidase and α-amylase enzymes (animal 
and in vitro studies).
Analysed/ major
polyphenols
Plant Food Experimental model Type of interaction Effect Reference
Phlorotannins  Ascophyllum  Porcine pancreatic α-
amylase
Acetone rat intestine
extract
p-hydroxybenzoic acid
α-D-glycopranoside  
IC50 α-amylase 0.1, α-glucosidase 20 
µg/ml GAE.
Nwosu et al.,
2010
Neoericitrin,
naringin, neo-
hesperidin
Bergamot Male Wistar rats Blood and faecal Decrease blood glucose level. Mollace et
al., 2011
Anthocyanins Blueberry C57/BI6 mice Fasting and postprandial
glucose
Reduced hyperglycaemia, body weight
gain, serum cholesterol
Roopchand et
al., 2013
Polyphenols, tannins Castenea
mollissima
spiny burs
STZ induced diabetic rats Glucose oxidase method Hypoglycaemic and hypolipidemic Yin et al.,
2011
Rutin, protocatechuic
acid
Cynidoscolus
chayamansa
STZ induced Wistar rats Fasting blood glucose
levels
Acute hyperglycaemic effect Loarca-Pina
et al., 2010
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Table 6 continued.
Analysed/ major
polyphenols
Plant Food Experimental model Type of interaction Effect Reference
CQA, diCQA,
feruloyl quinic acid
Coffee Acetone rat intestinal
sucrase and maltase
Glucose C2 test WAKO IC50 maltase 0.07 and sucrase 0.35
mg/ml.
Murase et al.,
2011
Eugenin, trapain,
1,2,3,6 tetra-O-
galloyl-β-D 
glucopyranose
Water chestnut
(Trapa
Japonica)
Human salivary α-amylase 
and α-glucosidase (acetone 
rat intestinal extract)
α-amylase: DNS 
α-glucosidase: Glucose 
C2 test WAKO test
IC50 α-amylase 53, maltase 159 and 
sucrase activity 654 µM.
Yosuda et al.,
2014
Chlorogenic acid,
cyanidin, quercetin
malonl-glucoside,
cyanidin malonl-
glucoside,
Lettuce High fat diet induced
C57BL/6 mice
Alphatrak glucometer No significant difference in plasma
glucose level.
Cheng et al.,
2014
Anthocyanins,
proanthocyanidins
Grape-soybean
flour complex
Hyperglycaemic C57BL/6J
mice
Glucometer Lower blood glucose level. Roopchand et
al., 2013
Ellagic acid,
quercetin
Muscadine  α -glucosidase from 
Saccharomyces cervisiae
α-D-glycopranoside  IC50 1.92 mg/ml. You et al.,
2012
Curcumin - Male Sprague Dawley rats 2-deoxy[3H] glucose Basal and insulin stimulated 2-
deoxyglucose uptake inhibited.
Green et al.,
2013
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1.5 Aim and objective
In order to prevent or delay type-2 diabetes, the blood glucose level needs to be
controlled. Polyphenols have been show to affect sugar metabolism. The aim of
this research is to investigate sucrase, maltase, isomaltase and human salivary α-
amylase inhibition by PFS extracts and the effect of PFS on sugar transporters
(SGLT1, GLUT2 and GLUT5). The evidence from the literature on the
inhibition of cellular glucose uptake and transport by polyphenols across Caco-2
cells is limited. To the best of our knowledge, this research is the first report
regarding the analysis of cellular uptake and transport of 14C-sucrose and 14C-
fructose using the Caco-2 cell monolayer with polyphenol-containing extracts.
The main objectives of the work are:
 To establish and characterise an in vitro model of the impact of PFS
extracts on sugar transporters using Caco-2 cells, and on digestive
enzymes using acetone-extract of rat intestinal tissues and human salivary
α-amylase. 
 To make a preliminary assessment of the capacity of PFS extracts to
reduce glucose, fructose and sucrose transport (acarbose-like activity)
across the Caco-2 cell monolayers and cellular uptake.
 To identify the mechanism by which polyphenol in German chamomile
extract was effective on the transport across the monolayer and cellular
uptake of glucose and fructose.
 To test whether modified German chamomile extract was affected on the
transport across the monolayer and cellular uptake of glucose.
 To identify the effect of FBS starvation on cells 12 h before the
experiment with/without German chamomile and sugars.
 PFS extracts were analysed for their possible interference with α-
glucosidase and α–amylase assays and assessed by considering critical 
parameters affecting the final inhibition.
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CHAPTER 2 CHARACTERISATION OF PLANT
FOOD SUPPLEMENTS AND INHIBITION OF
HUMAN SALIVARY α-AMYLASE BY PLANT 
FOOD SUPPLEMENTS
Abstract
This project is part of EU framework 7 project PlantLIBRA (Plant food
supplement: Levels of intake, benefit and risk assessment). This project aims to
investigate science-based decision making and safe use of PFS. This study
concentrated on the benefits of PFS extracts within the wider project. This
chapter is divided into two sections. The first section includes the effective
compounds of polyphenols that inhibit the sugar transporters or digestive
enzymes, and analyses the composition of PFS extracts. It was found that
German chamomile extract contains high levels of ferulic acid hexosides and
apigenin-7-O-glucoside, while EGCG was the most abundant catechin in green
tea extract. The second section includes the inhibition of human salivary α-
amylase by PFS extract. Human salivary α-amylase was chosen because it can 
help us understand the possible effects of PFS extracts in human α-amylase 
enzyme. The current methods found in the literature were optimised considering
critical parameters that may affect the final inhibition of α-amylase (e.g. DNS 
reacts with polyphenols and affects the final inhibition). Acarbose is an anti-
diabetic prescription drug used as a positive control for the treatment of type-2
diabetes. It inhibits the carbohydrate hydrolysis enzymes (α-glucosidase and α-
amylase). PFS extracts might also be considered to have the same effect
(acarbose-like effect). Both German chamomile and green tea extracts are found
to be moderate inhibitors of human salivary α-amylase with IC50 values of 2.5
and 1 mg/ml respectively. Also, acarbose at 0.1 mM concentration equals to 57%
inhibition.
These findings indicate that glycaemic responses may be reduced when German
chamomile and green tea extracts are taken during a meal due to their acarbose-
like activity.
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2.1 EU Project
The aim of this project is to encourage the safe use of food supplements. In this
project, 23 universities from different European countries are working in
different fields, sharing their work and expertise among themselves and with
leading stakeholders towards an integrated science of botanicals. The
development of PFS in Europe could bring substantial market growth. However,
the present scientific and regulatory situation for PFS creates barriers to such
growth. To protect consumers and exploit market opportunities, a new integrated
approach is needed in research. Therefore, both risk and benefit assessments are
undertaken in this project (http://plantlibra.eu).
This study is involved in the methodology for the benefit assessment of PFS,
corresponding to the application and validation work package of this project.
This work package aims to address the validation, achievement and application
of a methodology in order to establish the benefits of PFS consumption using
advanced in vitro approaches.
2.2 Characterization of PFS used for in vitro enzyme activity
measurements
PFS were received from the EU project, PhytoLab Co. KG.h (Vestenbergsgreuth,
Germany). While green tea extract is maltodextrin-free, German chamomile
contains 50%, Vitis Viniferae contains 17%, Echinacea contains 33% and
Pelargonium contains 75% of maltodextrin. Maltodextrin is added to increase the
water solubility of the extracts by the supplier. Maltodextrin consists of a
variable length of D-glucose units (between 3 to 17 glucose units long) linked
with α-1,4 glyosidic bonds. Therefore, maltodextrin is a potent substrate for 
intestinal enzymes and can interfere with the measurement of inhibition.
The composition and purification of German chamomile was analysed by
colleagues who were also involved in the EU project and were responsible for
those parts of the project.
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2.2.1 Removal of maltodextrin from PFS
To remove the maltodextrin from the German chamomile extract, a method was
developed using the Akta Purifier 1.0 by a colleague Mr. J. Alberto. The purified
fraction did not contain maltodextrin and the fraction was soluble in DMSO.
This extract was dissolved in 100% DMSO. The concentration of DMSO in the
final assay was 0.1%, which does not interfere with human salivary amylase.
The final concentration of DMSO in the inhibition of digestive enzyme assay
was 4%. The effect of DMSO to the enzyme activity was analysed and it was
found that DMSO inhibited the enzyme activity by 8%. This was adjusted for in
the relevant assays.
2.2.2 Identification of compounds in German chamomile using
HPLC with triple-quad mass spectrometric detection
The composition of German chamomile extract was analysed using triple-quad
mass spectrometric detection and single-quad mass spectrometric detection.
German chamomile extract solubilised in water was analysed using an Agilent
1200 HPLC coupled with a 6410 LCMS triple quadrupole fitted with an electro-
spray ionization source in the negative mode (Figure 6 and Figure 7). The
standard compounds were supplied by PhytoLab Co. KG.h (Vestenbergsgreuth,
Germany). Preliminary analysis identified many compounds, shown in Table 7.
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Figure 6 Analysis of German chamomile in water using HPLC with triple-quad
mass spectrometric detection excluding the ferulic acid hexosides, which
otherwise would dominate the chromatogram.
Figure 6 represented the expanded format of Figure 7 and peaks labelled with
same number in the figures represented the same compounds which were
explained in the figures.
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Figure 7 Analysis of German chamomile in water using HPLC with triple-quad
mass spectrometric detection.
- 42 -
Table 7 Characteristics of compounds identified in German chamomile using HPLC with triple-quad mass spectrometric detection.
Compound name Precursor ion Product
ion
Fragmentor Collision energy RT RT RT RT
Ferulic acid (FA) hexoside dimer
Quercetin 3-O-rutinoside
711
609
193
301
135
135
35
35
10.1
12.3
12.2 12.8 13.8
Kaempferol 3-O-rutinoside
di- caffeolyquinic acid (CQA)
593
515
285
353
135
135
30
30
13
13.7 15.2 14.6
Luteolin O-acylhexoside
Myricetin O-hexoside
489
479
285
317
135
135
30
25
14.6
12
15.9
Quercetin-3-O-glucuronide
Quercetin 3-O- glucoside
Luteolin 7-O-glucoside
477
463
447
301
301
285
135
135
135
35
25
25
13.2
12.5
13.5
14.5
13
14.5
Dimethoxy-cinnamic acid hexoside
5 O-feruloylquinic acid
369
367
189
191
135
135
30
30
14.7
11.8
16.9
13.7
19.5
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Cis/trans FA hexoside
Cis/trans FA hexoside
355
355
193
149
135
135
30
30
10.1
10.1
O-caffeolyquinic acid (CQA)
3-O-CQA
4-O-CQA
353
353
353
191
179
173
135
135
135
30
30
30
9.5
6.5
9.3
Coumaroyl quinic acid aglycone
Isohamnetin aglycone
Quercetin aglycone
337
315
301.1
191
300.3
151.2
135
135
135
30
20
20
11.2
21.5
17.5
Kaempferol aglycone
Luteolin aglycone
285.2
285.2
151.1
133.1
135
135
20
25
17.7
17.8
Apigenin aglycone
FA aglycone
269.2
193
151.2
149
135
135
20
10
20.6
10.2
12.3
Umbelliferone aglycone
Protocatechuic acid aglycone
161.1
153
133
109
135
135
20
10
7.9
5.3
9.2 12.3
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2.2.3 Quantification of compounds in German chamomile using
HPLC with single-quad mass spectrometric detection
German chamomile extract solubilised in water was analysed using Shimadzu
LC-2010 HT coupled with a LCMS-2020 quadrupole mass spectrometer fitted
with an electro-spray ionization source used in the negative mode. The standard
compounds were supplied by PhytoLab Co. KG.h and they were paired with
compounds in the German chamomile water extract solution, but due to lack of
standards the amount of ferulic acid hexosides could not be quantified.
Preliminary analysis identified many compounds, shown in Table 8. It was found
that German chamomile contains many phytochemicals and apigenin-7-O-
glucoside was predominant in the extract. Ferulic acid hexoside was also
apparently at a high level.
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Figure 8 Quantification of compounds in German chamomile dissolved in water
using HPLC with single quadrupole mass spectrometry.
Total ion current (TIC) of German chamomile without hydrolysis (A) identifying
the presence of umbelliferone (I) retention time (RT)= 11.7 min; apigenin (II)
RT= 20.9 min; luteolin (III) RT= 18.1min; apigenin-7-glucoside (IV) RT= 15.1;
luteolin-7-glucoside (V) RT= 13.9; 3,4-dicaffeoylquinic acid (VI) RT= 14.3 min;
3,5-dicaffeoylquinic acid (VII) RT= 14.7 min and 4,5-dicaffeoylquinic acid (VIII)
RT= 15.3 min
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Table 8 The polyphenol profile of German chamomile for samples without
hydrolysis (H2O); fraction after hydrolysis and precipitation of proteins by ACN,
followed by extraction into EtAC.
H2O ACN EtAC
Compound m/z(-) Retention time
(min)
Composition (%)
excluding maltodextrin
component
Umbelliferone 161 11.7 0.07 0.15 0.14
Apigenin 269 20.9 0.35 0.46 0.30
Luteolin 285 18.1 0.01 0.01 0.01
Apigenin-7-glucoside 431 15.1 5.69 0.58 0.32
Luteolin-7-glucoside 447 13.9 0.28 0.01 0.0*
3,4-dicaffeoylquinic acid 515 14.3 0.12 0.0* 0.0*
3,5-dicaffeoylquinic acid 515 14.7 0.08 0.01 0.01
4,5-dicaffeoylquinic acid 515 15.3 0.10 0.01 0.01
*0.0 equals to below detection limit.
Most of the phytochemicals present in PFS are linked with a sugar or organic
acids by glycosidic or ester linkages. To absorb those phytochemicals, those
linkages need to be removed as part of the digestive process with brush border β-
glucosidases in the small intestine or esterases and glycosidases from bacteria in
the colon. Then the product aglycone from the digestive process can be absorbed.
To analyse the effect of digestion on the biological activity of German
chamomile extract, the extract was subjected to enzymatic hydrolysis followed
by extraction as a model of the first step of digestion in the gut with ACN and
EtAC. Hydrolysis using hesperinidase and cellulose removed the sugars from the
polyphenols in the German chamomile and cleaved the ester bonds between
phenolic and quinic acid (the first step of digestion in the gut). This experiment
indicates that the digestion affects the biological activity of German chamomile
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due to glucose transport across the cell monolayer, which was decreased by
~50%.
2.2.3.1 Polyphenol profile of the main compounds from German
chamomile after hydrolysis
German chamomile hydrolysed samples were analysed using HPLC with single
quadrupole MS (Figure 9 and Figure 10). Preliminary analysis identified many
compounds, shown in Table 8. As expected after hydrolysis, the chromatogram
of the extract was less complex and the aglycones were revealed.
Figure 9 Quantification of compounds in German chamomile after hydrolysis
using HPLC with single quadrupole mass spectrometry.
Total ion current (TIC) of German chamomile with hydrolysis and extraction
with acetonitrile (B) identifying the presence of umbelliferone (I) retention time
(RT)= 11.7 min; apigenin (II) RT= 20.9 min; luteolin (III) RT= 18.1min;
apigenin-7-glucoside (IV) RT= 15.1; luteolin-7-glucoside (V) RT= 13.9; 3,5-
dicaffeoylquinic acid (VI) RT= 14.7 min and 4,5-dicaffeoylquinic acid (VII)
RT= 15.3 min
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Figure 10 Quantification of ethyl acetate-extracted compounds after hydrolysis
of German chamomile using HPLC with single quadrupole mass spectrometry.
Total ion current (TIC) of German chamomile with hydrolysis and extraction
with ethyl acetate (C) identifying the presence of umbelliferone (I) retention time
(RT)= 11.7 min; apigenin (II) RT= 20.9 min; luteolin (III) RT= 18.1min;
apigenin-7-glucoside (IV) RT= 15.1; luteolin-7-glucoside (V) RT= 13.9; 3,5-
dicaffeoylquinic acid (VI) RT= 14.7 min and 4,5-dicaffeoylquinic acid (VII)
RT= 15.3 min.
2.2.4 Quantification of compounds in the green tea extract using
reverse phase HPLC
Samples of green tea extract were characterized using reverse phase HPLC. A 5
µl sample was separated using the Eclipse Plus C18, 18 µm, 2.1x100 mm
column maintained at 30 0C. (Phenomenex, Cheshire, UK). Mobile phase A
consisted of 0.1% formic acid in water and mobile phase B consisted of 0.1%
formic acid in acetonitrile. Elution started at 10% solvent B at a flow rate of 0.25
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ml/min. Solvent B was increased to 15% after 9.5 min, and after 14.5 min it was
increased to 95% until 27 min (cleaning column) and held at 10% until 30 min
(re-equilibration of the column).
Standard curves of these compounds were run and used to quantify the
compounds in the green tea extract and taxifolin was used as the internal
standard (IS-10 µg/ml) (Figure 11, and Figure 12, Table 9). EGCG reported as
the highest concentration of flavanol in a cup of green tea and catechin reported
as the lowest (Cabrera et al., 2003; Frejnage, (2007); Reto et al., 2007). In the
current study the most abundant catechin in green tea extract was EGCG and
catechin was the lowest which is in the agreement of literature.
Figure 11 Quantification of the green tea extract in water using HPLC.
The red line indicates the standard mixture (C, EC, EGCG, EGC and IS) at a
concentration of 30 µg/ml and the green line indicates the 1 mg/ml green tea
extract with 30 µg/ml standard mixture spiked. Detection wavelengths were 260,
280 and 320 nm.
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Figure 12 Standard curve of catechin (C), epicatechin (EC), epigallocatechin
gallate (EGCG) and epigallocatechin (EGC) at the concentrations of 0, 10, 30, 50,
70, and 90 µg/ml.
Table 9 Polyphenol profile of the green tea extract.
Compound Retention time
(min)
Composition
(%)
µg/ml
Catechin 3.8 1.7 7.1
Epicatechin 6.07 4 17.3
Epigallocatechingallate 6.4 24 138.8
Epigallocatechin 12.1 7 11.2
The maltodextrin content of Vitis Viniferae extract did not removed because this
project mainly interested on the German chamomile and green tea extracts as
their inhibitory effect on transporters and digestive enzymes were higher than
Vitis Viniferae extract.
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2.3 INHIBITION OF HUMAN SALIVARY α-AMYLASE BY 
PLANT FOOD SUPPLEMENTS
Abstract
In this present work, it was investigated whether the presence of PFS extracts
can inhibit human salivary α-amylase. The initial steps of method development 
involved determining the activities of human salivary α-amylase on amylopectin 
and improving a previously published method by analysing reducing sugar
production from amylopectin. Purified German chamomile and green tea extracts
were found to be moderate inhibitors of α-amylase digestion of amylopectin with 
IC50 values of ~ 2.5 and ~1 mg/ml, respectively. Acarbose was also tested as a
positive control: at 0.1 mM, 57% inhibition was observed. Thus, 1 mg/ml green
tea was approximately equal to 0.0645 mg/ml acarbose concentration. Due to the
acarbose-like activity of PFS extracts, they may have a potential role to reduce
the risk of diabetes by inhibiting the hydrolysis of starches, and reducing post-
prandial blood glucose spikes.
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2.3.1 Introduction
The digestion of starch starts in the mouth by salivary α-amylase, which is 
hydrolysed to maltose, maltriose and small dextrins. Pancreatic α-amylase 
continues the digestion in the small intestine. The enzymes (maltase, sucrase,
and lactase (α-glucosidase enzymes)) that are located in the brush border of the 
small intestine complete the digestion process to glucose (Grabitske and Slavin,
2009). α-Amylase is produced by the salivary glands and pancreas, and both 
enzyme isoforms have considerable sequence homology (Williamson, 2013).
Amylose and amylopectin are hydrolysed by α-amylase by hydrolysis of α-1,4 
glycosidic bonds, but the branch points (α-1,6 glycosidic bonds) are not 
hydrolysed (Figure 13). The hydrolysis occurs randomly on the starch chain
(endo-acting enzyme). Acarbose is an anti-diabetic prescription drug used for the
treatment of type-2 diabetes. It inhibits the carbohydrate hydrolysis enzymes (α-
glucosidase and α-amylase). Miglitol and voglibose are also anti-diabetic 
prescription drugs used for the treatment of type-2 diabetes but both are an
inhibitor of α-glucosidase. PFS extracts might also be considered to lead the 
same effect (acarbose-like effect). Since acarbose has side effects such as
flatulence, diarrhoea and nausea, PFS extracts could be used in the prevention of
type-2 diabetes.
Starch digestion starts in the mouth (with human salivary α-amylase) quickly 
enough to contribute to the energy requirements of individuals. Human salivary
α-amylase was chosen because the aim was to understand the possible effect of 
PFS extracts in the human source of the α-amylase enzyme, while it was also a 
lot cheaper than human pancreatic α-amylase. The difference between human 
and pancreatic α-amylase originates in their active site region. Two substitutions 
(Thr 163 and Leu 196) in salivary α-amylase may have an effect on substrate 
binding (Brayer et al., 1995). Salivary α-amylase is an endo-amylase and it 
hydrolyses at the α-1,4 glycosidic bonds of the starch molecule (Bijttebier et al.,
2009).
Several studies have shown that polyphenol-rich plants and herbal extracts were
able to inhibit α-amylase activity (Kashket and Paolino, 1988; Zhang and 
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Kashket, 1998; Piparo et al., 2008; Boath et al., 2012; McDougall et al., 2005;
Shimizu et al., 2000; Podsedek et al., 2014).
A recent study tested the inhibitory activity of α-amylase from porcine pancreas, 
with 30 commonly consumed fruits purchased from a local supermarket. The
IC50 values of the tested fruits for pancreatic α-amylase were between 1 to 80 
mg/ml. Only half of the fruits at a 200 mg/ml concentration were able to inhibit
α-amylase activity by >50% (Posedek et al., 2014). The most effective inhibitors
were red and green gooseberries, chokeberry and redcurrant with IC50 values <2
mg/ml. Posedek and colleagues concluded that, as those fruits slow down the
release of glucose in the blood, they may be of use in the management of type-2
diabetes.
Figure 13 The hydrolysis of amylose and amylopectin by α-amylase.  
The red bond represents the α-1,6 glycosidic bonds (G: glucose). 
Phenolic-rich extract (PRE) and tannin-rich fraction (TRF) of edible seaweed
(Ascophyllum nodosum) were analysed for their porcine pancreatic α-amylase 
inhibitory activity. The PRE extract inhibited α-amylase with an IC50 ~0.05
µgGAE/ml whereas the inhibitory activity of TRF was three-fold less potent.
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The astringency of the tannin-like components were also reported to be related to
their inhibitory activity of amylase (Pantidos et al., 2014).
Phyllanthus amarus Schum and Thonn (Phyllanthaceae) herbs have been
traditionally used in the treatment of diabetes. Fawzi and Devi (2014) analysed
the aqueous and methanol extracts of leaf and stem of this herb against α-
amylase activity, and compared it with acarbose. The aqueous extraction of stem
(IC50 value of 35 µg/ml) showed the highest inhibitory effect against α-amylase 
and it was significantly lower than acarbose (IC50 value of 58 µg/ml). Methanol
leaf extract (IC50 value of 45 µg/ml) was also significantly lower than acarbose.
Aqueous leaf and methanol stem extracts exhibited IC50 values of 62 and 57
µg/ml, respectively.
Hara and Honda (1990) analysed the inhibitory effect of four different kinds of
catechins and theaflavins for salivary α-amylase. The effect of theaflavins was 
stronger than catechins. The effect of α-amylase inhibition was observed in the 
descending order of potency of theaflavins digallate> theaflavins monogallate>
theaflavins> catechins gallate> gallocatechin gallate> epicatechin gallate>
epigallocatechin gallate.
As explained above, previous studies have shown that polyphenol consumption
has an effect on type-2 diabetes. Polyphenols have the potential to inhibit α-
amylase, which in turn would slow down the formation of products. We tested
whether the PFS’ green tea, German chamomile, and Vitis Viniferae could inhibit
α-amylase. The assay was set up and validated, and the results of this are 
presented in the methods and results section.
2.4 Material and methods
The initial steps of method development involved determining the activities of
human salivary α-amylase on amylopectin and improving a previously published 
method (Akkarachiyasit et al., 2010) by analysing the reducing sugar production
from amylopectin.
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2.4.1 Chemical and reagents
Acarbose (A8980-IG), dinitrosalicylic acid solution (DNS; S2377), sodium
potassium tartrate solution (D-0550), human salivary amylase type XIII-A (A-
1031-5KU), maltose (M5885), monosodium phosphate (S8282) and disodium
phosphate (S9763) were purchased from Sigma-Aldrich Inc (St Louis, MO,
USA). Amylopectin was purchased from Fluka Biochemika. DNS and sodium
potassium tartrate solutions were prepared based on the Sigma protocol for
human salivary amylase (EC 3.2.1.1) (Colour reagent solution).
Stock solutions of amylopectin were dissolved in hot water, and prepared freshly
for each experiment.
2.4.2 Extract preparation
PFS was received from EU project, PhytoLab Co. KG.h (Vestenbergsgreuth,
Germany). Stock solutions of PFS were dissolved in millipore water at room
temperature, prepared freshly for each experiment, and then centrifuged at 17000
g for 5 min. Following this, supernatants were collected and used for analysis.
German chamomile contains 50% of maltodextrin which is also a potential
substrate of digestive enzymes. Therefore, this extract was purified by Jose
Alberto using the Akta Purifier 1.0. This extract was dissolved in 100% DMSO.
The concentration of DMSO in the final assay was 0.1%, which does not
interfere with human salivary amylase.
2.4.3 Enzyme preparation
Human salivary amylase was dissolved in 20 mM sodium phosphate buffer with
6.7 mM sodium chloride (S/3160/53 from Fisher Scientific, Loughborough, UK)
at pH 6.9 at room temperature. The enzyme solution was prepared freshly for
each experiment.
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2.4.4 Preparation of sodium tartrate solution
Into the 8 ml of 2 M NaOH, 12 g of sodium tartrate was added and placed on a
heating plate to dissolve. It was added to prevent oxidation of product (maltose)
and stabilise the colour.
2.4.5 Preparation of DNS solution
DNS powder (0.438 g) was added into 20 ml of deionized water and directly
placed on a heating plate to dissolve. DNS was used as the colour reagent for the
α-amylase reaction. When α-amylase hydrolyses starch it releases the reducing 
sugars as a product. DNS reacts with the free carbonyl group of the reducing
sugars under an alkaline condition and forms 3-amino-5-nitrosalicylic acid,
which could be measured at 540 nm (Goncalves et al., 2010). DNS changed the
colour as reducing sugars are released.
Colour reagent solution: Both prepared sodium tartrate and DNS solution were
added together with 40 ml of deionized water and stored in an amber bottle at
room temperature.
2.5 Inhibition of human salivary α-amylase by PFS 
The practical steps of the method are summarised in Figure 14. The assay was
conducted by mixing 200 μl of the substrate solution (different concentration for 
each sugar), 50 μl of 10 mM pH 7.0 sodium phosphate buffer, 50 μl of PFS 
extract or buffer with 200 μl enzyme solution (different concentration for each 
sugar) and vortexed for 10 seconds. The assay was carried out in triplicate.
Following this, the samples were incubated at 37 ºC for 10 min. After incubation,
1 ml of colour reagent solution was added to determine the production of
reducing sugar and vortexed for 10 seconds. To stop the enzyme reaction, the
samples were placed in a boiling water bath (GLS Aqua 12 plus) for 10 min and
then transferred into ice to cool down to room temperature. The sample volume
for analysing the production of reducing sugar was 250 µl and it was transferred
to a 96-well plate (Nunc A/S., Roskilde, Denmark). The absorbance was read at
540 nm with PHERAstar FS microplate reader (BMG LABTECH). Results are
presented as percentage inhibition relative to the blank control using Equation 1.
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Enzyme activity was measured in the presence of a variety of green tea and
German chamomile supplement extracts, and acarbose was used as a positive
control. At the concentration of 0.1 mM, acarbose inhibited α-amylase activity 
by 57 %.
%= x 100
Equation 1
It was observed that the colour reagent solution activity was promoted by green
tea and German chamomile extracts as it is known that the reducing potential of
polyphenols could interfere with the development of colour, and hence affect the
assay. Therefore, before adding the colour reagent solution, samples were
transferred to a boiling water bath for 10 min to stop the enzyme reaction. Then
they were transferred into ice to cool down to room temperature. Following this,
an SPE column (Waters Oasis MAX Cartridge 003036349A) was used to
remove the polyphenols from the green tea and German chamomile extracts. 1
ml of colour reagent solution was added to each sample and the samples were
transferred to a boiling water bath for 10 min again. Then the absorbance was
read at 540 nm.
2.6 Statistical analysis
IBM SPSS Statistics 22 was used for the analysis of the data. The Levene test
was used to evaluate the homogeneity of the means groups. If the criterion was
met the Tukey HSD post hoc test was applied: otherwise, the Dunnett C
followed the one way Anova. The values shown represent the mean values and
the error bars indicate the standard deviation (SD). Unless otherwise stated,
differences were considered as statistically significant when p≤0.05. 
Abs for control
Abs control-Abs sample
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Figure 14 Summary of the practical steps in the inhibition of human salivary α-
amylase assay.
200 µl substrate (amylopectin)
200 µl enzyme solution
50 µl PFS or Buffer
50 µl Buffer (10 mM pH 7.0)
Incubation (37 0C 10 min)
Heating (100ºC- 10 min- to stop the enzyme activity)
SPE (Oasis 3cc MAX- to remove the polyphenols)
Vortexed 10 sec
Cooling to room temperature
250 µl sample into a microplate
Read absorbance at 540 nm
Vortexed 10 secColour turns to yellow-brown
Colour changes yellow to dark red
Boling water bath (100ºC- 10 min)
Addition of colour reagent (1 ml DNS + Tartrate)
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2.7 Results
The standard curves obtained with pure maltose standard solutions were linear
and reproducible. The concentration range was between 0 to 10 mM and the
average of all the standard curves from each experiment are shown in Figure 15.
To establish and characterise, the Km for amylopectin with human salivary α -
amylase was measured (Figure 17). Time dependence was also assessed for three
different concentrations of enzyme (Figure 18). Figure 16 represented the
variations of absorbance reading for different days.
Figure 15 Standard curve of maltose in the reducing sugar assay.
Mean± SD (n=3 per concentration of maltose).
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A
B
Figure 16 A: Standard curve of maltose for different experiment days.
B: Expanded format of A. Three replicates for each concentration for each days.
Mean± SD (n=3 per concentration of maltose for each day).
The Michaelis-Menten kinetic parameters of human salivary α-amylase are 
shown in Figure 17. Using a chosen enzyme concentration and different
incubation times, the kinetic parameters of Km and Vmax were determined with
the Lineweaver-Burk plot. The Km value for the measurement of maltose
production from amylopectin was 1 mg/ml and Vmax was 0.12 mg substrate
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hydrolysed/min for human salivary α-amylase. The substrate concentration was 
adopted as 1 mg/ml, which was equal to the Km value.
Figure 17 Lineweaver- Burk plot for amylase digestion of amylopectin.
From this, Km= 1 mg/ml amylopectin and Vmax= 0.12 mg substrate
hydrolysed/min.
Mean± SD (n=3 for each concentrtion).
Maltose production from amylopectin was observed at the different
concentrations of human salivary α-amylase (Figure 18). The time dependence 
assessed for different concentrations of human salivary α-amylase was linear up 
to 10, 10 and 6 min for 1, 3 and 5 U enzyme concentrations, respectively.
Therefore an incubation time of 10 min and 3 U enzyme was chosen as the
optimum assay conditions using 1 mg/ml amylopectin. Different concentrations
of enzyme showed the same pattern of maltose production as in all cases, the
curve flattens at a certain time point. Hydrolysis of amylopectin became constant
with the increasing time points. The enzyme substrate complex rate was constant
during the steady state. The rate slows as substrate concentration continues to
increase until the curve flattens. This situation shows that the reaction has
y = 8.8003x + 8.6149
R² = 0.8994
-10
0
10
20
30
40
50
60
-2 -1 0 1 2 3 4 5 6
1/
V
(1
/m
g/
m
in
)
1/S (1/mg/ml)
- 62 -
reached maximum velocity and all free enzymes are saturated with substrate
(Nelson and Cox, 2000).
Figure 18 Time dependence of amylase hydrolysis of amylopectin.
Three different amounts of enzyme were used, 1, 3 and 5 U/ml.
Mean± SD (n=3 for each time points per sample).
The rate of enzyme reaction depending on the enzyme concentration was shown
in Figure 19. Increasing the concentration of enzyme also increases the rate of
enzyme reaction linearly.
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Figure 19 Data from Figure 18 replotted to show the dependence of rate upon
enzyme concentration.
2.7.1 Inhibition of α-amylase by green tea and German chamomile 
extracts
As German chamomile and Vitis Viniferae extracts contain some maltodextrin
(3.4.4), 20 mg/ml of maltodextrin was used as a substrate in the assay. It was
observed that maltodextrin was a potent substrate for α-amylase, and therefore 
Vitis Viniferae extract was not analysed. Purified German chamomile extract
(maltodextrin content of extract was removed) were analysed. Initially 2 mg/ml
of green tea and 0.4 mg/ml of purified German chamomile extracts were tested,
but both appeared to be activating the enzymatic reaction. To confirm this,
several experiments were performed; PFS extracts only were added to assay
(without enzyme and substrate), and PFS with enzyme added to assay without
substrate. It was found that the apparent activities were still higher than the
control sample (without inhibitor but with enzyme and substrate), and so it was
concluded that the polyphenol content of the extracts were interfering with the
DNS reaction. To prevent this problem, SPE columns were used to remove the
polyphenols after the assay but before the analysis. After the improvement of the
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assay, 2 mg/ml of green tea and 0.4 mg/ml of purified German chamomile
extract inhibited human salivary α-amylase activity by 40 and 30%, respectively.  
Both purified German chamomile and green tea extracts were moderate
inhibitors of amylase digestion of amylopectin with an IC50 value of ~2.5 and ~1
mg/ml, respectively (Figure 20). Acarbose was also tested as a comparison and
positive control. At the concentration of 0.1 mM (0.0645 mg/ml), this gave 57%
inhibition of amylase hydrolysis. Thus, 1 mg/ml green tea was approximately
equal to 0.0645 mg/ml acarbose.
Figure 20 Inhibition of human salivary amylase with different concentrations of
green tea and German chamomile extracts.
Mean± SD (n=3 per PFS concentration). Tukey HSD test applied.
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2.8 Discussion
Both purified German chamomile and green tea extracts were moderate
inhibitors of amylase digestion of the starch component, amylopectin. However,
due to the maltodextrin content of Vitis Viniferae extracts, the inhibitory effect
on α-amylase could not be analysed. Even German chamomile extract contains 
maltodextrin, which could still be pre-purified to remove its maltodextrin content.
Zhang and Kashket (1997) observed the inhibitory effect of black and green tea
on human salivary α-amylase activity. Volunteers were fed with salted crackers 
and then rinsed with black or green tea decoctions or water. They found that the
production of maltose was ~70% less after rinsing with tea compared to water
rinsing. The inhibitory activity of black teas was higher than green teas, and
when the tannins were removed, the inhibitory activity of both teas decreased.
Catechins were effective at a concentration of 2 mg/ml. In the current study,
green tea extract inhibited human salivary α-amylase activity with an IC50 value
of 1 mg/ml. Thus, catechins may contribute to the inhibitory effect of the extract.
Lee and colleagues (2010) analysed the inhibitory effect of black, green and
oolong teas for α-amylase activity. They found that black tea had the strongest 
inhibitory activity with IC50 value of 0.42- 0.67 mg/ml. In addition, theaflavins
show better inhibition activity compared to catechins (1.5 to 20 mM). Zhang and
Kashket (1997) also reported that the inhibition effect of black teas on α-amylase 
activity was higher than green tea. Gao and colleagues (2013) analysed the
combined effect of green tea extract (GTE), green tea polyphenols (GTP) and
EGCG with acarbose. Gao and colleagues found that GTE, GTP and EGCG
(without acarbose combination) inhibited α-amylase activity with an IC50 value
of 4020, 1370 and 1849 µg/ml, respectively. The effect of their α-amylase 
inhibition was poor. When they combined GTE and GTP with acarbose, they had
a synergistic effect on α-amylase when the inhibition percentage was <72 and 
40%, respectively. By contrast, EGCG and acarbose combination had only an
antagonistic effect at all concentrations.
In the literature there are some studies regarding the polyphenol content of green
tea and German chamomile extracts. Those studies also supported that PFS
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extracts may have a role in inhibiting α-amylase activity. The reported studies 
showed variations with regards to the type of the α-amylase (human, porcine or 
microorganisms) used in the assays.
He and colleagues (2006) study also supported that 0.05 mg/ml of catechins,
epigallocatechin gallate, epicatechin gallate, epigallocatechin and epicatechin
inhibited 61 % of α-amylase activity. Hara and Honda (1989) analysed the 
inhibitory effect of four different kinds of catechins and theaflavins for salivary
α-amylase. The effect of theaflavins was stronger than catechins. The effect of 
amylase inhibition was observed in the descending order of potency of
theaflavins digallate> theaflavins monogallate> theaflavins> catechins gallate>
gallocatechin gallate> epicatechin gallate> epigallocatechin gallate. Green tea
extract also contains catechins, epigallocatechin gallate, epicatechin gallate,
epigallocatechin and epicatechin. Therefore, those studies also supported the
inhibitory effect of green tea extract.
The inhibitory activity of luteolin for amylase was tested by Kim and colleagues
(2000). They reported that the inhibitory activity of luteolin was effective, but
however, not as potent as acarbose. They also tested 22 flavonoids for their
inhibitory effect on amylase activity. Luteolin, luteolin-7-O-glucoside and
kaempferol-3-O-glucoside inhibited α-amylase activity with IC50 values of 50-
500 µg/ml, 5 mg/ml and 5 mg/ml, respectively. In the current study, purified
German chamomile extract also contained luteolin and luteolin-7-O-glucoside,
and the Kim and colleagues study supports that they may contribute to the
inhibitory effect of extract. Tadera and colleagues (2006) observed that luteolin,
quercetin and myricetin inhibited α-amylase with IC50 values of 0.36, 0.50 and
0.38 mM, respectively. By contrast, they found that apigenin, kaempferol, fisetin
and cyanidin insignificantly inhibited the α-amylase activity. They concluded the 
inhibitory effect of the flavonols in the descending order of potency of
isoflavone >flavone >flavonol >anthocyanidins >flavanone=flavan-3-ol. Purified
German chamomile extract also contains a high amount of apigenin-7-O-
glucoside. One study reported that apigenin-7-O-glucoside inhibited porcine
pancreatic α-amylase activity (Funke and Melzig, 2006). Funke and Melzig 
observed the effect of traditionally used plants from Africa and Europe for
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diabetes, the leaves of Tamarindus indica inhibited 90% of the α-amylase 
activity. They also tested some of the phenolic compounds and the effect of
porcine pancreatic α-amylase inhibition were observed in the descending order 
of potency of acarbose> tannic acid> apigenin-7-O-glucoside> luteolin>
luteolin-7-O-glucoside> fisetin> chlorogenic acid. Therefore, those studies are
also in agreement of the current study regarding the inhibitory effect of German
chamomile extract.
There are also different polyphenols or fruits reported for their α-amylase 
inhibitory activity. The variety of studies is regarding the inhibition of α-amylase 
with berry species. Grussu and colleagues (2011) reported the inhibitory effect of
raspberry and rowanberry on α-amylase activity with an IC50 value of 21 and 4.5
µg/ml, respectively. They concluded that proanthocyanidins inhibited α-amylase 
activity more than the anthocyanidins content of berries. Among all the berries,
McDougall et al., 2005 reported that strawberry and raspberry were the most
effective inhibitors of human salivary α-amylase with Ki values of 120 and 150
µg of phenols/assay, respectively. They further analysed red grape juice and red
wine, which inhibited salivary α-amylase with Ki values of ~20 µg/assay. By
contrast, gallic acid and ellogallaic acid were ineffective.
Purified German chamomile and green tea extracts were found to be moderate
inhibitors of human salivary α-amylase digestion of the starch component, 
amylopectin. Therefore, we may conclude that the glycemic response may be
reduced when it is taken during a meal. These results indicate that PFS reduces
the digestion of starch-containing foods. These results illuminate the role of PFS
in reducing the diabetes risk.
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CHAPTER 3 INHIBITION OF DIGESTIVE
ENZYMES BY PLANT FOOD SUPPLEMENTS
Abstract
The purpose of the study was to determine the inhibitory effect of PFS on
carbohydrate digesting enzymes (rat intestinal sucrase/isomaltase and maltase).
The initial steps of method development involved determining the activities of
sucrase, maltase and isomaltase in an acetone-extract of rat intestinal tissues and
improving a previously published method by analysing glucose production from
sucrose, maltose and isomaltose using hexokinase.
Green tea extract inhibited maltase, sucrase and isomaltase activities in vitro
with IC50 values of 0.95± 0.05, 0.44± 0.04 and 0.69± 0.02 mg/ml, respectively.
Due to the maltodextrin content of German chamomile and Vitis Viniferae
extracts, their inhibitory effect on carbohydrate digestive enzymes could not be
analysed. Since maltodextrin is a substrate of digestive enzymes after
maltodextrin was removed from the German chamomile extract, this activated
isomaltase and sucrase but was ineffective on maltase (p<0.01). Acarbose (0.1
mM) as a positive control inhibited sucrase, isomaltase and maltase by 90± 3.5,
64± 4.8 and 100± 2 %, respectively. The findings demonstrate that green tea
might influence carbohydrate digestion via inhibition of gut α-glucosidases. 
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3.1 Introduction
Carbohydrates are major energy-containing components of the diet and are
classified into 4 groups: mono-, oligo- and polysaccharides and their derivatives
(Lindhorst, 2003). Oligo- and polysaccharides are synthesised from
monosaccharides (two or more joined together), and also, during digestion they
are catabolised to the monosaccharide form to provide energy. Sucrose, maltose
and isomaltose are examples of disaccharides synthesised by the reaction
between glucose and fructose and two glucose units, respectively. The difference
between maltose and isomaltose is the position of glycosidic links between
glucose molecules, as shown in Figure 21. Sucrose, maltose and isomaltose are
hydrolysed by sucrase/isomaltase and maltase/glucoamylase enzymes, which are
located in the small intestine. Both enzymes have α-glucosidase activity 
(Williamson, 2013). One glucose and one fructose unit comprise one unit of
sucrose, which is shown in Figure 21. Two glucose units with α-1,4 and α-1,6 
linkage comprise maltose and isomaltose, respectively.
Figure 21 Structure of sucrose, maltose and isomaltose.
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In the vast literature, α-glucosidase inhibitors are found as therapeutic drugs for
diabetes, and they inhibit carbohydrate metabolism (Yuk et al., 2011). In the
majority of the studies, phenolic compounds were investigated as α-glucosidase 
inhibitors (Bhandari et al., 2008; He et al., 2006; Kim et al., 2000; Lee et al.,
2008; Song et al., 2005; Zhang et al., 2007). The positive effects of polyphenols
on glucose homeostasis were observed in a large number of in vitro and animal
model studies. These models are supported by epidemiological evidence on
polyphenol-rich diets (fruit and vegetables, tea, coffee and some herbal
supplements) (Hanhineva et al., 2010; Boath et al., 2012; Hamer and Chida,
2007; Sakulnarmrat et al., 2014; Kamiyama et al., 2010; Huxley et al., 2009; van
Dieren et al., 2009).
Gao and colleagues (2007) studied the inhibitory effect on maltase, sucrose and
isomaltase by the fruits of Terminalia chebula Retz. The authors found that the
extracted polyphenols inhibited rat intestinal maltase activity; however, it did not
inhibit sucrase or isomaltase activity. Gao and colleagues concluded that the
phenolic compounds extracted from the fruits of Terminalia chebula Retz may
be useful as a natural source of α-glucosidase inhibitor.  It can potentially be 
utilised in the suppression of post-prandial hyperglycaemia in type-2 diabetes
management.
One of the recent studies reported that blackcurrant (rich in anthocyanins, ~70%
of the total) and rowanberry (rich in chlorogenic acids, ~65% of the total)
inhibited the α-glucosides with IC50 values of 20 and 30 µgGAE/ml. They found
that both berry extracts were as effective as the pharmaceutical inhibitor,
acarbose (IC50 ~40 µg/ml) (Boath et al., 2012).
Kamiyama and colleagues (2010) investigated the inhibition of digestive
enzymes by green tea extract. The IC50 value for the inhibition of rat intestinal
maltase was reported to be 45 µg/ml. The polyphenol content of green tea extract;
catechin-3-gallate, gallocatechin-3-gallate, epicatechin-3-gallate and
epigallocatechin-3-gallate, had IC50 values of 62, 67, 40 and 16 µM, respectively.
Sakulnarmrat and colleagues analysed the inhibition on α-glucosidase with 
Davidson’s Plum (DP) and quandong (QD), which are widely using in various
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food products (jam, sauces, wine or herbal tea) in Australia (Sakulnarmrat et al.,
2014). The polyphenol composition of DP contains ellagic acid and ellagitannins
together with the flavonoids myricetin, quercetin, rutin and anthocyanins, and
QD is rich in hydroxycinnamic acids, quercetin and cyaniding-3-glucoside. The
inhibitory activity of 1 mg/ml DP and QD was 93 and 65%, respectively. It was
concluded that the development of food supplements/nutraceuticals with
multifunctional polyphenols may be helpful to prevent metabolic syndrome.
Another study recently conducted tested the inhibitory activity of rat intestinal α-
glucosidase with 30 commonly consumed fruits purchased from their local
supermarket. The IC50 values of tested fruits were between 39.9 to 400 mg/ml.
The strongest IC50 value observed was for blue honeysuckle. Other potent
inhibitors were green gooseberry> blueberry> bilberry> blackcurrent> sweet
cherry> pink Vitis Viniferae and red gooseberry (Posedek et al., 2014). They
concluded that as those fruits slow down the release of glucose in the blood, they
may be of use in the treatment of type-2 diabetes.
The Phyllanthus amarus Schum and Thonn (Phyllanthaceae) herbs have been
traditionally used in the treatment of diabetes. Fawzi and Devi (2014) analysed
the aqueous and methanol extracts of the leaf and stem of this herb against α- 
glucosidase activity. They compared this with acarbose inhibitory activity.
Methanol extraction of the leaf (IC50= 0.674 µg/ml) showed the highest
inhibitory effect against α-glucosidase and it was significantly lower than 
acarbose (IC50= 6.77 µg/ml). Methanol stem extract (IC50= 6.73 µg/ml)
inhibitory activity was comparable to acarbose. Aqueous leaf and stem extracts
had IC50 values 8.97 and 8.60 µg/ml, respectively. The total phenolic content of
the extracts was highest in the aqueous stem (~0.08 gGAE/ml) and followed by
the aqueous leaf (~0.045 gGAE/ml)> methanol extract of stem (~0.045 gGAE/ml)
> methanol extract of leaf (~0.025 gGAE/ml).
The phenolic-rich extract (PRE) and tannin-rich fraction (TRF) of edible
seaweed, Ascophyllum nodosum, were analysed for their α-glucosidase inhibitory 
activity. Both extracts inhibited α-glucosidase equally effectively (IC50~10
gGAE/ml). The IC50 value for α-glucosidase inhibition was reported as 40 µg/ml 
(similar to the Boath et al., 2012 study). When TRF and acarbose were co-
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incubated at half their IC50 values, the inhibition was significantly increased.
This result indicates that the TRF components and acarbose are binding to
different sites on the enzyme. Therefore, they concluded that reducing the dose
of acarbose with the addition of TRF may provide an advantage for the diabetics
who react poorly to acarbose.
Polyphenols have the potential to inhibit digestive enzymes, which in turn would
slow down the products of the substrate (e.g. glucose and fructose) reaching the
blood. Previous studies have shown that polyphenol consumption has an effect
on type-2 diabetes. We tested whether plant food supplements (PFS; green tea
and purified German chamomile) could also lower blood glucose levels through
inhibition of digestive enzymes (α-glucosidase (sucrase/isomaltase and 
maltase)). The assay has been set up and validated, and the results of this are
presented in the methods and results sections.
3.2 Material and methods
The initial steps of method development involved determining the activities of
sucrase, maltase and isomaltase in an acetone-extract of rat intestinal tissues and
improving a previously published method (Gao et al., 2007) by analysing
glucose production from sucrose, maltose and isomaltose with the hexokinase
assay.
3.2.1 Chemicals and reagents
Sucrose (S9378), maltose (M5885), isomaltose (I7253), acarbose, glucose
hexokinase reagent (G3293), monosodium phosphate (S8282) and disodium
phosphate (S9763) were purchased from Sigma-Aldrich, Inc. (St Louis, MO,
USA). Glucose anhydrous (G/0450/60) and fructose (F/1950/50) purchased from
Fisher Scientific (Leicestershire, UK). Acetone (022928.K2) was purchased from
Alfa Aesar (Lancashire, UK). The PFS were provided by as a part of the EU
framework 7 project PLANTLibra. Stock solutions of carbohydrates were
dissolved in 10 mM (pH 7.0) sodium phosphate buffer, prepared freshly for each
experiment.
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3.2.2 Extract preparation
Stock solutions of PFS were dissolved in millipore water at room temperature,
prepared freshly for each experiment. The solutions were centrifuged at 17000 g
for 5 min. Following this the supernatant was collected and used for analysis.
German chamomile contains 50 % of maltodextrin, which is also a substrate of
digestive enzymes. Therefore, this extract was purified by Mr. J. Alberto using
the Akta Purifier 1.0 to remove the maltodextrin from the extract. Purified
German chamomile extract was dissolved in 100 % DMSO. The final
concentration of DMSO in the assay was 4 %. The effect of DMSO to the
enzyme activity was analysed and it was found that DMSO (4 %) inhibited the
enzyme activity by 8 % and the results corrected based on this inhibition.
3.2.3 Enzyme preparation
Intestinal acetone rat powder (I1630) was purchased from Sigma-Aldrich, Inc.,
and was prepared in 1 ml of 10 mM (pH 7.0) sodium phosphate buffer at the
desired concentration of powder. Subsequently, it was vortexed for 30 seconds
followed by centrifugation at 17000 g for 10 min. The supernatant was removed
and used for analysis. It was prepared freshly for each experiment.
3.2.4 Hexokinase assay
This method of detection and measurement of D-glucose in samples was based
on the detection at 340 nm of NADH produced using the assay. It is based on a
series of catalytic reactions between glucose and the glucose assay reagent. The
first reaction is catalysed by the hexokinase, where glucose is phosphorylated by
adenosine triphosphate (ATP). The glucose-6-phosphate (G-6-P) formed is then
oxidised to 6-phosphogluconate (6-PG) in the presence of nicotinamide adenine
dinucleotide (NAD). This reaction is catalysed by glucose-6-phosphate
dehydrogenase (G-6-PDH) (Figure 22). The consequent increase in NADH
concentration is directly proportional to the glucose concentration and can be
measured at 340 nm.
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Figure 22 Catalytic reactions between glucose and the glucose assay reagent
(hexokinase- HK).
3.2.5 Inhibition of digestive enzymes by PFS
The assay was conducted by mixing 200 μl of the substrate solution (different 
concentration for each sugar), 50 μl of 10 mM (pH 7.0) sodium phosphate buffer, 
50 μl of PFS extract or buffer with 200 μl enzyme solution (different 
concentration for each sugar) and vortexed for 10 seconds. The assay was carried
out in triplicate. Following this, the samples were incubated at 37 ºC for 20 min.
Following the incubation process, 750 μl of acetone was added to stop the 
enzyme reaction and vortexed for 10 seconds. The samples were centrifuged at
17000 g for 5 min. Nitrogen was used to remove the acetone and centrifugation
was repeated (17000 g for 5 min). Instead of using the genevac to remove the
acetone, a nitrogen cylinder was used as the genevac evaporated the acetone in
variable time (the time range was between 15 to 75 min). By contrast, it takes ~
20 min using nitrogen gas (Figure 23).
The hexokinase assay kit and method was carried out to detect the amount of
glucose produced. The sample volume for this determination was 10 µl, which
were transferred into a UV transparent 96-well plate (Greiner UV-star M3812,
Sigma). For this method, the hexokinase reagent was ordered individually and
the D-glucose standard was prepared freshly for each set of experiment.
Subsequently, 250 µl hexokinase reagent was added to those samples and
incubated at 37ºC for 15 min. Absorbance was read at 340 nm with the
PHERAstar FS microplate reader (BMG LABTECH). Results are presented as
percent inhibition relative to the blank control.
GLUCOSE ATP+ G-6-P ADP+
G-6-P NAD+ 6-PG NADH+
HK
G-6-PDH
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It was observed that the hexokinase assay reagent was inhibited by green tea and
German chamomile extracts. In this case, polyphenols had a role in the
hexokinase activity. Therefore, the polyphenol content of the samples needed to
be removed. Before adding the hexokinase reagent into the samples, SPE
columns (Waters Oasis MAX Cartridge 003036349A) were used to remove the
polyphenols (after solid phase extraction there were not any hexokinase
inhibition occurred) from the green tea and German chamomile extracts and the
hexokinase assay kit was then employed to determine glucose production.
3.3 Statistical analysis
IBM SPSS Statistics 22 was used for the analysis of the data. The Levene test
was used to evaluate the homogeneity of the means groups. If the criterion was
met the Tukey HSD post hoc test was applied: otherwise, the Dunnett C
followed the one way Anova. The values shown represent the mean values and
the error bars indicate the standard deviation (SD). Unless otherwise stated,
differences were considered as statistically significant when p≤0.05. 
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Figure 23 Practical steps involved in determining inhibition of the digestive
enzymes.
3.4 Results
Enzyme activity was measured in the presence of various concentrations of green
tea and purified German chamomile (maltodextrin-free) extracts. Acarbose was
used as a positive control.
The standard curves obtained with pure glucose standard solutions were all linear
and reproducible. The concentration range of glucose was between 0.3 to 20 mM
(Figure 24). The equation from the linear regression was used for the glucose
concentration calculation in the samples.
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Figure 24 Glucose standard curve with hexokinase assay (average of 22
experiment).
Mean± SD (n=3 per concentration for each 22 experiments).
The inhibition by the PFS extracts against rat intestinal sucrase/isomaltase and
maltase activities was measured by increasing substrate concentration with or
without PFS extracts at different concentrations. The enzyme inhibitory reaction
results were calculated according to Michaelis-Menten kinetics. Using a chosen
enzyme concentration and different incubation times, the kinetic parameters of
Km and Vmax were determined using a Lineweaver-Burk plot. Those calculated
kinetic parameters were compared with Hanes Woolf and Eadie Hofstee plots
and the Km and Vmax accepted as the average of these plots for each of the
digestive enzymes.
3.4.1 Inhibition of sucrase activity by PFS
To set up and validate the assay, the Km for sucrose with the rat intestinal
acetone extract was measured. The Km value for the measurement of glucose
production from sucrose was 18.3 mM and Vmax was 0.13 µmol substrate
hydrolysed/min for rat intestinal acetone extract (Figure 25). This value was
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close to the Km value of 18 mM determined for sucrase from mouse intestine
(Lee et al., 1998) and for purified sucrase it was 20 mM from Sprague-Dawley
rats (Conklin et al., 1975). The substrate concentration was adopted 16 mM due
to the average of the Lineweaver-Burk, Hanes Woolf and Eadie Hofstee plots.
Figure 25 Lineweaver-Burk plot for sucrase digestion of sucrose.
From this, Km= 18 mM sucrose and Vmax 0.13 µmol substrate hydrolysed/minute.
Mean± SD n=3.
Glucose production from sucrose was observed at different concentrations of rat
intestinal extract sucrase (Figure 26).
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Figure 26 Time dependence of glucose production from sucrose (16 mM) in the
presence of different concentrations of acetone extract of rat intestinal sucrase
(10, 20 and 40 mg/ml).
Mean ± SD (n=3 per time point). Tukey HSD test applied.
Table 10 Absorbance (340 nm) and concentration of glucose production from
sucrose with different concentrations of rat intestinal extract after 20 min
incubation.
Enzyme concentration
(mg/ml)
A340 Glucose (mM) Specific activity
(µmol/min/g)
10 0.082 0.341 8.5
20 0.188 0.731 9.1
40 0.266 1.358 8.5
From this data, the incubation time and enzyme concentration were chosen to
give the optimum assay conditions, 20 min and 20 mg/ml acetone rat intestinal
sucrase extract (Table 10). It was suggested in the hexokinase assay kit product
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information that the absorbance reading for glucose needed to be between 0.03
and 1.6.
The rate of reaction was dependent on the enzyme concentration (Figure 27).
Figure 27 Data from Figure 26 replotted to show the dependence of the rate
upon enzyme concentration.
3.4.2 Inhibition of maltase activity by PFS
Using a chosen enzyme concentration and different incubation times, the kinetic
parameters of Km and Vmax were determined with the Lineweaver-Burk plot. The
Km value for the measurement of glucose production from maltose was 3.4 mM
and Vmax was 0.26 mM substrate hydrolysed/min for rat intestinal maltase
(Figure 28). This value was close to the Km value of other studies; 2.7 mM
(Yoshikawa et al., 1997) and 3.3-3.7 mM determined for maltase from rat small
intestine. The substrate concentration adopted was 3 mM due to the average of
the Lineweaver-Burk, Hanes Woolf and Eadie Hofstee plots.
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Figure 28 Lineweaver-Burk plot for maltase digestion of maltose.
From this, Km 3.4 mM maltose and Vmax 0.26 µmol substrate hydrolysed/minute.
Mean± SD (n=3).
Figure 29 Time dependence of glucose production from maltose (3 mM) at
different concentrations of rat intestinal acetone extracts (2, 4, and 6 mg/ml).
Mean± SD (n=3 per time point for each enzyme concentration).
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Glucose production from maltose was observed at different concentrations of
acetone rat intestinal extract (Figure 29 and Figure 26). The concentration of
glucose as product increased with enzyme activity.
The incubation time and enzyme concentration were chosen for optimum assay
conditions as 20 min and 4 mg/ml acetone rat intestinal extract (Table 10).
Table 11 Absorbance (340 nm) and concentration of glucose production from
maltose at different concentrations of acetone rat intestinal extract after 20 min.
Enzyme concentration
(mg/ml)
A340 Glucose (mM) Specific activity
(µmol/min/g)
2 0.113 0.695 86
4 0.225 1.383 87
6 0.380 2.336 97
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Figure 30 Data from Figure 26 replotted to show the dependence of rate upon
enzyme concentration (2, 4 and 6 mg/ml solid).
The rate of enzyme reaction depends on the enzyme concentration (Figure 30).
Compared to sucrose hydrolysis, the hydrolysis of maltose was faster.
3.4.3 Inhibition of isomaltase activity by PFS
The Km value for glucose production from isomaltose was 5.7 mM and Vmax was
0.12 µmol substrate hydrolysed/min for rat intestinal acetone powder (Figure
31Figure 25). This value was close to the Km value of 4.5 mM (Yoshilawa et al.,
1997 and Oku et al., 2006). The substrate concentration was adopted 6 mM due
to the average of the Lineweaver-Burk, Hanes Woolf and Eadie Hofstee plots.
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Figure 31 Lineweaver-Burk plot for isomaltase activity.
From this, Km= 5.7 mM isomaltose and Vmax 0.12 µmol substrate
hydrolysed/minute. Mean± SD (n=3).
Glucose production from isomaltose was observed at different concentrations of
acetone rat intestinal extract (Figure 32).
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Figure 32 Time dependence of glucose production from isomaltose (6 mM) at
different concentration of rat intestine acetone extracts (10, 20, and 40 mg/ml).
The incubation time and enzyme concentration were chosen for optimum assay
conditions as 20 min and 20 mg/ml acetone rat intestinal extract (Table 12).
Table 12 Absorbance (340 nm) and concentration of glucose produced from
isomaltose at different concentrations of acetone rat intestinal extract after 20
min.
Enzyme concentration
(mg/ml)
A340 Glucose (mM) Specific activity
(µmol/min/g)
10 0.102 0.621 15.5
20 0.195 1.084 14.6
40 0.329 1.719 10.7
The rate of enzyme reaction depends on the enzyme concentration (Figure 33).
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Figure 33 Data from Figure 26 replotted to show the dependence of the rate
upon enzyme concentration (10, 20 and 40 mg/ml).
3.4.4 Effect of PFS extracts and maltodextrin on glucose hexokinase
reagent
PFS extracts contain maltodextrin (Table 14). To analyse any interference of the
hexokinase assay by PFS extracts and the maltodextrin content of the PFS
extracts, the test assay was modified. It was found that green tea extract was able
to inhibit hexokinase activity. The inhibitory activity of green tea extract was
from its polyphenol content (due to the reducing potential of polyphenols). To
remove the polyphenol content of green tea extract in the assay, an SPE column
was used, and two different columns were tested to choose the most effective
column for polyphenol content removal of extract. Waters Oasis Max Cartridge
(186000367) was more effective than Discovery DSC-18 SPE (52603-U) for
removing the polyphenols from the green tea extract. After centrifugation of
each sample to collect the supernatant (last process of inhibition assay steps),
each sample was extracted through the Waters Oasis Max Cartridge to remove
any polyphenols.
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Table 13 Added maltodextrin content of PFS extracts (PhytoLab information
sheet).
PFS extracts Maltodextrin (%)
Green tea 0
German chamomile 50
Vitis Viniferae 17
By contrast, maltodextrin did not have any inhibitory activity on hexokinase.
Also, German chamomile extract did not show any inhibitory activity on
hexokinase after removal of maltodextrin.
3.4.5 Effect of maltodextrin on the acetone rat intestinal extract
Maltodextrin is an oligosaccharide and consists of D-glucose units connected in
variable lengths. The glucose units are linked with α-1,4 glycosidic bonds and it 
is easily digested and absorbed as quickly as glucose. Therefore, it may be a
potential substrate for acetone rat intestinal extract. To analyse this, 2 mg/ml of
each PFS extract was tested to observe their inhibitory effect on rat intestinal
sucrase, maltase and isomaltase enzymes. Green tea extract inhibited maltase
activity more strongly than isomaltase and sucrase. Conversely, German
chamomile and Vitis Viniferae extracts were ineffective. Hence the effect of
maltodextrin on acetone rat intestinal extract was analysed.
Various concentrations of maltodextrin were added to the assay as a substrate
without any other sugar content and then the same process was performed with
inhibition of the digestive enzyme assay. It was found that maltodextrin was a
potent substrate for acetone rat intestinal extract. Therefore, analysis of PFS
extracts, which contain maltodextrin, cannot occur unless the maltodextrin
content is removed. Mr. J. Alberto purified the German chamomile extract using
the Akta purifier. The inhibition effect of this purified extract on digestive
enzymes was analysed.
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3.4.6 Inhibition of digestive enzymes with green tea extract
Enzyme activity was measured in the presence of different concentrations of
green tea extract. The maximum concentration of green tea extract was chosen as
2 mg/ml.
Maltose digestion was faster than isomaltose, and sucrose digestion was the
slowest (Figure 34). Also, increasing the green tea concentration increases the
percentage inhibition of sucrase, maltase and isomaltase (Figure 34).
Figure 34 Inhibition of digestive enzymes with different concentrations of green
tea extract.
Mean± SD (n=3 for each concentration from each substrate). Tukey HSD test
applied.
Figure 34 demonstrated that the inhibition of α-glucosidase enzymes was dose 
dependent. Both Figure 34 and Table 14 indicate that green tea extract inhibits
maltase more strongly than isomaltase and sucrase. This also supports the study
of Matsui and colleagues (Matsui et al., 2007). They analysed the inhibitory
effect of catechins and theaflavins, which are mainly present in green tea and
maltase activity was inhibited more strongly than sucrase.
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Table 14 IC50 values for rat intestinal α-glucosidases (sucrase, maltase and 
isomaltase) using green tea extract.
Enzyme IC50 (mg/ml)
Sucrase 0.95 ± 0.12
Maltase 0.44 ± 0.09
Isomaltase 0.69 ± 0.15
Mean± SD (n=3 for each concentration from each substrate). Tukey HSD test
applied.
3.4.7 Inhibition of digestive enzymes with purified German
chamomile extract
Purified German chamomile extract did not contain any maltodextrin and so it
was suitable to assess any inhibitory effect on digestive enzymes. As the extract
contained only polyphenols, the concentration to reach 50 % inhibition was
expected to be lower than green tea extract. There was a limitation with this
extract: it was not possible to dissolve this purified extract with deionized water
but it was soluble in 100 % DMSO.
3.4.7.1 Effect of DMSO on rat intestinal powder
The final concentration of DMSO in the assay was 4 %, therefore the effect of 4 %
DMSO on acetone rat intestinal extract has been analysed. It was observed that
4 % DMSO inhibited 8 % of acetone rat intestinal extract activity. Therefore, the
production of glucose needed to be corrected based on this result.
3.4.7.2 The inhibitory effect of purified German chamomile extract on
digestive enzymes
As German chamomile extract was purified, it was expected that with a lower
concentration there will be more inhibitory activity compared to green tea extract.
Intriguingly, the results showed that German chamomile extract activated the
sucrase and isomaltase activity; however, it was ineffective on maltase activity.
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Maltase activity was not affected by the purified extract (Table 15). To confirm
that purified extract was not affecting the glucose hexokinase reagent, the Waters
Oasis Max Cartridge was used to remove the polyphenol content of the purified
German chamomile extract (no inhibitory activity on hexokinase observed after
solid phase extraction) and it did not show any effect on the hexokinase reagent.
Table 15 Effect of 0.4 mg/ml purified German chamomile extract on sucrase,
maltase and isomaltase activity.
Enzyme GC (mg/ml) A340 Glucose
(mM)
Difference
(%)
Sucrase 0 0.131± 0.009 0.76
0.4 0.205± 0.007* 1.19 156
Isomaltase 0 0.135± 0.006 0.78
0.4 0.193± 0.009* 1.12 143
Maltase 0 0.236± 0.008 1.37
0.4 0.249± 0.011 1.44 105
Asterisk denote significant difference compare to control sample (*p<0.01).
Mean± SD (n=3 per inhibitor concentration). Tukey HSD test applied.
Isomaltase and sucrase enzymes are attached together with two active sites, so
the inhibition of both enzymes should be close or the same as each other. It is
quite close for green tea extract inhibition and also purified German chamomile
extract has a similar activation level for sucrase and isomaltase, whereas the
activation of maltase was low (Table 15).
Further analyses should be performed to understand which compound was
activating the sucrase/isomaltase in the German chamomile extract.
The concentration of all the substrates was increased four fold (12 mM maltose,
64 mM sucrose and 24 mM isomaltose) and incubation time and enzyme
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concentration of each substrate assay remained the same and the effect of
purified German chamomile extract assessed (Table 16).
Table 16 Inhibitory effect of 0.4 mg/ml purified German chamomile extract on
sucrase, maltase and isomaltase with a four times higher concentration of
substrates (64 mM sucrose, 24 mM isomaltose and 12 mM maltose).
Enzyme GC (mg/ml) A340 Glucose
(mM)
Difference (%)
Sucrase 0 0.270±0.010 2.0
0.4 0.357±0.009* 2.7 132
Isomaltase 0 0.263±0.007 2.0
0.4 0.356±0.014* 2.7 135
Maltase 0 0.388±0.005 2.9
0.4 0.370±0.007 2.8 95
Mean± SD (n=3 per concentration). Asterisk denote significant difference
compare to control sample (*p<0.05). Tukey HSD test applied.
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Table 17 Effect of DMSO at a 4-times higher concentration of substrates (64
mM sucrose, 24 mM isomaltose and 12 mM maltose).
Substrate A340 Glucose
(mM)
Inhibition (%)
Sucrose 0.389± 0.009 2.7
Sucrose+ DMSO 0.263± 0.011* 1.8 24
Isomaltose 0.276± 0.01 1.9
Isomaltose+ DMSO 0.266± 0.008 1.9 2
Maltose 0.420± 0.009 2.9
Maltose+ DMSO 0.399± 0.005 2.8 4
Mean± SD (n=3 per concentration). Asterisk denote significant difference
compare to DMSO free sample (*p<0.05). Tukey HSD test applied.
These results demonstrated that the effect of DMSO is different at higher
concentrations of substrate. According to Table 17, with a higher concentration
of sucrose, the inhibitory activity of DMSO was higher than the usual sucrose
concentration (16 mM- 8% inhibition). However, it was lower with isomaltose
and maltose concentrations. Therefore, Table 17 showed the inhibitor effect of
DMSO on sucrase/isomaltase and maltase activity, with a higher concentration
of substrate having a higher inhibition.
3.4.8 Effect of acarbose on digestive enzymes
There are certain drugs that are used for the treatment of type 2 diabetes, such as
acarbose; miglitol and voglibose are some of the examples of α-glucosidase 
inhibitors. However, these drugs may have side effects including diarrhea,
abdominal discomfort and flatulence.
In this experiment, due to the proven acarbose inhibitory activity (commonly
used in the literature), it was used as a positive control. With 0.1 mM acarbose
concentration the percentage inhibition of sucrase, isomaltase and maltase were
90± 3.5, 64± 4.8 and 100± 2 %, respectively.
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3.5 Discussion
There are prescription drugs available for the treatment of diabetes but these may
have unpleasant side effects (Kwon et al., 2007). Therefore, investigating
alternatives for management of diabetes has become popular in research.
Green tea extract inhibited maltase, sucrase and isomaltase activities in vitro
with IC50 values of 0.95, 0.44, and 0.69 mg/ml, respectively. This supports the
findings of Matsui (Matsui et al., 2007) where they analysed the inhibitory effect
of catechins and the flavins, which are mainly present in black tea and green tea,
and maltase was more strongly inhibited than sucrase. By contrast, Gupta and
colleagues (2007) reported that gallic acid, which is also present in tea, inhibited
sucrase more potently than maltase in rats.
Yilmazer- Musa and colleagues (2012) reported that grape seed extract strongly
inhibited α-glucosidases with an IC50 value of 8.7 µg/ml compared to green tea
extract with an IC50 value of 34.9 µg/ml. The authors also tested some of the
green tea polyphenols and found that EGCG, GCG and ECG inhibited α-
glucosidase with IC50 values of 24, 17 and 27 µg/ml, respectively. However C,
EC and EGC were weak in α-glucosidase inhibition. Gao and colleagues (2013) 
analysed the combined effect of green tea extract (GTE), green tea polyphenols
(GTP) and EGCG with acarbose. They found that GTE, GTP and EGCG without
acarbose combination inhibited α-glucosidase activity with IC50 values of 4.4, 10
and 5.2 µg/ml, respectively. Acarbose also inhibited with an IC50 value of 4.8
µg/ml. When they combined GTE, GTP and EGCG with acarbose, they showed
a synergistic effect at low concentration. By contrast, the higher concentrations
showed an antagonistic effect (combination index). The combination of GTE,
GTP and EGCG with acarbose had a synergistic effect on α-glucosidase when 
the inhibition percentage was below 47, 62.5 and 68%, respectively. The results
of this investigation regarding green tea extract appear to be in agreement with
others that describe the effect of green tea and its polyphenols on sucrase and
maltase activity. Kamiyama and colleagues (2010) investigated the inhibition of
maltase by green tea extract and catechins. Green tea extract inhibited rat
intestinal maltase with IC50 value of 45 µg/ml. The authors analysed the IC50
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values for catechin 3-gallate (CG), gallocatechin 3-gallate (GCG), epicatechin 3-
gallate (ECG) and epigallocatechin 3-gallate (EGCG). They were good inhibitors
of maltase, however, EGCG showed good inhibition towards maltase expressed
in Caco-2 cells, with an IC50 value of 27 µM. The gallated catechins showed
significant inhibition while the ungallated catechins did not show significant
effects. They concluded that gallated catechins or the green tea extract containing
gallated catechins in dietary supplementation would contribute to the protection
or improvement of type-2 diabetes and it may also explain the medicinal use of
green tea as an anti-diabetic treatment in some cultures.
The inhibition of α-glucosidase and α-amylase was analysed with luteolin. The 
inhibitory activity of luteolin for α-glucosidase was stronger than acarbose. 
Luteolin, at 0.5 mg/ml, inhibited α-glucosidase by 36% (Kim et al., 2000). They
also tested 22 flavonoids for their inhibitory activity of α-glucosidase and α-
amylase. The inhibitory activity of luteolin on yeast α-glucosidase was stronger 
than acarbose with IC50 0.5 and 5 mg/ml, respectively. Luteolin-7-O-glucosidase
also inhibited the activity of α-glucosidase significantly. Those analysed 
compounds are present in the German chamomile extracts (GCE) and in contrast
to the current study, luteolin-7-O-glucoside and luteolin represented the
inhibition effect on enzymes. Kato and colleagues (2008) reported the inhibition
of pancreatic α-amylase and rat intestinal maltase and sucrase activities in the 
presence of chamomile and some of the active component of chamomile.
Chamomile extract inhibited maltase and sucrase activity with IC50 values of 2.6
and 0.9 mg/ml, respectively. The effect of major components of chamomile
(esculetin, apigenin, luteolin and quercetin at 400 µM) has also been tested in a
hot water extract on sucrase and maltase activity. It was found that inhibition of
maltase with quercetin was the highest (63 %), apigenin was about 35 % and
luteolin was 15 %. Also, the inhibitory effect of esculetin was higher on sucrase
activity (72.5 %) and quercetin showed the lowest effect (8.5 %). However, GCE
and all compounds were weaker inhibitors than acarbose and, therefore it was
concluded that the hot water extract of GCE had a weak inhibitory activity
against rat intestinal maltase and sucrase. Esculetin and quercetin inhibited with
IC50 values of 72 and 71 µM, respectively. They also analysed the effect of hot
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water extract, esculetin and quercetin on the blood glucose levels of fasted mice.
After sucrose loading (2.5 g/kg body weight) to fasted mice, it was observed that
GCE and quercetin decreased the blood glucose concentration at 30 and 60 min.
Esculetin (50 mg/kg) showed a suppressive effect at 15 and 30 min on blood
glucose level. By contrast, findings of this project showed that purified German
chamomile extract activated the sucrase and isomaltase activity and it was
ineffective on maltase activity.
Oku et al., 2006 investigated the inhibitory effect of the leaves of Morus alba
(ELM) on human intestinal disaccharides and the inhibitory activities of ELM
were investigated. Sucrase, maltase and isomaltase of the human small intestine
were conspicuously inhibited by ELM, whereas trehalase and lactase were not so
strongly inhibited. The inhibitory effects became significant as the concentration
of ELM increased. All of the inhibitory activities by ELM for sucrase, maltase
and isomaltase of the rat small intestine were competitive inhibitory activities.
In the current study, green tea, German chamomile and Vitis viniferae extracts
was analysed for their possible interference with α-glucosidase assays and 
assessed by considering critical parameters affecting the final inhibition
(maltodextrin content of the extract, polyphenol reduction potential (the number
of OH groups in the chemical structure) causing an interference with hexokinase
reagent (Rice-Evans et al., 1996) and the effect of DMSO to enzyme activity).
After the enzymatic hydrolysis of substrates the potential reactive inhibitors were
removed by SPE and then hexokinase reagent was used to assess the product.
Therefore, in many published studies the reducing capacity of polyphenols was
ignored and the results of the inhibition may be inconsistent.
The results of this investigation appear to be in agreement with others that
describe the effect of polyphenols on sucrase, maltase and isomaltase activity for
the effect of green tea extract.
Whilst it can be considered that inhibition of α-glucosidase enzymes could 
potentially reduce postprandial blood glucose levels, specific activity of the
enzymes in human intestine and reactivity of polyphenols with other compounds
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must be taken into account. The findings of this study revealed that green tea
extract could inhibit sucrase, maltase and isomaltase activity. As a result it might
be useful as a supplement for use in suppressing postprandial hyperglycaemia in
the management of type-2 diabetes.
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CHAPTER 4 INHIBITION OF GLUCOSE
TRANSPORT AND METABOLISM BY PLANT
FOOD SUPPLEMENTS
Abstract
Plant food supplements may have a major role in mediating intestinal glucose
transport across the brush border membrane of enterocytes and so they may
improve the management of diabetes (acarbose-like activity). Glucose transport
across the Caco-2 cell monolayer was significantly attenuated in the presence of
PFS. Green tea, German chamomile and Vitis Viniferae extracts inhibited both
the uptake and transport of glucose when tested independently. By contrast,
Pelargonium and Echinacea were ineffective. Using Na+-containing and Na+-free
conditions in the presence of German chamomile, we concluded that the
inhibition of GLUT2 was greater than SGLT1. Accordingly, the results indicate
that apical GLUT2 is the primary target of the compounds from the German
chamomile extract.
Some of the compounds that are present in German chamomile extract were also
tested to determine their contribution to the inhibition of transport and uptake of
glucose. Luteolin was the most effective compound to inhibit glucose transport;
on the other hand, luteolin-7-O-glucoside produced the most effective inhibition
of cellular glucose uptake. To analyse the effect of digestion on the biological
activity of German chamomile extract, the extract was subjected to enzymatic
hydrolysis followed by extraction as a model of the first step of digestion in the
gut. Hydrolysis using hesperinidase and cellulose removed the sugars from the
polyphenols in the German chamomile and cleaved the ester bonds between
phenolic and quinic acid (the first step of digestion in the gut). This digestion
affects the biological activity of German chamomile due to glucose transport
across the cell monolayer, which was decreased by approximately 50%. The
response of the Caco-2 cell line to stress (FBS starvation or glucose load
overnight) was assessed after treatment with German chamomile or additional
glucose. Both transport and uptake of glucose were tested. FBS starvation or
addition of German chamomile overnight (12 h) did not have any effect on the
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cellular uptake and transport of glucose. However, overnight incubation with a
lower glucose concentration (1 mM) increased the transport of glucose
significantly, but did not affect the cellular uptake. Transport of deoxyglucose
was significantly inhibited by the same PFS treatments that affected glucose. In
contrast to glucose, deoxyglucose uptake was not changed by any PFS
treatments. In summary these results show, PFS may be effective on the
management of diabetes due to their effect on glucose transport and metabolism.
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4.1 Introduction
Carbohydrates and sugars make up the most important energy containing
components of the diet. After consumption of carbohydrates or sugars, digestive
processes lead to the appearance of glucose in the blood. Glucose is the main
product of sugar and starch digestion, and is transported to the blood from the
intestinal lumen by active transport via SGLT1 and by facilitated sodium-
independent transport via GLUT2 (Goodman, 2010). After two Na+ ions bind to
SGLT1 on the luminal side of the intestinal brush border membrane, a
conformational change takes place that allows glucose binding. A second
conformational change allows glucose and Na+ to enter the enterocyte
(Goodman, 2010). Glucose is released from the enterocyte via the GLUT2
passive transporter at the basal surface and enters circulation. The process of
uptake and expulsion is simultaneous (Figure 35) (Goodman, 2010). It should
also be noted that the transporters have different Km values and specificity for the
carbohydrate substrates. Hediger and Rhoads (1994) reported a Km for SGLT1 of
0.8 mM, whereas GLUT2 has a high capacity for glucose transport with a Km
value of 17 mM (Thorens, 1996).
Consumption of plant foods is thought to lower the risk of chronic diseases
including diabetes, cardiovascular diseases and cancer (Scalbert et al., 2005;
Crozier et al., 2009; Clifford et al., 2004; Knekt et al., 2002). The highest
concentration of polyphenols is in the gut lumen compared to any other tissue in
the body (Williamson, 2012). After consumption of polyphenol-rich beverages,
such as coffee, tea and orange juice, polyphenols can reach millimolar
concentrations in the gut lumen (Williamson, 2012). Therefore, glucose transport
and metabolism in the gut lumen may potentially be affected by polyphenols.
However, as their concentrations are <0.005 mM in the blood and tissues,
polyphenol effects in peripheral tissues are expected to be less potent
(Williamson, 2012).
A plethora of in vitro, ex vitro, animal and human intervention studies has shown
that various dietary polyphenols may influence carbohydrate metabolism at
many levels. The possible mechanisms proposed include inhibition of digestive
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enzymes for glucose production, inhibition of glucose transporters in the
intestine, stimulation of insulin secretion from the pancreatic β-cells, activation 
of insulin receptors and glucose uptake in the insulin-sensitive tissues,
modulation of glucose release from the liver, and modulation of intracellular
signalling pathways and gene expression (Hanhineva et al., 2010).
Figure 35 Mechanism of glucose absorption to basolateral compartment in a
Caco-2 cell system (G: glucose).
Phytochemicals are known to affect the apical membrane SGLT-1. Phloridzin is
a commonly used inhibitor of nutrient absorption across the apical membrane of
enterocytes (Buddington et al., 2003). By decreasing SGLT-1 activity (some
polyphenols inhibit the transport of glucose), soy isoflavones partly affect post-
prandial glucose levels; tea polyphenols have been shown to lower the rate of
glucose transport by non-specific binding to proteins; and catechins and other
phytochemicals are able to change the brush border fluidity potentially
influencing the function of transporters. A concentration of 100 µM (+)-
catechin, (-)- epicatechin, epicatechin gallate, epigallocatechin and
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epigallocatechin gallate also reduced sodium-dependent glucose uptake
(Johnston et al., 2005).
Manzano and Williamson (2010) reported that strawberry and apple extracts
inhibited glucose transport and uptake across a Caco-2 cell monolayer dose-
dependently. GLUT2 inhibition was more potent than SGLT1 based on the IC50
values. Johnston et al. (2005) and Kwon et al. (2007) also investigated glucose
uptake inhibition by quercetin at physiologically relevant concentrations.
Treatment with 100 µM epicatechin gallate and quercetin-3-O-glucoside were
also reported to competitively inhibit GLUT2 (Chen et al. 2007).
A more recent investigation of glucose uptake in Caco-2 cell monolayers was
reported in the presence of an anthocyanin-rich berry extract in two conditions;
after acute exposure glucose uptake was significantly decreased for both SGLT1
and GLUT2 and during a longer term exposure the extract significantly reduced
both GLUT2 and SGLT1 mRNA and protein levels (Alzaid, 2013).
Although many studies exist on the health effects of polyphenol-rich foods, such
as fruits & vegetables (including oranges, apples, strawberries and onions) or
beverages (including coffee, tea, wine and orange juice), limited studies have
been performed to specifically determine the effect of PFS on glucose transport.
Yeh et al. (2003) reviewed 58 control clinical trials involving individuals with
diabetes (mostly type 2) or impaired glucose tolerance (36 herbs used). A total of
44 out of 58 (76%) subjects showed improved glucose control with the tested
supplements (e.g. Coccinia indica, American ginseng, Chromium, Gymnema
sylvestre, Aloe vera, Vanadium, Momordica charantia, and Nopal). However, no
definitive conclusions were made regarding the activity of these herbs and
supplements for diabetes. In this regard, further analysis is needed.
Another recent review regarding herbal supplements was published by
Suksamboon et al. (2011). The review was related to glycaemic control. The
review showed that Ipomoea batatas, Silybum marianum and Trigonella foenum-
graecum, but not Cinnamomum cassia, may improve glycemic control in Type 2
diabetes.
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PFS contain concentrated sources of plants, their extracts or derivatives, and they
are able to deliver physiological effects. Throughout history, plants and herbs
have been part of the diet not only because they provide nutrients, but also for
their health-promoting properties. This remains the case today, and the
consumption of plant based foods has been increasing (Moini et al., 2000; Weiss
et al., 2006; Seeram et al., 2006; Dabaghian et al., 2012). The aim of this
investigation was to determine the effect of polyphenols from different plant
food supplements (green tea, German chamomile, Vitis viniferae, Pelargonium,
and Echinacea) on cellular glucose uptake and transport of glucose from the
apical to basolateral compartment using a Caco-2 intestinal cell model.
4.2 Material and methods
4.2.1 Standards and reagents
D-[U-14C] glucose 250 µCi (9.25 MBq) was purchased from Perkin Elmer
(Boston, USA). D-glucose was purchased from Fisher Scientific Ltd,
(Leicestershire, UK G/0450/60). The PFS were supplied by PhytoLab & Co
(Vestenbergsgreuth, Germany) within a European FP7 project framework
(PlantLibra). Dulbecco's Modified Eagle's Medium DMEM; including 1000 mg
glucose/L, L-glutamine, NaHCO3 and pyridoxine HCl) were purchased from
Sigma (Dorset, UK; D6046). Caco-2 cells (HTB-37) were obtained from the
American Type Culture Collection (LGC Promochem, Middlesex, UK).
4.2.2 Cell Culture
Cells were routinely grown in DMEM media containing low D-glucose (5 mM)
supplemented with 15% (v/v) fetal bovine serum (FBS; F7524), 100 U/ml
penicillin, 0.1 mg/ml streptomycin out of a solution containing (10,000 U/ml-10
mg/ml; P0781), and 0.25 µg/ml amphotericin B (250 μg/ml, A2942). Cells were 
propagated in 25 cm2 (Corning® 430639) and 75 cm2 (Corning® 430641) cell
culture flasks in a 95% air/5% CO2 incubator at 37°C. Every second or third day
the growth medium was replaced with fresh medium. When cells reached 80-90%
confluence they were detached from the flask using 0.25% trypsin-EDTA
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solution (T4049). Caco-2 cells were plated on Transwell® plates (Corning®
3412) at a density of 6.43 x 104 cells/cm2. Growth media contained 10% FBS
(v/v), 100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.25µg/ml amphotericin
B in DMEM media and replaced every other day in both compartments until full
differentiation of the monolayer (between 21 and 23 days).
4.3 Glucose transport in Caco-2 cells
4.3.1 Preparation of Reagents
All the reagents were prepared freshly on the day of the experiment. A solution
(TBS) prepared to use in the transport experiment with no glucose content. TBS
was prepared according to the HBSS formulation without the addition of glucose.
TBS contained 5.4 mM potassium chloride (P5405), 0.441 mM potassium
phosphate (P0662), 0.352 mM sodium phosphate dibasic (S9763), 4.2 mM
sodium bicarbonate (S5761), 1.8 mM calcium chloride dihydrate (C7902) and
0.1 mM ascorbic acid (A4544) (all from Sigma, Dorset, UK) and 137 mM
sodium chloride (Fisher Scientific Ltd, Leicestershire, UK S5886), dissolved in
water and the pH was adjusted to 7.4 with 1M HCl before being sterile filtered
(Corning® 430049). The buffer was pre-warmed at 37°C.
4.3.2 Glucose
A stock solution of 10 mM glucose was prepared. Briefly, 180 mg of glucose
(Fisher Scientific; G/0450/60) was dissolved in 100 ml of transport buffer
solution. 1 ml of stock solution with/without PFS was added to TBS to a final
volume of 10 ml containing 9 µl of 0.1 µCi/µl 14C-glucose (Perkin-Elmer;
product number: NEC042X250UC). The pH was adjusted to 7.4 at 37 0C for
each sample with 1 M HCl or NaOH.
4.3.3 Plant Food Supplement extracts preparation
10 mg of each PFS was weighed and dissolved in 1 ml of TBS (v/v) and
centrifuged at 17000 g for 5 min. The supernatant was collected and the relevant
volume added to 10 ml TBS solution containing 1 mM glucose and 0.045 µCi/ml
glucose.
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To increase the water solubility of the supplements (except for the green tea
extract), different concentrations of maltodextrin were added by the supplier
(PhytoLab). Maltodextrin consists of D-glucose units linked by α-1, 4 glycosidic 
bonds with variable length. However, the use of radiolabelled glucose mixed
with non-radiolabelled substrate allows for high sensitivity of the obtained
counts. The relatively small amount of radiolabelled glucose (1 mM glucose
including 9 µl of 0.1 µCi/µl D-[14C]-glucose stock solution) mixed with
sufficient unlabelled glucose (1 mM) means that the maltodextrin contained in
the PFS did not interfere with the assay. The amount of maltodextrin in every
PFS was: 50 % in German chamomile and Echinacea, 13 % in grape extract and
70 % in Pelargonium. We also determined that maltodextrin (0.5 mg/ml) to does
not interfere with the assay (Figure 49). The final PFS concentration was
corrected for the maltodextrin content.
4.3.4 Preparation of German chamomile active components
The individual compounds (apigenin, A7G, luteolin, L7G, diCQA, umbelliferone)
tested were diluted in TBS from a 30 or 50 mM stock solution prepared in 100 %
DMSO. All of the compounds were supplied by PhytoLab & Co.
(Vestenbergsgreuth, Germany). The final concentration of DMSO in the assay
did not exceed 0.1 %.
4.4 Inhibition assay protocol
Cells between passage 36 and 50 were utilised in the investigation of glucose
transport. A minimum of four or six replicates were allocated per experimental
condition.
On or after 21 days, transport studies were initiated by replacement of growth
medium with TBS in both compartments, and cells were washed three times with
addition of TBS to both compartment. After washing cells, 2 ml TBS was added
to both apical and basolateral sides and pre-incubated for 30 min at 37 °C under
a humidified atmosphere. Differentiation of the monolayer was assessed by
measurement of trans-epithelial electrical resistance (TEER) of the cell
monolayer. Only Transwell® inserts with a resistance exceeding a blank
membrane by 300 Ω were utilized in the experiment. A low TEER value may 
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indicate less well-formed tight junctions and a potential increase in paracellular
transport of glucose across the membrane. After equilibration, TEER values
were taken from three positions per insert and TBS was carefully aspirated to
waste. For experiments, 2 ml TBS containing 1 mM glucose solution and 0.045
µCi/ml glucose with or without PFS extracts (pH 7.4) was added to the apical
compartment and 2 ml TBS in the basal compartment. Cells were incubated for
25 min at 37°C. Following incubation, TEER values were measured again as
above and solutions from apical and basolateral compartments were removed in
to 2 ml centrifuge tubes and immediately placed on ice. To wash cells of any
residual radioactivity, 2 ml TBS was added to each compartment and then
removed to 2 ml centrifuge tubes and placed on ice. Following this, 1 ml of 1 M
NaOH solution was added to detach the cells from the membrane and plates were
shaken for 30 min on a horizontal shaker. Suspended cells were transferred to
eppendorf tubes. To neutralize the NaOH, 1 ml of 1 M HCl was added per tube.
To analyse for counts in the different compartments the samples were vortexed
to ensure homogeneity, and 0.25 ml from apical and sample blanks, and 0.5 ml
from the cell suspension, basolateral and wash buffer were transferred to
scintillation vials containing 5 ml of scintillation liquid. Radioactivity was
determined using a Packard 1600 TR Liquid Scintillation Analyser (Figure 36).
Light emission was counted for 10 min per vial and the number of counts per
min (CPM) was calculated by the equipment software.
4.4.1 Liquid scintillation counting (LSC)
A Packard 1600 TR Liquid Scintillation Analyser was used for liquid
scintillation counting (LSC). In this experiment, the D-[14C]-glucose isotope
(Perkin-Elmer, NEC042V250UC) was used for the assessment of glucose
transport and cellular uptake.
The carbon-14 isotope emits high-energy beta radiation which is absorbed by the
scintillation cocktail into detectable light pulses. This scintillation cocktail serves
as an energy-collecting solvent to transfer the emitted energy efficiently to light.
Beta particles emitted from the [14-C]-glucose isotope transfer their energy to
solvent molecules. This energy is absorbed by the scintillator (phosphor
facilities). The absorption of energy excites the phosphor causing it to emit light
- 106 -
energy that is detected by the photomultiplier tube (PMT) of the liquid
scintillation counter (Figure 37).
4.5 Statistical analysis
IBM SPSS Statistics 22 was used for the analysis of the data. The Levene test
was used to evaluate the homogeneity of the means groups. If the criterion was
met the Tukey HSD post hoc test was applied: otherwise, the Dunnett C
followed the one way Anova. The values shown represent the mean values and
the error bars indicate the standard deviation (SD). Unless otherwise stated,
differences were considered as statistically significant when p≤0.05. 
Figure 36 Summary of the practical steps involved in the glucose transport
assay.
- 107 -
Figure 37 Summary of the scintillation process.
After 14C molecules emit beta (β) radiation the solvent molecules become excited 
and their energy is transferred to the phosphor molecule to emit light. The light is
detected by PMT.
4.6 Results
4.6.1 Set up and validation of the D-[14-C]-glucose transport across
Caco-2 cells
A calibration curve of radioactivity as a function of [14-C]-glucose quantity was
prepared. With the y-intercept fixed at zero the gradient was calculated as
135756 CPM/µmol and the adjusted R2 was 0.9999. This data indicates a good
proportionality of radioactivity and molar quantity (Figure 38). Counting
precision of the equipment was assessed by comparing the reference calibration
solution of 123000 CPM/KBq (the typical count was average 118549 CPM). The
results were corrected for the counter efficiency based on background
absorbance standard signals (the typical count was on average 28.8 CPM, the
solutions involved in the experiment (HCl+ NaOH mixture) had a typical count
of 38.6 CPM, and TBS was 36.1 CPM).
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Figure 38 Glucose standard curve for radioactivity measurements (CPM = D-
[14C]-glucose counts per min).
Where not visible, error bars are smaller than the size of the data point. Mean±
SD (n=6 measurements from per experiment for each 21 experiment).
Caco-2 cells were plated on 6-well plates at a density of 6.43 x 104 cells/cm2.
The experiments were performed after the cell monolayer reached the full
differentiation. The differentiation of the monolayer was assessed by
measurement of the TEER values of the cell monolayer. Only Transwell® inserts
with a resistance exceeding a blank membrane by 300 Ω were utilized in the 
experiment. TEER values <300 Ω may be demonstrating the less well-formed 
tight junctions between the cells. The TEER value of the cells was measured
after the pre- and post-incubation process. There was no significance in the pre-
incubation TEER values of each well. However, after exposing cells to glucose
and PFS extracts (post-incubation), the TEER values were significantly different
for some PFS extracts (Table 18). It was hypothesized that higher concentrations
of green tea and Vitis Viniferae extracts may improve the electrical resistance of
the monolayer.
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Table 18 Blank corrected TEER of Caco-2 monolayers measured after pre-
incubation with TBS (30 min) and post-incubation with test substrate (25 min) in
the absence (control) and presence of PFS extracts.
PFS
extracts
Concentration
of PFS
(mg/ml)
TEER
(pre-
incubation)
TEER
(post-
incubation)
% Difference
(pre-post
incubation)
Control 0 519.7± 12 412.1 ± 29 20
German
chamomile
1 479.3±8 386.2 ± 40 19
Green tea 1 486.2±22 486.7 ± 46 * 0
Vitis
Viniferae
3 535.4±36 537.1 ± 16 * 0
% difference demonstrates the difference between pre- and post-incubation
TEER values. The asterisk denotes a significantly different TEER measurement
relative to control TEER measurement (p<0.05). Mean ± SD (n=6 measurement
per sample and 18 times readings from each sample).
The rate of transport from apical to basolateral cell culture medium was 10.4
nmol/min cell culture medium and cellular uptake of D-[14C]-glucose (1 mM)
was 0.5 nmol/min in the control sample (Figure 41 and Figure 42). The effect of
PFS extracts on the transport of glucose from apical to basolateral and cellular
uptake of glucose was investigated. Some of the active components of German
chamomile were also individually assayed to explore the possibility that they
were able to moderate glucose uptake and transport at concentrations relevant to
the German chamomile extract. The inhibition of glucose transport by German
chamomile extract was also investigated with/without Na+ in the transport cell
culture medium. It is expected that SGLT1 and GLUT2 will be active at the
apical surface (with Na+ but not under Na+ free conditions) and GLUT2 will be
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active at the basolateral side in the media with and without Na+. Under Na+-free
conditions, only GLUT2 will operate at the apical surface, and SGLT1 will be
inactive.
To analyse the effect of digestion on the biological activity of German
chamomile extract, it was subjected to enzymatic hydrolysis followed by
extraction with ACN and EtAC as a model of the first step of digestion in the gut.
Hydrolysis using hesperinidase and cellulase removed the sugars from the
polyphenols in the German chamomile and cleaved the ester bonds between
phenolic and quinic acid. This experiment indicates that digestion affects the
biological activity of German chamomile since glucose transport across the cell
monolayer decreased approximately 50 %. German chamomile enzymatic
hydrolysis was performed by Ms R Gutierrez-Riviera.
Basolateral transport of D-[14C]-glucose (1 mM) was analysed at different time
points with and without overnight FBS starvation to analyse the effect of
different time starvation stress on Caco-2 cells. There was a linear increase of
glucose transport with time (Figure 39). Overnight FBS starvation had no effect
on D-[14C]-glucose transport from the apical to basolateral side at any time point.
Cellular uptake of glucose increased linearly with time (Figure 40). By contrast,
cellular uptake of glucose decreased with overnight FBS starvation at both the 10
and 30 min time points (p<0.01) (Figure 40).
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Figure 39 Transport of D-[14C]-glucose from the apical to basolateral side with
and without FBS pre-treatment.
Transport of 14C-glucose was significantly different to zero at all time points
(p<0.01). Transport of 14C-glucose was not significantly different and without
FBS pre-treatment points (p<0.05). Where not visible, error bars are smaller than
the size of the data point. Mean ± SD (n=6 per time point). Tukey HSD test
applied.
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Figure 40 Intracellular glucose after incubation with apical 1 mM glucose with
and without FBS pre-treatment.
Cellular uptake of 14C-glucose was significantly different to zero at all time
points (p<0.01). The asterisk denotes significant difference from the treatment
with FBS and pre-treatment without FBS (p<0.05). Where not visible, error bars
are smaller than the size of the data point. Mean ± SD (n=6 per time point).
Tukey HSD test applied.
Vmax and Km of apical to basolateral transport was calculated using nonlinear
regression analysis using the Michaelis-Menten equation for cells incubated only
with glucose and when co-incubated with 1 mg/ml German chamomile extract.
The rate of apical to basolateral glucose transport was significantly decreased
dose-dependently in the presence of German chamomile extract (p<0.01). The
transport of glucose from the apical to basolateral compartment increases with
substrate concentration, consistent with transporter-mediated processes following
Michaelis Menten kinetics (Km was equal to 8.1 mM and Vmax was 0.09
µmol/min) (Equation 2).
Cellular uptake of glucose increased from the lowest to highest glucose
concentration and uptake of cellular glucose was inhibited significantly in the
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presence of 1 mg/ml German chamomile at all glucose concentrations (p<0.01)
(Figure 42).
Equation 2
V0
Vmax [S]= Km + [S]
Vmax
V0 (Km + [S])= [S]
Km
Vmax [S]=
V0
[S]-
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Figure 41 A: Inhibition of glucose transport by 1 mg/ml German chamomile and
transport of glucose at different concentrations of apical glucose.
B: Lineweaver-Burk plot for transport of glucose with/without 1 mg/ml German
chamomile. From this, Km = 8.1 mM glucose and Vmax = 0.09 µmol substrate
hydrolyzed/min. Plot indicative of competitive inhibition. Mean ± SD (n=6 per
concentration point).
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
0 5 10 15 20 25 30
B
as
ol
at
er
al
14
C
-g
lu
co
se
(µ
m
ol
/m
l)
glucose concentration (mM)
glucose glucose+GC
y = 85.379x + 10.605
R² = 0.9996
y = 605.32x + 4.7431
R² = 0.9996
-200
-100
0
100
200
300
400
500
600
700
-0.4 -0.2 0 0.2 0.4 0.6 0.8 1 1.2
Ba
so
la
te
ra
l
14
C
-g
lu
co
se
(1
/µ
m
ol
/m
in
)
glucose (1/mM)
glucose glucose+GC
- 115 -
A
B
Figure 42 Cellular glucose uptake by 1 mg/ml German chamomile at different
concentrations of apical glucose was significantly decreased (p<0.01).
B: Lineweaver-Burk plot for cellular uptake of glucose with/without 1 mg/ml
German chamomile. From this, Km = 8.1 mM glucose and Vmax = 0.09 µmol
substrate hydrolyzed/min. Plot indicative of mix competitive inhibition. Mean ±
SD (n=6 per concentration point).
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4.6.2 Inhibition of glucose transport and uptake by PFS
German chamomile (Figure 43) and green tea (Figure 45) are very effective at
attenuating the rate of glucose cellular uptake and basolateral transport.
According to the experimental results, Vitis Viniferae extract was less effective
and Pelagonium and Echinacea were ineffective (Figure 46, Figure 47 and
Figure 48). In the intestine, glucose transport is mediated by SGLT1 and GLUT2
at the apical side and exported to the basolateral side via GLUT2. Under Na+-
free conditions, only GLUT2 will actively transport the glucose and export to the
basolateral side via GLUT2 (Kellett and Brot-Laroche, 2005). Under Na+-
dependent conditions and in the absence of German chamomile extract, 9.9
nmol/min of 14C-glucose was transported into the basolateral compartment. Co-
incubation of 1 mM glucose with 1 mg/ml German chamomile extract inhibited
the apical to basolateral transport and cellular uptake of glucose up to 82 and
53 %, respectively. Under the same conditions but without Na+ in the transport
buffer and in the absence of German chamomile extract, 6.47 nmol/min of 14C-
glucose was transported into the basolateral compartment. The basolateral
transport of glucose and cellular uptake of glucose was also inhibited up to 51
and 58 %, respectively (Figure 44). Each concentration of German chamomile
extract with and without Na+ significantly reduced the concentration of
basolateral glucose (p<0.01 and p<0.05, respectively). These results
demonstrated that the transport of glucose from the apical to basolateral side was
lower with Na+ treatment than without Na+ treatment (p<0.01). However,
cellular uptake of glucose remained the same in both conditions (no significant
difference). There are numerous studies regarding green tea or the effect of its
polyphenols on health in the literature but there are only a few studies regarding
chamomile. Therefore, this study mainly focuses on the effect of German
chamomile extract on glucose transport.
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Table 19 Effect of PFS on glucose transport across the intestinal monolayer
model and on cellular uptake.
Supplement extract IC50 (mg/ml) transport IC50 (mg/ml) uptake
German chamomile 0.31 ± 0.05φγ 0.56 ± 0.12γ
Green tea 0.26 ± 0.04φγ 0.55 ± 0.17γ 
Vitis Viniferae 0.91 ± 0.07 αβ 1.53 ± 0.14αβ
Pelargonium None None
Echinacea purp rad None None
German chamomile Na+- free 0.89 ± 0.19 αβ 0.60 ± 0.10αγ  
For transport means of same row followed by Greek letters α represents 
significant difference compare to German chamomile and β denotes significant 
difference to green tea, φ represents significantly difference compare to German 
chamomile Na+-free extract and γ represents significantly difference compare to 
Vitis Viniferae extract (p<0.05). Mean ± SD (n=4 per concentration of
inhibitior). Tukey HSD test applied.
The concentrations required for the IC50 value for basolateral transport and
cellular uptake are shown in Table 19. According to Table 19, the green tea
extract has the highest inhibitory activity for both uptake and transport of
glucose.
The results of these assays indicate that apical GLUT2 is the primary target of
the compounds from the German chamomile extract, and the absence of Na+
(inactivation of SGLT1) did not greatly affect the uptake.
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Figure 43 A: Inhibition of glucose transport across Caco-2 differentiated
monolayers by different concentrations of German chamomile (GC); inset shows
the magnified section with estimation of IC50.
B: Cellular uptake of glucose at different concentrations of GC. The asterisks
denotes the significantly different cellular concentration relative to control
(*p<0.05, **p<0.01). Where not visible, error bars are smaller than the size of
the data point. Mean ± SD (n=4 per concentration point). Tukey HSD test
applied.
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Figure 44 A: Comparison of Na+-dependent and Na+-free glucose transport
across the Caco-2 differentiated monolayers by different concentrations of GC.
B: Intracellular uptake of glucose with and without Na+ in the transport buffer.
The Latin letters denote the significantly different transport relative to the control
of each treatment and the Greek letters denote the significantly different
transport relative to the same concentration of extract for both treatments
(p<0.01). Mean ± SD (n=6 per concentration point for each condition). Tukey
HSD test applied.
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Figure 45 A: Inhibition of glucose transport across the Caco-2 differentiated
monolayers by different concentrations of green tea (GT); inset shows the
magnified section with estimation of IC50.
B: Cellular uptake of glucose at different concentrations of GT. The asterisks
denote the significantly different cellular concentration relative to the control
(*p<0.05, **p<0.01). Where not visible, error bars are smaller than the size of
the data point. Mean ± SD (n=4 per concentration point). Tukey HSD test
applied.
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Figure 46 A: Inhibition of glucose transport across the Caco-2 differentiated
monolayers by different concentrations of Vitis Viniferae.
The inset shows the magnified section with estimation of IC50. B: Cellular uptake
of glucose at different concentrations of Vitis Viniferae. The asterisks denotes the
significantly different cellular concentration relative to the control (*p<0.05,
**p<0.01). Where not visible, error bars are smaller than the size of the data
point. Mean ± SD (n=4 per concentration point). Tukey HSD test applied.
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Figure 47 A: Inhibition of glucose transport across Caco-2 differentiated
monolayers by echinacea.
B: Cellular uptake of glucose at the different concentrations of echinacea. Where
not visible, error bars are smaller than the size of the data point. Mean ± SD (n=4
n=4 per concentration point). Tukey HSD test applied.
-0.001
0.001
0.003
0.005
0.007
0.009
0 0.5 1 1.5 2I
nt
ra
ce
llu
la
r
14
C
-g
lu
co
se
(µ
m
ol
)
Echinacea concentration (mg/ml)
- 123 -
A
B
Figure 48 A: Inhibition of glucose transport across the Caco-2 differentiated
monolayers by different concentrations of pelargonium.
B: Cellular uptake of glucose at different concentrations of pelargonium. Where
not visible, error bars are smaller than the size of the data point. Mean ± SD (n=4
per concentration point). Tukey HSD test applied.
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Figure 49 Intracellular uptake and transport of D-[14C]-glucose with/without 0.5
mg/ml maltodextrin.
Mean ± SD (n=6 per concentration point). Tukey HSD test applied.
4.6.3 Inhibition of glucose transport with the hydrolysed and
extracted form of German chamomile from ethyl acetate and
acetonitrile
The impact of metabolism on the efficacy of inhibition was analysed after
enzymatic hydrolysis of German chamomile. The extract of German chamomile
was hydrolysed using the hesperidinase/cellulase method to resemble the
digestion in the gut (Pimpao et al., 2013). Hydrolysis using hesperinidase and
cellulose removed the sugars from the polyphenols in the German chamomile
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and cleaved the ester bonds between phenolic and quinic acid. As a part of the
digestion process, sugars are removed from flavonoid glycosides by the brush
border beta-glucosidases in the small intestine (the first step of digestion). This
experiment indicates that the digestion affects the biological activity of German
chamomile due to glucose transport across the cell monolayer has been
decreased approximately 50 % (Figure 50).
One of the main components of German chamomile was apigenin-7-O-
glucoside. Ferulic acid hexosides were also present at high levels but could not
analysed due to absence of standard. German chamomile contains higher amount
of apigenin-7-O-glucoside after hydrolysis and after exposing with solvent ACN
(but its concentration decreased 10 times compared to the water extract due to
deglycosylation), and also contains apigenin, umbelliferone and a low
concentration of luteolin-7-O-glucoside and luteolin. The composition of
German chamomile after hydrolysis and extraction using EtAC contains
predominantly apigenin-7-O-glucoside, apigenin, umbelliferone and a low
concentration of luteolin (see chapter 2 section 2.2.2 and 2.2.3).
The inhibition of glucose transport with untreated German chamomile and ACN
dissolved sample at the same concentration (0.5 mg/ml) resulted in 67 and 32%
inhibition, respectively. In comparison, the EtAC-extract sample (0.25 mg/ml)
showed 34% inhibition of the glucose transport. Concentration of both extracted
samples was different due to the volume of solvent used during hydrolysis of
German chamomile process.
TEER measurements during pre- and post-incubation were both >300 Ω for all 
conditions. According to Table 20, the constituents of the hydrolysis assay have
an effect on glucose transport. The matrix of the hydrolysis assay content had an
effect on the glucose transport. Therefore the constituents of the hydrolysis
reaction assay, not containing German chamomile, were tested to determine their
affect on glucose transport (EtAC control- ACN control samples). Ultimately,
these results were subtracted from the experiment containing hydrolysed German
chamomile (Table 20). The transport and uptake of glucose with ACN-control
sample decreased significantly compare to control sample (without extract in the
glucose transport assay), but EtAC-control was not significant than control
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sample. The transport of glucose with the German chamomile hydrolysed sample
decreased significantly for both EtAC extraction and ACN treatment (p<0.05,
p<0.01 respectively) (Table 20). The cellular uptake glucose was significantly
decreased with German chamomile hydrolysed ACN treated sample but the
cellular uptake of glucose with EtAC-extracted sample was significantly
increased compare to control sample. However the cellular uptake of glucose
with ACN-control sample and ACN treated sample were same therefore it was
concluded that the background of the hydrolysis process is affecting the cellular
uptake. The EtAC-extracted sample soluble at a final concentration of 0.01 %
DMSO in TBS; however, it participated in the apical compartment after the
incubation process. This might explain the reason for the increase in the cellar
uptake of D-[14C]-glucose. It may also come from the quenching effect of the
EtAC extracted sample to the radiolabelled sucrose.
These results suggested that after ingestion of the PFS, the intact and hydrolysed
polyphenols (in the gut lumen) have an important role in the attenuation of
glucose absorption.
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Table 20 Cellular uptake and transport of D-[14C]-glucose (nmol/min) with
German chamomile, with hydrolysis followed by extraction with EtAC and
ACN.
The hydrolysed control is the extract which is only the matrix of the hydrolysis
process without any extract and hydrolysed is with GC. The asterisk denotes a
significantly different glucose transport relative to the control (*p<0.01). The
asterisk denotes a significantly different cellular concentration relative to the
control (**p<0.05). Mean ± SD (n=6 per concentration). Tukey HSD test applied.
A
Sample
Condition
(nmol/min)
GC- EtAC
(0.255 mg/ml)
GC- ACN
(0.512 mg/ml)
Control Transport 10.7±0.010 11.8±0.012
Uptake 1.6±0.004 1.6±0.002
Non-GC hydrolysed
(EtAC & ACN-control)
Transport 9.9±0.013 7.2±0.015 *
Uptake 1.6 ±0.005 0.71±0.003 **
Hydrolysed
GC
Transport 6.3±0.08 * 3.3±0.005 *
Uptake 2.1±0.004 ** 0.69±0.003 **
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B
C
Figure 50 A: Inhibition of glucose transport by the hydrolyzed and non-
hydrolyzed German chamomile (ACN and EtAC) extracts.
B: Basolateral concentration of glucose. C: Intracellular glucose concentration.
The asterisks denote the significant different concentrations relative to the
control samples (*p<0.05, **p<0.01). Mean ± SD (n=6 per measurement). Tukey
HSD test applied.
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4.6.4 Inhibition of 14C- deoxyglucose by PFS extracts
The same method as described for the D-[14C]-glucose transport was used to
analyze [14C]-deoxyglucose transport using the Caco-2 cell line. Deoxyglucose
cannot be further metabolised in the intestine since the 2-hydroxyl group is
replaced by hydrogen; therefore, it is phosphorylated rapidly and completely and
is not effluxed following phosphorylation (Olefsky, (1978), Burant and Bell
1992). Deoxyglucose is not transported by SGLT1 (Wright et al., 2001; Kwon et
al., 2006; Kellett, 2001; Kimmich and Randles, 1976; Shirazi-Beechey and
Soraya, 1995) and is only transported by GLUTs (Waki et al., 1998; Nelson et
al., 1996; Burant and Bell 1992). In the presence and absence of Na+, the
transport of glucose was 9.9 and 6.47 nmol/min, respectively, for the control
samples. In the absence of PFS (control sample), the rate of deoxyglucose
transport was 10.2 nmol/min. SGLT1 is inactive for the glucose transport under
Na+-free conditions and deoxyglucose transport. Therefore, the results of these
experiments may show that there are other GLUTs that are responsible for the
transport of deoxyglucose in the intestine which is in accordance with Burant
and Bell (1992). According to Figure 51, there is a substantial inhibition of the
[14C]-deoxyglucose transport to the basolateral side (p<0.01). The transport of
deoxyglucose to the basolateral side is comparable to the transport of glucose to
the basolateral side as they are transported by the same transporters. Green tea
and German chamomile extracts (1 mg/ml) inhibited D-[14C]-glucose transport
by 90 and 83 %, respectively. [14C]-deoxyglucose transport is inhibited by green
tea and German chamomile extracts (1 mg/ml) by 80 and 71%, respectively.
In contrast with the cellular uptake of glucose, deoxyglucose uptake into the cell
was not inhibited by PFS. Inside the cell, glucose is converted into pyruvate by
glycolysis. The first step is phosphorylation of glucose by hexokinase which
adds a charged phosphate group to glucose (glucose-6-phosphate). Subsequently,
glucose phosphate isomerases glucose 6 phosphate to fructose 6 phosphate and
then by phosphofructokinase (PFK1) to fructose 1,6 biphosphate and ADP. The
latter is important for glycolysis as it is an irreversible step. This enzyme is an
allosteric enzyme, controlled by some activators (AMP, fructose 2-6
biphosphate) and inhibitors (ATP, glucagon, low pH). Deoxyglucose is also an
- 130 -
inhibitor of PFK as there is no signaling involved with deoxyglucose inside the
cell while glucose signals to PFK. It may be concluded that PFS extracts play an
important role in glucose metabolism leading to a decrease in the cellular uptake
of glucose.
A
B
Figure 51 A: Inhibition of deoxyglucose (1 mM) transport across the Caco-2
differentiated monolayers by 1 mg/ml PFS extracts. Asterisks denote
significantly different glucose transport relative to the control (*p<0.01). B:
Cellular uptake of deoxyglucose in the presence of 1 mg/ml PFS extracts. Mean
± SD (n=6 per measurment). Tukey HSD test applied.
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Figure 52 A: Percentage inhibition of deoxyglucose (1 mM) and glucose (1 mM)
(with/without Na+) transport across the Caco-2 differentiated monolayers by 1
mg/ml PFS extracts.
B: Percentage inhibition of intracellular uptake of deoxyglucose and glucose in
the presence of 1 mg/ml PFS extracts. Mean ± SD (n=6 per measurment). Tukey
HSD test applied. Inhibition of intracellular deoxyglucose was not observed with
extracts.
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4.6.5 Glucose transport inhibition by German chamomile active
components in Caco-2 cells
Inhibition of D-[14C]-glucose uptake and transport was tested with some of the
available compounds, which are present in the German chamomile extract.
Luteolin was the most effective inhibitor of D-[14C]-glucose transport and
luteolin-7-O-glucoside was the most effective inhibitor for cellular uptake of
glucose. Following this, apigenin-7-O-glucoside and luteolin-7-O-glucoside also
inhibited D-[14C]-glucose uptake and transport. Quercetin and apigenin also
demonstrated some inhibition (Figure 53 and Figure 54).
Apigenin, luteolin and quercetin did not dissolve completely, and so we assume
that they were saturated in the transport buffer. Apigenin-7-O-glucoside,
luteolin-7-O-glucoside, diCQAs and umbelliferone were soluble under all the
assay conditions.
Figure 53 Inhibition of glucose uptake by German chamomile (GC) active
components (control represent the sample without any inhibitor).
A: Apigenin, A7G: Apigenin-7-O-glucoside, L: Luteolin L7G: Luteolin-7-O-
glucoside, diCQA: 100 µM of each 3,4-dicaffeoylquinic acid, 3,5 diCQA and 4,5
diCQA, Umb: Umbelliferone. The asterisk denotes a significant difference from
the corresponding control value, *p<0.01, **p<0.05. Mean ± SD (n=6 per
measurment). Tukey HSD test applied.
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Figure 54 Inhibition of glucose transport to the basolateral side by the German
chamomile (GC) active components (control represents the sample without any
inhibitor compound).
A: Apigenin, A7G: Apigenin-7-O-glucoside, L: Luteolin L7G: Luteolin-7-O-
glucoside, Q: Quercetin diCQA: 100 µM of each 3,4-dicaffeoylquinic acid, 3,5
diCQA and 4,5 diCQA, Umb: Umbelliferone. The asterisks denotes a significant
difference from the corresponding control value, *p<0.05, **p<0.01. Mean ± SD
(n=6 per measurement). Tukey HSD test applied.
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4.6.6 Glucose transport after overnight FBS starvation
FBS contains important components such as hormones and growth factors.
Therefore, the addition of FBS to the cell medium promotes cell adhesion and
proliferation (epidermal growth factor, fibronectin, and thyroxine). To create
starvation stress in the cells, FBS was removed from the cell culture medium 12
h before the experiment.
According to these results, 14C-glucose transport was not-significantly decreased
with FBS starvation compared to the presence of FBS (p<0.05) and cellular
uptake was also not affected. Addition of German chamomile during the
transport experiment after overnight FBS starvation had an 89 % inhibition of
glucose transport (not different from FBS-treated cells in the presence of PFS
extract). The cellular uptake of glucose was also significantly decreased when
cells were treated with German chamomile after FBS starvation (12 h). By
contrast, pre-treatment of cells with German chamomile and without FBS to
analyse glucose retention was investigated, and transport and cellular uptake of
glucose was not affected. Therefore, it may be assumed that relevant transcript
regulation was not occurred (
Table 21). Addition of extra glucose (1 mM) to the feeding medium overnight
(12 h) did not have any effect on the transport and cellular uptake of D-[14C]-
glucose (p<0.05).
Cells deprived from FBS 12 h before the experiment did not show any
differences in glucose transport and cellular uptake.
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Table 21 Inhibition of glucose uptake and transport compared between FBS starvation overnight and/or treatment with German chamomile
and glucose (1 mM) overnight with FBS treatment overnight.
The asterisks denote a significantly different transport and cellular uptake concentration relative to the control (with FBS 12h to look at
glucose) (*p<0.01, **p<0.05). Mean ± SD (n=6 per measurement per treatment).
Pre-treatment
(12 h)
Transport
(25 min)
FBS
(%)
GC
(mg/ml)
Glucose
in pre-treatment
(mM)
Transport (a to b)
(µmol glucose)
Uptake into cell
(µmol glucose)
no FBS Glucose 0 0 0 0.269±0.005 0.008±0.0003
no FBS+ GC Glucose+ GC 0 1 0 0.029±0.001* 0.006±0.0003**
no FBS+ GC Glucose 0 1 0 0.286±0.007 0.008±0.0002
FBS+ Glucose Glucose 10 0 1 0.313±0.008 0.008±0.0001
FBS Glucose 10 0 0 0.296±0.005 0.009±0.0004
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4.7 Discussion
In the literature there is growing evidence regarding the effect of polyphenols
from green tea or its components on glucose metabolism (interactions of
polyphenols with enzymes or transporters) and their promising benefits for the
management of type-2 diabetes. There are also some animal model studies and
limited human intervention studies regarding the chamomile and grape extracts
or their active components on glucose metabolism. However, the literature
evidence for the inhibition of cellular glucose uptake and transport by
polyphenols across Caco-2 cells is limited. The objective of this study was to
make a preliminary assessment of the capacity of PFS extracts to reduce glucose
transport across the Caco-2 cell monolayers.
The current study suggested that polyphenols from the PFS extracts were able to
decrease the transport of glucose across the cell monolayer. Structural changes
may result in altered biological activity (Kellett and Brot-Laroche, 2005).
Therefore, the impact of metabolism on the efficacy of inhibition was analysed
after enzymatic hydrolysis of the German chamomile. These results suggested
that after ingestion of the German chamomile extract, the intact and hydrolysed
polyphenols (in the gut lumen) have an important role in the attenuation of
glucose absorption. Farrell and colleagues (2013) investigated the effect of
hydrolyzed and unhydrolyzed herbal extracts on glucose transport and uptake
using the Caco-2 cell line and reported that herbal extract mixtures decreased
glucose transport up to 54 %. After enzymatic hydrolysis of herbal extract
mixture with glucosidase and esterase activity, polyphenolic fractions were
collected using EtAC. This hydrolyzed extract reduced the transport of glucose
by 70 %. In the current study, the effect of enzymatic hydrolysis assay
constituents (without substrate) on glucose transport was also analysed (40 %
inhibition- due to enzymatic hydrolysis there are compounds which were
unknown appear and may have an influence on cellular uptake and transport of
14C-glucose) and this result was subtracted from the hydrolyzed extract sample
(72 % inhibition).
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Kamiyama et al., 2010 investigated the inhibition of maltase by EGCG using
maltase-expressed Caco-2 cells, with an IC50 value of 27 µM. The gallated
catechins showed significant inhibition while the ungallated catechins did not.
Alzaid et al., 2013 observed that the glucose transport in Caco-2 cells in the
presence of berry extract was significantly decreased (58 % of total glucose
uptake). They also investigated the effect of cyanidin, cyanidin glucoside and
cyanidin rutinoside on glucose uptake (approximately 21, 20, and 21 % of total
glucose uptake) and found that all these compounds significantly inhibited
glucose uptake.
Johnston et al., 2005 analysed the effect of different classes of dietary
polyphenols on glucose uptake with Caco-2 cells (cells were seeded to plates
therefore there were not any monolayer). They investigated Na+-dependent and
Na+-free conditions for glucose uptake in the presence of flavonoid glycosides,
non-glycosylated polyphenols, aglycones and phenolic acids. They found that
aglycones inhibited GLUT2 and glycosides inhibited SGLT1. Under Na+-
dependent conditions, the catechins, EC, EGCG, EGC and ECG, significantly
decreased glucose uptake. Under Na+-free conditions, EGCG, EGC and ECG
reduced glucose uptake by 37, 60 and 65 %, respectively; however, catechin and
EC were ineffective. Under Na+-free conditions, quercetin, apigenin and
myricetin also inhibited glucose uptake significantly. In the current study, under
Na+-dependent conditions, polyphenols from the German chamomile extract
were analysed to discover their individual effect on glucose transport and uptake.
As was reported by Johnston and colleagues (2005), our data also represented
that flavonoid glycosides inhibited both transport and uptake of glucose, and
while cellular uptake and transport of glucose was not affected by phenolic acids.
In contrast to the Johnston et al., (2005) study, apigenin significantly inhibited
both transport and cellular uptake of glucose under Na+-dependent conditions.
Aglycone flavonoids (especially luteolin) also inhibited both transport and
cellular uptake of glucose conversely to the Johnston and colleagues (2005)
study.
Under Na+-free and Na+-dependent conditions, the transport of glucose was
analysed in the presence of the polyphenol-rich herbal extract using Caco-2 cells
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and showed 54 and 35 % of inhibition, respectively (Farrell et al., 2013). While
the uptake of glucose was not affected under Na+-dependent conditions, it was
significantly decreased under Na+-free conditions. In contrast to this, cellular
uptake of glucose with/without Na+ did not change in the current study, but they
were both lower than control (without PFS) samples. The transport of glucose
was also lower in the presence of Na+ compared to Na+-free conditions.
It was reported that flavonoid glycosides interact with SGLT1 (Day et al., 2003),
and therefore they may compete with glucose for absorption. Kottra and Daniel,
(2007) reported that flavonoids were not absorbed through SGLT1 using SGLT1
expressed in Xenopus laevis oocytes. Kobayashi et al. (2000) reported that tea
polyphenols inhibited SGLT1 competitively, whereas Hossain et al. (2002)
reported that SGLT1 was inhibited by tea polyphenols non-competitively. Kwon
et al. (2007) analysed glucose, 2-deoxyglucose and fructose transport using
GLUT2 expressed Xenopus laevis oocytes in the presence of quercetin, myricetin
and isoquercetin. They reported that GLUT2 was non-competitively inhibited by
those compounds, whereas SGLT1 was not affected. At a concentration of 50
µM quercetin, the transport of glucose was inhibited completely. Quercetin,
myricetin, luteolin and apigenin inhibited 2-deoxyglucose transport with an IC50
value of 12.7, 17.2, 30.4 and 65.7 µM, respectively. Our study showed that the
inhibition of GLUT2 is greater than SGLT1 as the absence of Na+ did not greatly
affect the pattern of inhibition. The transport of deoxyglucose was also decreased
in the presence of PFS extracts and the transport of glucose in the absence of Na+
was slightly lower than deoxyglucose transport (in both analyses SGLT1 is
inactive). In addition, cellular uptake of deoxyglucose was analysed and PFS did
not affect the cellular uptake. The reason for this may be that PFS has an effect
on glucose metabolism inside the cell. By contrast, PFS may not have an effect
on cellular uptake of deoxyglucose as it is not further metabolised inside the cell.
These results may in part explain the inhibitory effect of PFS extracts on glucose
uptake and transport in the current study.
The effect of polyphenols on sugar metabolism has also been investigated in
several human intervention studies. Toolsee et al. (2013) studied pre-diabetic
subjects who consumed 3 cups of green tea or water as a control daily for 14
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weeks. They found that green tea consumption did not affect fasting glucose but
prevented impaired fasting glucose from a significant increase as compared to
the control. Therefore, they concluded that green tea is a potent glycaemic
regulator. Park et al. (2009) found that circulating green tea catechins elevated
blood glucose level by preventing normal glucose uptake into tissues resulting in
secondary hyperinsulinemia. Zunino (2009) reviewed several reports and
concluded that grapes or grape products could be used in the management of
type-2 diabetes due to their abundant polyphenol content and low glycaemic
index. Banini et al, (2006) observed the effect of muscadine grape juice (MJ),
muscadine grape wine (MW) and dealcoholized muscadine grape wine (dMW)
on blood glucose levels of healthy and type-2 diabetic subjects over 28 days.
Daily intake of 150 ml of MW and dMW consumption with meals decreased
blood glucose levels compared to diabetics administered MJ. The effect of the
ethanolic chamomile flower extract was analysed for the treatment and
prevention of type-2 diabetes with both in vivo and in vitro studies (Weidner et
al., 2013). The in vitro study showed that chamomile flower extracts activate
PPARγ which regulates insulin sensitivity. Their in vivo study showed the
reduction of insulin resistance and glucose intolerance with C57BL/6 mice that
were fed with chamomile flower extract (200 mg/kg body weight) for 6 weeks.
Suksomboon et al. (2011) identified 9 randomised placebo-controlled trials and
consumed plant supplements studies. They reported that lpomoea batatas,
silybum marianum and trigonella foenum-graecum were shown to improve
glycaemic control in diabetic patients.
The effect of polyphenols on sugar metabolism was also investigated with
animal intervention studies. Cemek et al. (2008) observed the effect of
chamomile ethanolic extract (70mg/kg body weight) on hyperglycaemia using
streptoztocin (STZ)-induced diabetic rats. They found that treatment with the
chamomile extract significantly reduced postprandial hyperglycaemia. The
fasting and postprandial blood glucose level of alloxan-induced diabetic rats was
observed in the presence of chamomile tea and glibenclamide (standard drug for
diabetic treatment) in their diet for 60 days. The measurement of fasting and
postprandial blood glucose level was performed on days 7, 30 and 60. Both
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fasting and postprandial glucose levels were significantly reduced compared to
controls (chamomile replaced with water) for all three days; and was
significantly lower than glibenclamide on day 30 only (Khan et al., 2014).
Another study investigated the blood glucose levels of STZ-induced diabetic rats
and healthy controls when fed with a polyphenol extract of French red wine, or
ethanol, or both together (Al-Awwadi et al., 2004). They reported that when
control and diabetic rats were fed with only the red wine extract, their blood
glucose level decreased. When diabetic rats received only the ethanol or red wine
extract, with ethanol there was a reduction in hyperglycaemia compared with the
untreated groups. Orhan et al. (2006) analysed the effect of aqueous extract from
the leaves of Vitis Vinifera L. on hyperglycaemia and antihyperglycaemia of
healthy, glucose hyperglycaemic and STZ-induced diabetic rats. Treatment with
the ethylacetate fraction (polyphenol-enriched extract) reduced blood glucose in
the diabetic rats compared to the control animals. Pinent et al., 2004 reported the
effect of a grape seed procyanidins extract on glucose metabolism using STZ-
induced diabetic rats. A single oral dose of extract (250 mg/kg body weight)
significantly decreased the blood glucose level in diabetic rats.
Human and animal studies support the theory of inhibition of glucose transport
in the small intestine may prevent hyperglycaemia. As some PFS were very
effective on decreasing glucose transport and uptake, they may replace the
present management of diabetes treatment (such as acarbose) avoiding some of
their side effects. In summary, green tea and German chamomile extracts were
very effective at decreasing the glucose absorption across the intestine. The Vitis
Viniferae extract was less effective compared to green tea and German
chamomile extracts. By contrast, PFS of the Pelargonium and Echinacea extracts
were ineffective for both transport and uptake of glucose. In the light of these
present results, PFS may have a major role in mediating intestinal glucose
transport across the brush border membrane of enterocytes; therefore, due to
their biological activity, they may improve the management of diabetes.
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CHAPTER 5 TRANSPORT AND METABOLISM OF
FRUCTOSE IN CACO-2 CELLS IN THE
PRESENCE OF PLANT FOOD SUPPLEMENTS
Abstract
Fructose transport across the Caco-2 cell monolayer was significantly reduced in
the presence of PFS, which may have a major role in mediating intestinal
fructose transport across the brush border membrane of enterocytes. Green tea,
German chamomile and Vitis viniferae extracts were effective on both uptake
and transport of fructose dose dependently. Although, 3 mg/ml Vitis viniferae
extract was not able to achieve 50% inhibition of the transport. The uptake and
transport was also tested at different time points. It was observed that both
uptake and transport of fructose was time dependent. After FBS overnight
starvation, it was observed that the cellular uptake and transport of fructose was
not significant compared to the normal condition FBS treatment.
Different concentrations of fructose were also analysed in the presence of 1
mg/ml German chamomile extract to determine the kinetic mechanism of
inhibition. 14C-fructose uptake and transport significantly decreased at all various
fructose concentrations with 1 mg/ml German chamomile (p<0.01). To analyse
the most active inhibitor in the German chamomile extract, some of the
components were analysed. Some of those compounds inhibited both uptake and
transport of 14C-fructose. However, none showed high inhibition that could
affect both uptake and transport of fructose. Umbelliferone and diCQA
(3,4diCQA, 3,5 diCQA and 4,5 diCQA) were ineffective on the cellular uptake
and transport of fructose. The response of Caco-2 cells to the stress (FBS
starvation or fructose load overnight) was assessed after treatment with German
chamomile or additional fructose. Both transport and uptake of fructose were
tested. FBS starvation or the addition of German chamomile overnight (12 h)
were ineffective on both cellular uptake and transport of fructose, however,
- 142 -
addition of German chamomile extract without FBS overnight treatment and
during the transport experiment, fructose significantly decreased (p<0.01).
Fructose intake is increasing dramatically, especially with the consumption of
processed foods. Due to the inhibitory effect of PFS on fructose metabolism,
they may have a role in managing metabolic disorders.
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5.1 Introduction
5.1.1 Transport of Fructose Metabolism in Caco-2 cell model
Fructose has been a part of the human diet for thousands of years but its
consumption has been increasing dramatically. Fruits have the highest
concentration of fructose and it is also widely used as a sweetener in processed
foods, such as high fructose corn syrup in beverages. Cereals and beverages are
rich in dietary fructose. The American diet has taken 17-20 % of the daily energy
intake (330-380 kcal/day) from fructose (Elliot et al., 2002). High dietary levels
of fructose intake could lead to the development of type-2 diabetes, through fat
storage leading to insulin resistance (Törrönen et al., 2010; Hansen et al., 2012;
Halschou et al., 2012).
The absorption rate of fructose in the small intestine is slower than glucose. This
difference comes from the absorption process of these monosaccharides.
Fructose is absorbed from the lower part of the duodenum and jejunum by the
facilitated glucose transporter (GLUT5) at a slower rate. Following this, fructose
is transported into the blood by GLUT2 (Riby et al., 1993; Ferraris, 2001).
Fructose is transported to the blood from the intestinal lumen by facilitated
sodium-independent transport via the glucose transporters GLUT5 and GLUT2.
GLUT5 is in the apical and GLUT2 is in the basolateral membrane of
enterocytes. The Km of GLUT5 for fructose is 6 mM and GLUT2 is 11 mM
(Manolescu et al., 2007). From the lumen, fructose is transported to enterocytes
by GLUT5 (Figure 55). Inside the enterocytes, part of the fructose is converted
into lactate (12% of absorbed fructose) and released into the portal circulation
(Tappy and Le, 2010), and the other part is diffused into the blood vessels by
GLUT2 (Figure 55). Fructose present in the blood is extracted by the liver. Some
studies have shown that fructose absorption is quantitatively limited compared to
glucose absorption, for example fructose loading without glucose may cause
diarrhoea and flatulence in humans due to the different degree of absorption of
fructose (Tappy and Le, 2010).
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Figure 55 Mechanism of fructose absorption in to basolateral side in a Caco-2
cell model (F: Fructose).
Numerous studies here tried to link high fructose intake and GLUT5 expression
levels with the risk of type-2 diabetes and obesity (Pagliasotti and Horton, 2004;
Bizeau and Pagliasotti, 2005; Havel, 2005; Montenen et al., 2007). There are
inconsistencies between those studies’ in the correlation of diabetes with serum
fructose concentration. The serum fructose concentration and urinary fructose
excretion were measured for 2 weeks in Japanese healthy volunteers (diabetic
and non-diabetic patients). Kawasaki and colleagues reported that the serum
fructose concentration and urinary fructose excretion increased significantly in
diabetic Japanese patients (Kawasaki et al., 2002). By contrast, Pitkanen, 1996,
reported that serum fructose concentrations did not show any difference among
healthy and type 1 or 2 diabetes Finnish volunteers. Only a few of the studies
investigated the link between diabetes and GLUT5. These studies also have
some contradictory findings. In the light of these studies, fructose may have an
effect on the pathogenesis of diabetic complication (Gaby, 2005; Gross et al.,
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2004; Le and Tappy, 2006; Pagliasotti and Horton, 2005). An inconsistent
correlation between GLUT5 and diabetes may come from two reasons: diabetes
may have an effect on GLUT5 (age- or insulin-dependent) or different levels of
dietary fructose in diabetic patients may affect GLUT5 (Douard and Ferraris,
2008). Dyer et al. (2002), reported that GLUT5 expression is affected by
diabetes in the small intestine. They found that patients with type 2 diabetes had
three to four-fold more duodenal GLUT5 mRNA and protein levels. Also, they
reported that lowering hyperglycaemia in certain patients down regulated
GLUT5. They concluded that the level of fructose in the blood has an effect on
GLUT5 expression in the intestine of diabetic patients. In contrast to this study,
Zucker diabetic fatty rats and lean control rats were fed with troglitazone (drug
improving insulin action) and their mucosa of the small intestine extracted. It
was observed that the protein and mRNA levels of GLUT5, GLUT2 and SGLT1
were the same in both types of rats.
There are a number of studies regarding the fructose transporters and diabetes
association in human or rats, however, there are few studies for the inhibition of
fructose transport by polyphenols. There is one previous study that analysed the
inhibition of fructose transport with myricetin, quercetin and isoquercitrin using
GLUT2-expressed Xenopus laevis oocytes (Kwon et al., 2007) and the half
inhibitory concentration was 42.2, 15.9 and 38 µmol respectively.
In this chapter, substantial inhibition on fructose transport and uptake was
observed by PFS extracts from green tea, German chamomile and Vitis Viniferae.
5.2 Material and methods
5.2.1 Standards and reagents
D-[14C]-fructose 0.1 µCi/ml (ARC 0116A) was purchased from American
Radiolabelled Chemicals (St Louis, USA). Fructose was purchased from Fisher
Scientific (F/1950/50; Loughborough, UK). PFS extracts were supplied by
PhytoLab Co. KG (Vestenbergsgreuth, Germany). Dulbecco's Modified Eagle's
Medium (DMEM; including 1000 mg glucose/L, L-glutamine, NaHCO3 and
pyridoxine HCl) were purchased from Sigma (Dorset, UK; D6046). Caco-2 cells
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(HTB-37) were obtained from the American Type Culture Collection (LGC
Promochem, Middlesex, UK).
5.2.2 Cell cultures
Chapter 4 section 4.2.2.
5.2.3 Fructose transport measurements in Caco-2 cells
5.2.3.1 Preparation of reagents
All the reagents were prepared freshly on the day of the experiment.
5.2.3.2 Transport buffer solution (TBS)
Chapter 4, Section 4.3.1.
5.2.3.3 Fructose
A stock solution of 10 mM fructose was prepared. Briefly, 180 mg of fructose
(Fisher Scientific; F/1950/50) was dissolved in 100 ml of TBS. 1 ml of stock
solution with/without PFS was added to TBS to a final volume of 10 ml
containing 9 µl of 0.1 µCi/µl 14C-fructose. The pH was adjusted between 7.2 to
7.6 at 37 0C for each sample with 1 M HCl or NaOH.
5.2.3.4 PFS extracts preparation
Chapter 4, Section 4.3.1.
5.2.3.5 Preparation of German chamomile active components
Chapter 4, Section 4.3.4.
5.2.4 Inhibition assay protocol
Cells between passage 36 and 50 were utilised in the investigation of fructose
transport and cellular uptake. A minimum of six replicates was allocated per
experimental condition.
On or after 21 days, transport studies were initiated by replacement of growth
medium with TBS and cells were washed three times with it. After washing cells,
0.5 ml TBS was added to the apical and 1 ml added to the basolateral, which
were pre-incubated for 30 minutes at 37 °C under a humidified atmosphere.
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Differentiation of the monolayer was assessed by TEER of the cell monolayers.
Only Transwell® inserts with a resistance exceeding a blank membrane by 300Ω 
were utilised in the experiment. If it is a low value it may increase the
paracellular transport of fructose across the membrane due to less well-formed
tight junctions. After equilibration, TEER values were recorded from three
positions per insert, and subsequently the compartments were carefully aspirated
to waste. For experiments, 0.5 ml TBS containing 5 mM fructose solution and
0.045 µCi/ml [14C]-fructose with or without PFS extracts (pH 7.4) was added to
the apical compartment and 1 ml TBS was added to the basal receiver
compartment. Cells were then incubated for 60 min at 37°C. Following
incubation, TEER values were measured from three positions per insert again
and solutions from the apical and basolateral compartments were removed to
scintillation vials immediately. To wash cells for radioactivity assessment, 0.5 ml
TBS was added to the apical and 1 ml added to the basolateral compartment, and
then transferred into the scintillation vials. Following this, 0.5 ml of 1 M NaOH
solution was added to detach the cells from the membrane. The plates were
placed on a plate shaker for 30 minutes. Subsequently, the suspended cells were
transferred to 1.5 ml centrifuge tubes and 0.4 ml was moved to the scintillation
vials to neutralize the cell suspension with 0.4 ml of 1 M HCl. The remaining
cell suspension was stored in the freezer. The scintillation cocktail was added to
the apical, basolateral and cell suspension samples at a volume of 10, 5 and 5 ml,
respectively. All the vials were mixed. Radioactivity was determined using a
Packard 1600 TR Liquid Scintillation Analyser. Light emission was counted for
10 min per vial and the number of counts per minute (CPM) was calculated by
the equipment software (for the liquid scintillation analysis method, see chapter
4 (section 4.4.1).
5.2.5 Statistical analysis
IBM SPSS Statistics 22 was used for the analysis of the data. The Levene test
was used to evaluate the homogeneity of the means groups. If the criterion was
met, the Tukey HSD post hoc test was applied; otherwise, the Dunnett C
followed the one way Anova. The values shown represent the mean values and
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the error bars indicate the standard deviation (SD). Unless otherwise stated,
differences were considered as statistically significant when p≤0.05. 
5.3 Results
5.3.1 Set up and validation of the D-[14 C]-fructose transport across
Caco-2 cells
A calibration curve of radioactivity as a function of [14C]-fructose quantity was
prepared. With the y-intercept fixed at zero the gradient was calculated as 40030
CPM/µmol and the adjusted R2 was equal to 0.999, suggesting good
proportionality of radioactivity and molar quantity (Figure 56). Counting
precision of the equipment was assessed by comparing the reference calibration
solution of 123000 CPM/KBq (the typical average count was 118679 CPM). The
results were corrected for the counter efficiency based on background
absorbance standard signals (the typical average count was 29.7 CPM, the
solutions involved in the experiment (HCl + NaOH mixture) had a typical count
of 37.2 CPM and for TBS this was 35.9 CPM) (n=8).
Figure 56 Fructose standard curve for radioactivity measurements.
(CPM = [14C]-fructose counts per minute). Mean ± SD (n=6 per concentration
for each of 8 experiment).
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Caco-2 cells were plated on 6-well plates at a density of 6.43 x 104 cells/cm2.
The experiments were performed after the cell monolayer reached full
differentiation. The differentiation of the monolayer was assessed by
measurement of TEER values of the cell monolayer. Only Transwell® inserts
with a resistance exceeding a blank membrane by 300 Ω were utilised in the 
experiment. TEER values <300 Ω may be demonstrating the less well-formed 
tight junctions between the cells. The TEER value of the cells was measured
after the pre- and post-incubation process. There was no significance in the pre-
incubation TEER values of each well. However, after exposing cells with
fructose and PFS extracts (post-incubation) the TEER values were significantly
different for some PFS extracts (Table 22). It appears that higher concentrations
of Green tea and Vitis Viniferae extracts may improve the electrical resistance
between the cells.
Table 22 Blank corrected TEER of Caco-2 monolayers measured after pre-
incubation (25 min) and post-incubation (60 min) in the absence (control) and
presence of PFS extracts.
PFS
concentration
(mg/ml)
TEER
(pre-
incubation
30 min)
TEER
(post-
incubation
60 min)
% difference
extracts (pre-postincubation)
Control 0 822 643 22
German
chamomile 1 1075 930 14
Green tea 1 807 * 836 * 0
Vitis Viniferae 1 973 * 956 * 0
% difference demonstrates the difference between pre- and post-incubation
TEER values. Asterisks denote significantly different cellular concentrations
relative to the control (p<0.01). Mean ± SD (n=6 measurement per sample and
18 times readings from each sample). Tukey HSD test applied.
The effect of PFS extracts on the transport of fructose from the apical to
basolateral compartment and cellular uptake of fructose was investigated. The
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rate of basolateral transport from cell culture medium was 1.7 nmol/min and
cellular uptake of D-[14C]-fructose (5 mM) was 0.6 nmol/min. Addition of
different concentrations of German chamomile, green tea and Vitis viniferae
extracts decreased the transport of D-[14C]-fructose to the basolateral side.
Basolateral transport of D-[14C]-fructose (5 mM) was analysed at different time
points with and without overnight FBS starvation to analyse the starvation stress
on Caco-2 cells. There was a linear increase of fructose transport with time
(Figure 57). Starvation of FBS for 12 h had no effect on D-[14C]-fructose
transport from the apical to basolateral side at any of the time points. Cellular
uptake of fructose increased linearly with the time (Figure 58). By contrast,
cellular uptake of fructose decreased with overnight FBS starvation at both the
10 and 30 min time points (Figure 58).
Figure 57 Transport of 5 mM 14C-fructose from the apical to basolateral side
with and without overnight FBS pre-treatment.
The Greek letter denotes the significance difference from the treatment with FBS
and pre-treatment without FBS for 30 min and the asterisks denote the
significance differences of the time points compared to the 5 min time point
(*p<0.05, **p<0.01). Where not visible, error bars are smaller than the size of
the data point. Mean ± SD (n=6 per time point). Tukey HSD test applied.
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Figure 58 Intracellular concentration of 14C-fructose after incubation with apical
5 mM fructose with and without overnight FBS pre-treatment.
The Latin letters denote the significance differences from the treatment with FBS
and pre-treatment without FBS (30 and 60 min) and the asterisks denote the
significance differences of the time points (*p<0.05, **p<0.01). Where not
visible, error bars are smaller than the size of the data point. Mean ± SD (n=6 per
time point). Tukey HSD test applied.
Figure 59 shows the effect of various concentrations of fructose on the rate of
14C-fructose transport. The rate increases significantly with substrate
concentration. In the presence of 1 mg/ml German chamomile extract, the
transport of 14C-fructose from the apical to basolateral compartment decreased
significantly for various fructose concentrations. Cellular uptake of 14C-fructose
was inhibited in the presence of 1 mg/ml German chamomile at all fructose
concentrations (Figure 60).
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Figure 59 A: Inhibition of 14C-fructose transport by GC at different
concentrations of apical fructose. The Latin letters denote the significant
differences between specific fructose concentration and treatments with/without
German chamomile (1 mg/ml) and the asterisks denote the significant
differences of the concentration (*p<0.05). B: Lineweaver-Burk plot for cellular
uptake of fructose with/without 1 mg/ml German chamomile. From this, Km =
142 mM fructose and Vmax = 0.05 µmol substrate hydrolyzed/min. Plot indicative
of competitive inhibition. Where not visible, error bars are smaller than the size
of the data point. Mean ± SD (n=6 per concentration point). Tukey HSD test
applied.
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Figure 60 A: Inhibition of cellular 14C-fructose uptake by German chamomile at
different fructose concentrations. The Latin letters denote the significant
differences between specific fructose concentration and treatments with/without
German chamomile (1 mg/ml) and the asterisks denote the significant
differences of the concentration (**p<0.01). B: Lineweaver-Burk plot for
cellular uptake of fructose with/without 1 mg/ml German chamomile. From this,
Km = 33 mM fructose and Vmax = 0.004 µmol substrate hydrolyzed/min. Plot
indicative of uncompetitive inhibition. Where not visible, error bars are smaller
than the size of the data point. Mean ± SD (n=6 per concentration point). Tukey
HSD test applied.
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5.3.2 Inhibition of fructose transport and uptake by PFS
Co-incubation of 5 mM fructose with green tea, German chamomile and Vitis
Viniferae extracts attenuated both uptake and transport of D-[14C]-fructose dose
dependently. However, the highest concentration of Vitis Viniferae extract (3
mg/ml) was not able to achieve 50% inhibition for transport of D-[14C]-fructose.
Each concentration of green tea, German chamomile and Vitis Viniferae extracts
significantly reduced the transport of fructose, p<0.01.
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Figure 61 A: Inhibition of 14C-fructose transport across Caco-2 differentiated
monolayers by different concentrations of German chamomile (GC); inset shows
magnified section with estimation of IC50. B: Cellular uptake of 14C-fructose at
different concentrations of GC. Asterisks denote significantly different cellular
concentrations relative to the control (*p<0.01). Where not visible, error bars are
smaller than the size of the data point. Mean ± SD (n=6 per concentration point).
Tukey HSD test applied.
The rate of transport from the apical to basolateral compartment was 1.7
nmol/min and cellular uptake of D-[14C]-fructose was 0.6 nmol/min without
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extracts. Table 23 indicates that extracts from green tea and German chamomile
inhibited both the cellular uptake and basolateral transport of D-[14C]-fructose.
Vitis viniferae extract also inhibited the cellular uptake of D-[14C]-fructose but
the highest concentration of the extract was not able to achieve 50% inhibition of
D-[14C]-fructose transport. In the presence of 1 mg/ml German chamomile, green
tea and Vitis viniferae extracts, cellular uptake of D-[14C]-fructose (5 mM) was at
a rate of 0.2, 0.3 and 0.26 nmol/min, respectively. Addition of those extracts at
different concentrations to the apical side led to a dose-dependent inhibition of
cellular uptake and basolateral transport of D-[14C]-fructose (Figure 61, Figure
62, Figure 63). In the presence of 1 mg/ml German chamomile, green tea and
Vitis viniferae extracts, the rate of basolateral transport from the apical
compartment was 1, 0.8 and 0.3 nmol/min, respectively.
The concentration required for IC50 was calculated for cellular uptake and
transport of D-[14C]-fructose (Table 23). Green tea extract had the highest impact
on D-[14C]-fructose. This table explains that there is a substantial capacity to
inhibit D-[14C]-fructose transport with green tea and German chamomile extracts.
The highest inhibition of cellular uptake of D-[14C]-fructose was with the green
tea extract. Besides this, the Vitis Viniferae extract inhibited cellular uptake of D-
[14C]-fructose better than the German chamomile extract.
Table 23 Effect of PFS on fructose transport across the intestinal monolayer
model, and on cellular uptake.
Supplement extract IC50 (mg/ml) transport IC50 (mg/ml) uptake
German chamomile 1 ± 0.12 2.0 ± 0.17 β
Green tea 0.8 ± 0.09 0.7 ± 0.08 α
Vitis Viniferae Not achievable 1.5 ± 0.12 αβ
For cellular uptake, means of same row followed by Greek letters α denotes the 
significant difference than German chamomile and β represent the significant
difference from green tea (p<0.05). Mean ± SD (n=6 per concentration point).
Tukey HSD test applied.
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Figure 62 A: Inhibition of 14C-fructose transport across the Caco-2 differentiated
monolayers by different concentrations of green tea (GT); inset shows magnified
section with estimation of IC50.
B: Cellular uptake of 14C-fructose at different concentrations of GT. Asterisks
denote significantly different cellular concentrations relative to the control
(*p<0.01). Where not visible, error bars are smaller than the size of the data
point. Mean ± SD (n=6 per concentration point). Tukey HSD test applied.
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Figure 63 A: Inhibition of 14C-fructose transport across the Caco-2 differentiated
monolayers by different concentrations of Vitis Viniferae extract; inset shows
magnified section with estimation of IC50.
B: Cellular uptake of 14C-fructose at different concentrations of Vitis Viniferae
extract. Asterisks denote significantly different cellular concentrations relative to
the control (*p<0.05, **p<0.01). Where not visible, error bars are smaller than
the size of the data point. Mean ± SD (n=6 per concentration point). Tukey HSD
test applied.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0 0.5 1 1.5 2 2.5 3 3.5
14
C
-f
ru
ct
os
e
(µ
m
ol
/m
l)
Vitis viniferae (mg/ml)
Apical Basolateral
0.00
0.05
0.10
0.15
0 1 2 3 4
*
* * * *
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1 1.5 2 2.5 3 3.5
In
tr
ac
el
lu
la
r
14
C
-f
ru
ct
os
e
(µ
m
ol
)
Vitis viniferae (mg/ml)
* *
*
*
*
- 159 -
According to the experiments, PFS extracts can inhibit 14C-fructose transport
across the Caco-2 cell monolayer. It was considered that they have a major role
to inhibit GLUT2 activity, as the IC50 values of German chamomile extract for
glucose transport without Na+ and fructose transport experiments were similar
(chapter 4 section 4.6.2). In the first case, SGLT1 was not active and the extract
could inhibit only GLUT2, and in the second case it could inhibit GLUT5 or
GLUT2. The IC50 values of these two experiments were not significantly
different so this may indicate that the extract inhibited only GLUT2 and not
GLUT5 for the transport of 14C-fructose to the basolateral compartment.
5.3.3 14C-Fructose transport inhibition by German chamomile active
components in Caco-2 cells
Some of the active components of German chamomile were also individually
assayed to explore the possibility that they were able to moderate fructose uptake
and transport at concentrations relevant to the German chamomile extract.
German chamomile is rich in polyphenols, containing predominantly apigenin-7-
O-glucoside (A7G) and ferulic acid hexosides.
None of the analysed compounds were particularly effective on both uptake and
transport of 14C-fructose. The inhibition of transport from the apical to
basolateral compartment for apigenin, A7G and L7G was 39, 38 and 34%,
respectively. However, the inhibition for the cellular uptake of D-[14C]-fructose
was 4, 35 and 27%, respectively. diCQA and umbelliferone were ineffective for
the transport and cellular uptake of D-[14C]-fructose (Figure 64 and Figure 65).
The experiment discussed above was limited by the solubility of the components
within the transport solution. Apigenin was not fully dissolved and it was
saturated in the transport buffer immediately after adding into TBS. A7G (300
µM) partly precipitated after the incubation step. However, A7G (150 µM), L7G,
diCQAs and umbelliferone were dissolved and analysed without any
precipitation.
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Figure 64 Inhibition of 14C-fructose transport to the basolateral side by German chamomile active components (control represent the sample
without any inhibitor compound.
A: Apigenin, A7G1: Apigenin-7-O-glucoside, diCQA: 100 µM each of 3,4dicaffeoylquinic acid, 3,5 diCQA and 4,5 diCQA, Umb:
Umbellifeone 300 µM, L7G: Luteolin-7-O-glucoside 300 µM. Asterisk denotes a significant difference from the corresponding control value,
**p<0.01, *p<0.05. Mean ± SD (n=6 per sample). Tukey HSD test applied.
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Figure 65 Inhibition of cellular 14C-fructose uptake by German chamomile active components (control represent the sample without any
inhibitor compound.
A: Apigenin, A7G1: Apigenin-7-O-glucoside, diCQA: 100 µM each of 3,4dicaffeoylquinic acid, 3,5 diCQA and 4,5 diCQA, Umb:
Umbellifeone 300 µM, L7G: Luteolin-7-O-glucoside 300 µM. Asterisk denotes a significant difference from the corresponding control value,
**p<0.01, *p<0.05. Mean ± SD (n=6 per sample). Tukey HSD test applied.
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5.3.4 Fructose transport under overnight FBS starvation
The FBS in the cell medium promotes cell adhesion and proliferation since it
contains hormones and growth factors (epidermal growth factor, fibronectin, and
thyroxine). Therefore, there will be a starvation stress in the cells in the absence
of FBS for 12 h. The effect of FBS starvation on Caco-2 cells was observed in
FBS-deprived cells 12 h before the fructose transport experiment. Also, to
analyse the effect of German chamomile extract, the cells were treated with 1
mg/ml extract 12 h before the experiment.
When the cells were deprived of FBS overnight, uptake into cells and transport
of 14C-fructose to the basolateral side was hardly affected (not significant of the
control). Therefore, starving the cells from FBS had no affect on cellular uptake
of fructose. Addition of German chamomile (1 mg/ml) overnight (12 h) without
FBS pre-treatment did not affect the transport of 14C-fructose, but cellular uptake
of D-[14C]-fructose was significantly lower than with FBS pre-treatment
(p<0.05). Addition of German chamomile extract during pre- and post-treatment
represented the same inhibition as the usual treatment with German chamomile
extract, and cellular uptake and transport of D-[14C]-fructose was significantly
decreased (Table 24).
Cells deprived from FBS 12 h before the experiment did not show any change in
fructose transport and cellular uptake. However, the German chamomile pre-
treated cells significantly decreased the cellular uptake of fructose therefore it
may be concluded that German chamomile may interact with signaling pathways
or transcription.
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Table 24 Effect of FBS starvation and with/without German chamomile (1 mg/ml) overnight treatment on 14C-fructose cellular uptake and
transport across the Caco-2 cell monolayer.
Asterisks denote significantly different transport and cellular uptake concentrations relative to the control (with FBS overnight to assess
fructose) (*p<0.05, **p<0.01). Mean ± SD (n=6 per concentration point). Tukey HSD test applied.
Pre-treatment
(12h)
Transport
(1h)
FBS
(%)
GC (mg/ml) Transport (a to b) (µmol) Uptake into cell (µmol)
FBS Fructose 10 0 0.113±0.003 0.0025±0.0006
non FBS+ GC Fructose 0 1 0.110±0.002 0.0022±0.0006
non FBS+ GC Fructose+ GC 0 1 0.072±0.002** 0.0017±0.0001*
Non FBS Fructose 0 0 0.112±0.003 0.0023±0.0009
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5.4 Discussion
The intake of fructose causes an increase of portal and peripheral blood fructose
concentrations of up to 1 and 0.1 mM, respectively (Douard and Ferraris, 2013).
Sweetened beverages are the dominant source of fructose in our diet, and high
consumption of these beverages may increase the risk of diabetes. It is reported
that high dietary intake of fructose increased serious adverse metabolic effects in
both humans and rodents (increased plasma triglyceride concentration, impaired
glucose tolerance and insulin resistance) (Gaby, 2005; Gross et al., 2004; Le and
Tappy, 2006; Pagliasotti and Horton, 2005; Tappy and Le 2012; Simopoulos,
2013; DiNicolantonio et al., 2015).
There are only few studies that have investigated the link between fructose
transport and diabetes. The results of these studies were inconsistent, although
GLUT5 may be affected by diabetes. In this study, it was observed that fructose
uptake and transport to the basolateral compartment were decreased in the
presence of PFS, using Caco-2 cells. This is the first report regarding the analysis
of fructose transport and metabolism in Caco-2 cells with polyphenol-containing
extracts.
Diabetes significantly affects the expression of GLUT5 and fructose uptake rates.
Duodenal GLUT5 mRNA and protein levels were three to four-fold higher in
type 2 diabetic subjects (Douard and Ferraris, 2008). GLUT5 is a high-affinity
facilitative transporter in the basolateral membrane with 12 transmembrane
domains and intracellular N and C terminals; and GLUT2 is a low affinity, high-
capacity facilitative transporter in the basolateral membrane with 12
transmembrane domains and intracellular N and C terminals for transport of
fructose (Drozdowski and Thomson, 2006). GLUT5 is the main transporter for
fructose absorption. Gouyon et al, (2003) reported that if the fructose
concentration in the lumen is low, GLUT5 may be sufficient for transport of
fructose to enterocytes. By contrast, a large intake of fructose in GLUT2-null
mice showed that GLUT5 was not able to compensate the missing transport
capacity fully. Therefore GLUT2 could be upregulated for fructose absorption.
They analysed the fructose uptake using isolated brush border membrane
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vesicles from high fructose diet fed mice and found that the uptake was ~ 6-fold
higher compared to low carbohydrate diet mice. In the current study it was
discovered that the presence of some PFS extracts had an influence on fructose
uptake and transport to the basolateral compartment by inhibiting the activities of
glucose transporters. The active inhibitor compounds in PFS influence either the
glucose transporters in the apical side (GLUT5 /GLUT2) and/or the transporters
in the basolateral side (GLUT2). The rate of 14C-fructose transport was lower
than 14C-glucose transport. Riby et al, (1993), and Ferraris, (2001) also reported
that the rate of fructose absorption is slower than glucose in the small intestine.
Using GLUT2 expressed in Xenopus oocytes, myricetin, quercetin, isoquercetrin,
luteolin and apigenin were shown to inhibit the transport of fructose with IC50
values of 12, 16, 38, 23 and 65 µM, respectively (Kwon et al., 2008). In the
current study, apigenin, A7G and L7G inhibited the transport of 14C-fructose at a
percentage inhibition of 39, 38 and 34% for transport. Also, the cellular uptake
of 14C-fructose was inhibited by apigenin, A7G and L7G with a percentage
inhibition of 4, 35 and 27%, respectively. Cellular uptake and transport of
fructose were not inhibited by diCQA and umbelliferone.
There are several human and animal intervention studies reported in the literature
regarding to relationship of fructose and diabetes. The Finnish Mobile Clinic
Health Examination Survey collected dietary and life style information from
51,522 subjects, aged 40-60 years during the period of 1966-1972. Montonen
and colleagues analysed this cohort study with regards to several conditions
(Montonen et al., 2007). They assessed 4,304 non-diabetic men and women at
the beginning of the study. They reported that a combined intake of glucose and
fructose, consumption of sweetened fruit juices and soft drinks could increase
the risk of diabetes. Therefore, the daily sugar intake should be limited. The
American Health Association reported this limit for women and men as 100 and
140 kcal/d, respectively (Tappy et al., 2010).
Some other promising animal studies reported that myricetin, cinnamon,
fenugreek seed extract or quercetin and longan flower extract were able to
balance the glucose-insulin metabolism with fructose-rich diet fed rats (Liu et al.,
2007; Kannappan and Anuradha, 2009; Tsai et al., 2008; Qin et al., 2004).
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Shrestha et al. (2009) reported on a fructose fed ovariectomized rats diet
supplemented with 0.5 and 1 % of green tea for 6 weeks and they found that the
liver triglycerides concentrations were reduced 27-30% when compared to
fructose and starch fed control diets. Cinnamon extracts enhanced the in vivo
insulin-regulated glucose utilisation with high fructose diet fed rats (Qin et al.,
2003; Qin et al., 2004). Another animal study observed the effect of dietary
EGCG (3.2 g/kg diet) supplementation on high fat diet fed mice for 16 weeks
(Bose et al., 2008). They reported that an EGCG supplemented diet reduced the
blood glucose levels and liver triglyceride contents. Girniene and colleagues
observed the effect of conformationally locked carbohydrates, 1,3- oxazolidin-2-
thione or 1,3-oxazolidin-2-one (OZO)-derived sugars for the fructose uptake
using GLUT5-expressed Chinese hamster ovary cells (Girniene et al., 2003). L-
sorbose-Bn-OZO showed the greatest inhibitory activity of fructose uptake with
a Ki value of 3.1 mM.
In summary, the compounds in the green tea, German chamomile and Vitis
viniferae extracts crossed the cell membrane and inhibited the basolateral
transport and cellular uptake of 14C-fructose due to the inhibitory effect on
GLUT5/GLUT2. Comparison of IC50 values of the Na+-free German chamomile
extract in the glucose transport (0.89 mg/ml) (only GLUT2 is active on the apical
part) and transport of fructose in the presence of same extract (1 mg/ml) could
indicate that the extracts inhibited the activity of GLUT2 more than GLUT5.
Therefore, PFS may have a major role in mediating intestinal fructose transport
across the brush border membrane of enterocyte. As it is already reported that
high intake of fructose is a potential trigger for diabetes, the biological activity of
the PFS extracts may improve the management of diabetes.
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CHAPTER 6 TRANSPORT AND METABOLISM OF
SUCROSE IN THE PRESENCE OF PLANT FOOD
SUPPLEMENTS IN CACO-2 CELLS
Abstract
Sucrose transport across the Caco-2 cell monolayer was significantly reduced in
the presence of green tea, German chamomile and Vitis Viniferae extracts. These
extracts were effective on the transport of D-[14C]-sucrose significantly (p<0.01).
German chamomile, green tea and Vitis Viniferae extracts did not show any
inhibitory activity on the cellular uptake of sucrose. Green tea and German
chamomile extracts inhibited sucrose transport with IC50 values of 0.98, and 1.12
mg/ml, respectively. In contrast to this situation, Pelargonium and Echinacea
were ineffective.
The response of the Caco-2 cell line to stress (FBS starvation or sucrose load)
overnight (12 h) was assessed after treatment with German chamomile or
additional sucrose (5 mM). FBS starvation and the addition of German
chamomile overnight (12 h) significantly increased the cellular uptake of D-
[14C]-sucrose (p<0.05). However, the addition of German chamomile extract
during pre-treatment and treatment steps brought sucrose retention in cells back
to the normal concentration (same as control sample). Overnight (12 h)
incubation with sucrose (5 mM) increased the transport of sucrose significantly
(p<0.05) but cellular uptake remained the same. A repeated dose of German
chamomile (incubation with extract overnight and during the experiment)
reduced the transport of D-[14C]-sucrose in the absence of FBS but did not affect
cellular uptake. Inhibition of sucrose transport was also analysed with TC7 cells
(subclone of Caco-2). It was reported that TC7 cells have higher sucrase activity
than Caco-2 cells. Transport of radiolabelledsucrose or its products to the
basolateral side with German chamomile and Vitis viniferae extract show a
similar degree of inhibition with the Caco-2 cell transport study; however, the
results for the inhibition activity of green tea extract were different in the two
cell lines. More radiolabelled sucrose or its products were taking by TC7 cells
compare to Caco-2 cells results in the higher activity of sucrase. For the three
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PFS extracts, cellular uptake of sucrose was reduced significantly (p<0.01).
Acarbose (0.1 mM) also inhibited 48% of sucrose transport across TC7 cells.
Due to their inhibitory activity (acarbose-like activity) on liberated glucose
transport or hydrolysis of sucrose by sucrase activity, green tea, German
chamomile and Vitis viniferae extracts may improve the management of diabetes
in response to sucrose intake.
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6.1 Introduction
Consumption of carbohydrate-rich food, meals or beverages increases the
postprandial blood glucose level. Sucrose is a disaccharide consisting of one
glucose and one fructose unit linked with a α-1,4 glycosidic bond. As sucrose 
can cause an increase of the postprandial glucose concentration (liberated
glucose from sucrose) and liberated fructose is utilized in the liver to make
products like glucose, glycogen, lactate and pyruvate, and also might affect
insulin resistance and type 2 diabetes (Törrönen et al., 2010; Hansen et al., 2012;
Halschou et al., 2012). Sucrose is hydrolysed by sucrase/isomaltase located in
the small intestine. Monosaccharide products are then transported by active
transport SGLT1 and by facilitated transport GLUT2. After two Na+ ions bind to
SGLT1 on the luminal side of the intestinal brush border membrane, a
conformational change occurs which allows glucose binding. A second
conformational change allows glucose and Na+ to enter the enterocyte. Glucose
is released from the enterocyte via the GLUT2 passive transporter at the basal
surface and enters the circulation. The process of uptake and expulsion is
simultaneous (Goodman, 2010; Nelson and Cox, 2000). Fructose enters
(GLUT5) and exits (GLUT2) the cells via facilitated diffusion (Figure 66). The
digestion and absorption of carbohydrates in the intestinal tract can be retarded
using a strong inhibitor of α-glucosidase. Therefore, whether PFS extracts may 
have a role to inhibit sucrose transport and/or hydrolysis of sucrose by sucrase
was analysed.
There is a large number of studies on carbohydrate-metabolising enzymes that
are present in the small intestine, and these studies are generally focused on α- 
amylase and α- glucosidase (sucrase and maltase) (Hansawasdi and Kawabata, 
2006; Laurent et al., 2007; Zhong, et al., 2006; Trugnen et al., 1986; Kano et al.,
1996; Gupta et al. 2007; Adisakwattana and Chanathong 2011; Pereira et al.
2011; Minai-Tehrani et al., 2010). The majority of these studies showed
inhibition of the enzyme by phenolic compounds.
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Figure 66 Absorption of sucrose into the blood. G: glucose and F: fructose.
Grape seed extract (GSE) contains a high concentration of flavanols (54%)
which reduced sucrase activity by 61% in the Caco-2 cell line at a concentration
of 0.3 g/l, with a degree of polymerisation greater than the dimer (Laurent et al.,
2007). Hansawasdi and Kawabata (2006) also investigated the effect of mulberry
tea on sucrose transport on α-glucosidase-expressing Caco-2 cells. The liberated 
glucose concentration in both apical and basolateral compartments was measured
using the glucose oxidase method and reported that mulberry tea inhibited
sucrase activity and transportation at a lower concentration (IC50 was not
achievable). There are several animal and human intervention studies reported in
the literature regarding the effect of polyphenols on sucrose metabolism. Wilson
et al. (2008) studied twelve healthy participants fed with sucrose (35 g) and
berries (150 g puree consisting of bilberries, blackcurrants, cranberries and
strawberries providing nearly 800 mg polyphenols). Berries are rich sources of
anthocyanins, flavonols, proanthocyanidins and phenolic acids. Participants who
consumed sucrose without berries produced a different postprandial glycemic
response compared to the subject who ate with berries. Törrönen et al. (2010) fed
their volunteers, who had a normal plasma glucose level, with 150 g berry puree
containing 35 g sucrose or a control sucrose load in a randomized, controlled
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cross-over design and showed that the plasma glucose concentration was
significantly lower at 15 and 30 min and significantly higher at 150 min
compared to the control meal.
Zhong et al. (2006) reported that 100 mg tea extract (black, green and mulberry)
is able to induce carbohydrate malabsorption in healthy human volunteers
following the consumption of a carbohydrate-rich meal, suggesting that tea
extracts are potentially able to reduce post-prandial blood glucose. One previous
study regarding the inhibition of purified human sucrase-isomaltase by
ethanolamine derivatives including tris showed that tris is a strong inhibitor of
both sucrase and isomaltase but bis-tris inhibits sucrase more than isomaltase
(Kano et al., 1996). Recently, there have been studies on sucrase activity with
therapeutic drugs. Codeine has been reported to inhibit yeast sucrase activity
(Minai-Tehrani et al., 2010) and castanospermine inhibits sucrase in the Caco-2
cell line (Trugnan et al., 1986).
The effect of polyphenols from different plant food supplements (green tea,
German chamomile, Vitis viniferae, Pelargonium and Echinacea) on the transport
of sucrose from apical to basolateral and cellular uptake was investigated using
Caco-2 intestinal cell monolayers. Substantial inhibition on sucrose transport
was observed by plant food supplement extracts from green tea and German
chamomile.
6.2 Material and methods
6.2.1 Standards and reagents
Sucrose was purchased from Sigma (Dorset, UK - S0389). PFS was supplied by
PhytoLab Co. KG (Vestenbergsgreuth, Germany). Dulbecco's Modified Eagle's
Medium (DMEM; including 1000 mg glucose/L, L-glutamine, NaHCO3 and
pyridoxine HCL) was purchased from Sigma (D6046). Caco-2 cells (HTB-37)
were obtained from the American Type Culture Collection (LGC Promochem,
Middlesex, UK).
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6.2.2 Cell Cultures
Please see chapter 4 section 4.2.2.
6.3 Sucrose transport measurements in Caco-2 cells
6.3.1 Preparation of Reagents
All the reagents were prepared freshly on the day of the experiment.
6.3.1.1 Transport buffer solution (TBS)
Please see chapter 4 section 4.3.1.
6.3.1.2 Sucrose:
D-[14C] sucrose 50 µCi (1.85 MBq) (NEC100X050UC) was purchased from
Perkin Elmer (Boston, USA). D-[14C] sucrose is universally labelled 14-C and the
basolateral activity measured was a combination of glucose and fructose
liberated from sucrose hydrolysis, and the apical compartment included
radioactive-labelled sucrose, glucose and fructose.
A stock solution of 100 mM sucrose was prepared. Briefly, 342.3 mg of sucrose
was dissolved in 10 ml of transport buffer solution. 0.5 ml of stock sucrose
solution with/without PFS was added to TBS to a final volume of 10 ml
containing 9 µl of 0.1 µCi/µl 14C-sucrose. To provide the best activity for the
enzymes the pH was adjusted to 7.4 at 37 0C for each sample with 1 M HCl or
NaOH.
6.3.1.3 Plant Food Supplement extracts preparation
Please see chapter 4 section 4.3.4.
6.3.2 Inhibition assay protocol
Cells between passage 36 and 50 were utilised in the investigation of sucrose
transport and cellular uptake. A minimum of six replicates was allocated per
experimental condition.
On or after 21 days, transport studies were initiated by replacement of growth
medium with TBS and cells were washed three times with it. After washing cells,
2 ml TBS was added to the apical and basolateral sides and pre-incubated for 30
- 173 -
minutes at 37 °C under a humidified atmosphere. Differentiation of the
monolayer was assessed by trans-epithelial electrical resistance (TEER) of the
cell monolayers. Only Transwell® inserts with a resistance exceeding a blank
membrane by 300Ω were utilised in the experiment. A low value may indicate 
increased paracellular transport of glucose across the membrane due to less well-
formed tight junctions. After equilibration, TEER values were recorded from
three positions per insert and subsequently the compartments were carefully
aspirated to waste. For the experiments, 2 ml TBS containing 5 mM sucrose
solution and 0.045 µCi/ml [14C]-sucrose with or without PFS extracts (pH 7.4)
was added to the apical compartment and 2 ml TBS in the basal receiver
compartment. Cells were incubated for 60 min at 37°C. Following incubation,
the TEER values were measured at three positions per insert again and the
solutions from apical and basolateral compartments were removed to scintillation
vials immediately. To wash cells for radioactivity assessment, 2 ml TBS was
added to the apical and basolateral compartments, which was removed to the
scintillation vials. Following this, 1 ml of 1 M NaOH solution was added to
detach the cells from the membrane and the plates were placed on a plate shaker
for 30 minutes. The suspended cells were removed to 1.5 ml centrifuge tubes.
Subsequently, 0.7 ml of NaOH was removed to the scintillation vials and to
neutralize the pH, 0.7 ml of 1 M HCl was added to tube. The remaining NaOH
sample was stored at -20ºC. The scintillation cocktail was added to the apical,
basolateral and cell suspension samples at a volume of 10, 5 and 5 ml,
respectively, and all the vials were mixed. Radioactivity was determined using a
Packard 1600 TR Liquid Scintillation Analyser (see chapter 4 section 4.4.1).
Light emission was counted for 10 min per vial and the number of counts per
minute (CPM) was calculated by the equipment software.
6.3.3 Statistical analysis
IBM SPSS Statistics 22 was used for the analysis of the data. The Levene test
was used to evaluate the homogeneity of the means groups. If the criterion was
met, the Tukey HSD post hoc test was applied; otherwise, the Dunnett C
followed the one way Anova. The values shown represent the mean values and
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the error bars indicate the standard deviation (SD). Unless otherwise stated,
differences were considered as statistically significant when p≤0.05. 
6.4 Results
6.4.1 Set up and validation of D-[14C]-sucrose transport across Caco-
2 cells
A calibration curve of radioactivity as a function of [14C]-sucrose quantity was
prepared. With the y-intercept fixed at zero, the gradient was calculated as 21967
CPM/µmol and the adjusted R2 was equal to 0.999, suggesting good
proportionality of radioactivity and molar quantity (Figure 67). Counting
precision of the equipment was assessed by comparing the reference calibration
solution of 123000 CPM/KBq and background noise (n=14).
The results were corrected for the counter efficiency based on background
absorbance standard signals (the typical count averaged 34.9 CPM, and the
solutions involved in the experiment (HCl + NaOH mixture and TBS) had a
typical average count of 42.9 and 39.7 CPM, respectively) (n=3 measurement for
14 times experiment).
Figure 67 Sucrose standard curve for radioactivity measurements (CPM = [14C]-
sucrose counts per minute). Mean ± SD (n=6 per concentration point, total 11
samples).
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The effect of PFS extracts on apical to basolateral transport and cellular uptake
of sucrose was investigated using the Caco-2 and Caco-2 /TC7 cell lines. Caco-2
and TC7 cells were plated on 6-well and 12-well plates, respectively, at a density
of 6.43 x 104 cells/cm2. The experiments were performed after the cell
monolayer reached the full differentiation. The differentiation of the monolayer
was assessed by measurement of the TEER values of the cell monolayer. Only
Transwell® inserts with a resistance exceeding a blank membrane by 300 Ω 
were utilized in the experiment. TEER values <300 Ω may be demonstrating less 
well-formed tight junctions between the cells. The TEER value of the cells was
measured after the pre- and post-incubation process. There was no significance
in the pre and post-incubation TEER values of each well (Table 25). Therefore,
PFS extracts did not affect the electrical resistance between the cells.
Table 25 Blank corrected TEER of Caco-2 monolayers measured after pre-
incubation (30 min) and post-incubation (60 min) in the absence (control) and
presence of PFS extracts.
PFS Concentration of
PFS (mg/ml)
TEER post-
incubation
%
difference
extracts
Control 0 378.3 ± 40 12
German chamomile 1 305 ± 12* 9
Green tea 1 390 ± 32 2
Vitis Viniferae 3 333 ± 11* 8
% difference demonstrates the difference between pre and post-incubation TEER
values. The asterisk denotes a significantly different TEER measurement relative
to control TEER measurement (p<0.05). Mean ± SD (n=6 measurement per
sample and 18 times readings from each sample). Tukey HSD test applied.
The rate of transport from apical to basolateral cell culture medium was 2.4
nmol/min and cellular uptake of D-[14C]-sucrose (5 mM) was 0.15 nmol/min
without PFS (control sample).
Basolateral transport of D-[14C]-sucrose (5 mM) was analysed at different time
points with and without 12 h FBS treatment to analyse the effect of starvation
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stress on Caco-2 cells. There was a linear increase on sucrose transport at
different time points (Figure 68). Transport of D-[14C]-sucrose to the basolateral
side significantly decreased slightly under FBS starvation only at 30 min.
Cellular uptake of sucrose increased over time. Sucrose uptake also significantly
increased with 12 h FBS starvation compared to FBS-treated cells (p<0.01)
(Figure 69).
Figure 68 Transport of 5 mM [14C]-sucrose from the apical to basolateral side
with and without overnight FBS pre-treatment.
Asterisks denote a significant difference from control samples and Greek letter
denotes a significant difference from the related time point (FBS treated and FBS
starvation 12h) (p<0.01). Where not visible, error bars are smaller than the size
of the data point. Mean ± SD (n=6 per time point). Tukey HSD test applied.
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Figure 69 Intracellular sucrose after apical incubation with 5 mM sucrose with
and without overnight (12 h) FBS pre-treatment.
Asterisk denotes a significant difference from control samples (p<0.05) and
Greek letters denote significant differences from the related time point (FBS
treated and FBS starvation 12h) (p<0.01). Where not visible, error bars are
smaller than the size of the data point. Mean ± SD (n=6 per time point). Tukey
HSD test applied.
Figure 70 shows the effect of various concentrations of sucrose on the rate of
transport from apical to basolateral (a to b) and basolateral to apical (b to a).
Sucrose is transported to the blood in two ways: i) hydrolysis to glucose and
fructose by sucrase and then transport to blood via glucose transporters or ii)
paracellular transport. It is possible that sucrose may also be transported back to
the lumen paracellularly. Approximately half of the amount of sucrose was
transported back to lumen (Figure 70). In both conditions, the rate of transport
increased with substrate concentration. Also, cellular uptake of D-[14C]-sucrose
remained constant from a to b but it was slightly increased from b to a. Sucrase
has an activity only on the luminal side, therefore it may have an effect on
cellular up of D-[14C]-sucrose from a to b (Figure 70).
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A
B
Figure 70 A: Transport of [14C]-sucrose from apical to basolateral (a to b) and
basolateral to apical (b to a) at different concentrations of sucrose.
Related concentration points of two data significantly different than each other.
B: Cellular uptake of [14C]-sucrose from apical to basolateral (a to b) and
basolateral to apical (b to a) at different concentrations of sucrose. Mean ± SD
(n=6 per concentration point).
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6.4.2 Inhibition of sucrose transport and uptake by PFS
The addition of different concentrations of PFS extracts reduced the transport of
D-[14C]-sucrose to the basolateral side. The IC50 of cellular uptake and transport
of D-[14C]-sucrose was calculated (Table 26). Without PFS extracts (control
sample), the rate of basolateral transport from cell culture medium was 2.4
nmol/min and cellular uptake of D-[14C]-sucrose (5 mM) was 0.15 nmol/min.
For co-incubation of 5 mM sucrose with green tea and German chamomile, the
extracts dose dependently attenuated the transport of D-[14C]-sucrose to the
basolateral side. These IC50 values showed that green tea extract had the highest
impact on D-[14C]-sucrose transport. Vitis Viniferae extract also dose
dependently attenuated the transport of D-[14C]-sucrose but its highest
concentration did not reach the IC50 value. 1 mg/ml Pelargonium and Echinacea
extracts were ineffective for both uptake and transport of D-[14C]-sucrose. The
compounds in green tea and German chamomile extracts can cross the cell
membrane and inhibit the basolateral transport of sucrose more effectively than
other PFS extracts. The results indicated that cellular uptake of sucrose was not
affected by the PFS extracts (Figure 71, Figure 72, and Figure 73 B).
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A
B
Figure 71 A: Sucrose uptake is significantly inhibited by different
concentrations of German chamomile across Caco-2 differentiated monolayers
The inset shows the magnified section with estimation of IC50 for transport of
radiolabelled sucrose and its products to basolateral compartment. B: Cellular
uptake of sucrose in Caco-2 cells at different concentrations of German
chamomile (**p<0.01, *p<0.05). Where not visible, error bars are smaller than
the size of the data point. Mean ± SD (n=6 per concentartion point). Tukey HSD
test applied.
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Addition of PFS extracts to the apical side at different concentrations led to a
dose-dependent inhibition of basolateral transport of D-[14C]-sucrose (Figure 71,
Figure 72 and Figure 73). In the presence of 1 mg/ml German chamomile, green
tea and Vitis Viniferae extract, the rate of basolateral transport from the apical
compartment was 0.8, 0.9 and 0.5 nmol/min, respectively. In the presence of 1
mg/ml German chamomile, green tea and Vitis Viniferae extracts, cellular uptake
of D-[14C]-sucrose (5 mM) was at a rate of 0.09, 0.11 and 0.13 nmol/min well,
respectively.
Table 26 Effect of PFS on sucrose transport across the intestinal monolayer
model, and on cellular uptake.
Supplement extract IC50 (mg/ml) transport IC50 (mg/ml) uptake
German chamomile 1.12 ± 0.17 None
Green tea 0.98 ± 0.12 None
Vitis Viniferae Not achievable None
Pelargonium None None
Echinacea None None
Mean± SD (n=3) Tukey HSD test applied.
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B
Figure 72 Sucrose transport and uptake were significantly inhibited by different
concentrations of green tea extract across Caco-2 differentiated monolayers.
B: Cellular uptake of sucrose in Caco-2 cells at different concentrations of green
tea extract. Inset shows a magnified section with estimation of IC50. Where not
visible, error bars are smaller than the size of the data point. Mean ± SD (n=6 per
concentration point). Tukey HSD test applied.
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B
Figure 73 Sucrose uptake and transport were not significantly inhibited by
different concentrations of Vitis viniferae extract across Caco-2 differentiated
monolayers (p<0.01).
B: Cellular uptake of sucrose in Caco-2 cells at different concentrations of Vitis
viniferae extract. Vitis viniferae extract was unable to achieve 50% inhibition of
sucrose transport at concentrations <3 mg/ml. Where not visible, error bars are
smaller than the size of the data point. Mean ± SD (n=6 per concentration point).
Tukey HSD test applied.
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6.4.3 Sucrose transport under overnight FBS starvation
FBS contains important components such as hormones and growth factors.
Therefore, the addition of FBS to cell medium promotes cell adhesion and
proliferation (epidermal growth factor, fibronectin, and thyroxine). To create
starvation stress in the cells, FBS was removed from the cell culture medium 12h
before the experiment. Beside, cells were treated with 1 mg/ml German
chamomile extract and sucrose (5 mM) 12 h before the experiment.
When the cells were deprived of FBS overnight, uptake of D-[14C]-sucrose into
the cells was 0.016 µmol/well. Cellular uptake of D-[14C]-sucrose was 0.012
µmol/well in the presence of FBS. This shows that FBS starvation significantly
increases the cellular uptake of D-[14C]-sucrose (p<0.05). On the other hand,
when the Caco-2 cells were treated with German chamomile for 12 h in the
absence of FBS, cellular uptake of D-[14C]-sucrose was increased significantly
(p<0.05). However, the addition of German chamomile extract (1 mg/ml)
overnight (12 h) and during the experiment decreased the cellular uptake of
sucrose to the same extent as the control sample without FBS treatment (
Table 27). Pre-treated cells with sucrose (5 mM) without FBS starvation did not
effect the cellular uptake of D-[14C]-sucrose.
German chamomile extract inhibited the cellular uptake of D-[14C]-sucrose with
an IC50 value of 0.309 mg/ml. By contrast, the cells (deprived of FBS 12 h) that
were exposed to German chamomile extract overnight and during the transport
experiment did not inhibit cellular uptake of D-[14C]-sucrose. FBS starvation and
German chamomile extract affected the amount of cellular sucrose therefore it
may conclude that relevant transcript regulation occurred and could be further
analysed. When the cells were deprived of FBS for 12 h, transport of D-[14C]-
sucrose to the basolateral compartment increased significantly (p<0.05), the
same as cellular uptake. Under FBS starvation, pre-treatment with German
chamomile (12 h) increased the transport of D-[14C]-sucrose further, similar to
the retention inside the cells. Pre-treatment with sucrose (12 h) significantly
increased the D-[14C]-sucrose transport across compared to the control sample
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(p<0.05). This may be due to the transporters evolving because of sucrose
overnight (12 h) in the presence of sucrose.
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Table 27 Effect of 12 h treatment of FBS starvation and with/without German chamomile (1 mg/ml) on sucrose cellular uptake and transport
across the Caco-2 cell monolayer.
Asterisk denotes significantly different transport and cellular uptake concentration relative to the control (with FBS 12 h to assess sucrose)
(*p<0.05, **p<0.01). Mean ± SD (n=6 measurement). Tukey HSD test applied.
Pre-treatment
(12h)
Transport
(1h)
FBS
(%)
GC
(mg/ml)
Sucrose
in pre-treatment
(mM)
Transport (a to b)
(µmol sucrose)
Uptake into cell
(µmol sucrose)
No FBS Sucrose 0 0 0 0.160±0.005* 0.016±0.0001
No FBS+ GC Sucrose+ GC 0 1 0 0.094±0.006** 0.012±0.0001
No FBS+ GC Sucrose 0 1 0 0.145±0.009* 0.022±0.0002*
FBS+ Sucrose Sucrose 10 0 5 0.129±0.004* 0.012±0.0001
FBS Sucrose 10 0 0 0.114±0.002 0.012±0.0001
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6.4.4 Inhibition of sucrose uptake and transport to the basolateral
side using the TC7 cell line
Caco-2 cells are commonly used in research as they are able to differentiate in
long-term culture. They are also able to mimic the intestinal enterocyte with a
continuous monolayer of cells linked by tight junctions. However, it consists of a
heterogeneous cell population and highly depends on the culture conditions
(Delie and Rubas, 1997; Turco et al., 2011). To reduce the heterogeneity of the
Caco-2 cells, the TC7 clone obtained was isolated from a late passage of the
parental Caco-2 line (Turco et al., 2011; Cheng et al., 2014). This clone is
characteristic of more developed intercellular junctions and more representative
functions of the small intestinal enterocyte and more homogeneous population
(Turco et al., 2010). Caro et al. (1995) reported that TC7 cells show higher
sucrase/isomaltase activity. Another study also observed that the TC7 clone
population is more homogeneous and the intercellular junctions are more
developed than the Caco-2 cell line (Zucco et al., 2005). The clone is used as an
alternative model for permeability assessments. In this experiment, transport and
uptake of D-[14C]-sucrose was compared between TC7 and the Caco-2 cell line.
The TEER value of the TC7 cells was measured after the pre- and post-
incubation process. There was no significance between the pre- and post-
incubation TEER values of each well, except for the green tea extract (Table 28).
Higher concentrations of green tea extracts may improve the electrical resistance
of the TC7 cell monolayers. TEER values between TC7 and Caco-2 cells were
somewhat different when compared between themselves (Table 18 and Table 28).
The orientation of tight junction proteins (claudin and occludin) is different
between the two cell lines and this has been offered as a possible explanation in
the literature. Growth conditions, e.g. the absence of FBS in the basolateral
compartment after 7 days of attachment with TC7 cells, can also affect TEER
values.
German chamomile and Vitis viniferae extracts inhibited D-[14C]-sucrose
transport in both cell lines. For the green tea extract, the transport of D-[14C]-
sucrose from the apical to basolateral side was 0.143 µmol in Caco-2 cells and
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0.060 µmol in TC7 cells (the surface area of the two cell lines is different;
transport experiments with TC7 cells were carried out transwells with a surface
area that is 4 times larger than transwells used for Caco-2 cell experiment, and
therefore, the result for transport was corrected based on this difference. Delie
and Rubas, 1997 reported that pore size influences cell growth and transport.
However for both cell lines pore size was same (0.4 µM) in the current study.
These results indicate that the activity of sucrase is higher in TC7 cells, and
therefore, the transport of D-[14C]-sucrose or its products from apical to
basolateral side was higher than for the Caco-2 cells (cells are breaking sucrose
to glucose and fructose and therefore more glucose is transported from the apical
to basolateral compartment). The uptake in Caco-2 cells was 0.009 µmol of D-
[14C]-sucrose and for TC7 cells it was 0.026 µmol D-[14C]-sucrose. In the
presence of green tea and German chamomile extracts, cellular uptake of D-
[14C]-sucrose was reduced significantly for the concentration points of 0.125 and
0.25 mg/ml (p<0.01) but it was not possible to reach IC50. By contrast, the
presence of higher concentrations of green tea and German chamomile extracts
improved the cellular uptake of D-[14C]-sucrose (Figure 74 and Figure 75). Vitis
viniferae extract did not affect the cellular uptake (Figure 76). Table 29 shows
the IC50 values of D-[14C]-sucrose transport and uptake with PFS extracts.
Transport of D-[14C]-sucrose to the basolateral side was significantly different
for all the concentrations of green tea and German chamomile extracts compared
to the control samples (p<0.01) and only the highest concentration of the Vitis
Viniferae extract was significantly different to the control sample (p<0.01).
Acarbose (0.1 mM) also inhibited 48 % of sucrose transport across the TC7 cells.
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Table 28 Blank corrected TEER of TC7 monolayers measured after pre-
incubation (30 min) and post-incubation (60 min) in the absence (control) and
presence of PFS extracts.
PFS PFS
(mg/ml)
TEER pre-
incubation
TEER
post-
incubation
%
difference
extracts
Control 0 333 323 ± 9 3
German chamomile 1 311.5 311.3 ± 5 0
Green tea 1 330 391 ± 30 * 118
Vitis Viniferae 1 343 326 ± 12 5
% difference demonstrates the difference between pre and post-incubation TEER
values. The asterisk denotes a significantly different TEER measurement relative
to control TEER measurement (p<0.05). Mean ± SD (n=6 per sample and 18
values for each sample). Tukey HSD test applied.
Table 29 Effect of PFS on sucrose transport across the TC7 intestinal monolayer
model, and on cellular uptake.
Supplement extract IC50 (mg/ml) transport IC50 (mg/ml) uptake
German chamomile 0.56 ± 0.035* None
Green tea 0.32 ± 0.05 None
Vitis Viniferae Non detectable None
Asterisk denotes significant difference of German chamomile compare to green
tea extract (p<0.01). Mean ± SD (n=6 per inhibitor concentration). Tukey HSD
test applied.
- 190 -
A
B
Figure 74 A: Transport of radiolabelled sucrose and its products at different
concentrations of German chamomile extract using TC7 differentiated
monolayers.
B: Intracellular uptake of sucrose and its products in to TC7 cells at different
concentrations of German chamomile extract. Inset show the magnified section
with estimation of IC50. The asterisks denotes the significantly different cellular
concentration relative to control (*p<0.05, **p<0.01). Mean ± SD (n=6 per
concentration). Tukey HSD test applied.
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A
B
Figure 75 A: Transport of radiolabelled sucrose and its products at different
concentrations of green tea extract using TC7 differentiated monolayers.
B: Intracellular uptake of sucrose and its products in to TC7 cells at different
concentrations of green tea extract. Inset show the magnified section with
estimation of IC50. The asterisks denotes the significantly different cellular
concentration relative to control (*p<0.05, **p<0.01). Mean ± SD (n=6 per
concentration). Tukey HSD test applied.
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A
B
Figure 76 A: Transport of radiolabelled sucrose and its products at different
concentrations of Vitis viniferae extract using TC7 differentiated monolayers.
B: Intracellular uptake of sucrose and its products in to TC7 cells at different
concentrations of Vitis viniferae extract. Mean ± SD (n=6 per concentration).
Tukey HSD test applied.
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6.5 Discussion
Sucrose contains one glucose and one fructose molecule. After hydrolysis of
sucrose to glucose and fructose the absorbed glucose is used by primarily
peripheral tissues in an insulin-dependent manner. Fructose is transported to liver
and due to its lipogenic activity, it may contribute to the development of
cardiovascular diseases, insulin resistance and type-2 (Hansen et al., 2012).
In the literature, there is no study regarding radiolabelled sucrose transport to the
basolateral side and cellular uptake analysis using the Caco-2 cell line. The
presence of some PFS extracts has an influence on sucrose uptake and transport
to the basolateral compartment by inhibiting the activities of either glucose
transporters or sucrase. The active inhibitor compounds in the PFS influence
either the glucose transporters on the apical side (GLUT5, GLUT2 or SGLT1)
and/or the transporters on the basolateral side, GLUT2 or GLUT5. They may
also have an effect on the villous membrane-bound sucrase activity in Caco-2
cells. Sucrose was transported from the basolateral to apical side paracellularly
and transport of sucrose (after hydrolysis by sucrase to glucose and fructose)
across the basolateral side was 2.4 nmol/min (approximately half of the
transported radiolabelled sucrose and its products concentration was transported
back to apical compartment) (Figure 77). Therefore, it may be concluded that the
activity of the sucrase enzyme is not high. While green tea and Vitis Viniferae
extracts were ineffective on the cellular uptake of sucrose, German chamomile
extract inhibited it with an IC50 value of 0.309 mg/ml. It may be concluded that
German chamomile extracts have the ability to inhibit sucrase activity more
effectively than other PFS extracts.
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Figure 77 Absorption of sucrose in to the blood. G: glucose F: fructose.
Hansawasdi and Kawabata (2006) reported, using Caco-2 cells, that Mulberry
(Morus Alba) tea inhibited sucrase activity and glucose transport to the
basolateral side. They analysed the glucose concentration of the apical and
basolateral compartment media using the glucose oxidase assay. They also
reported the effect of the commercial α-glucosidase inhibitor drug known as 1-
deoxynojirimycin as a positive control with an IC50 value of 7.7x10-5 mM. The
villous membrane-bound sucrase activity in Caco-2 cells and the transport of
glucose to the basolateral media were inhibited by a hot water extract of
mulberry tea. Another study regarding grape seed extract (GSE), rich in
flavanols (54%), analysed its inhibitory effect on sucrase activity (Laurent et al.,
2007). GSE reduced the sucrase activity by 61% in the Caco-2 cell monolayer at
a concentration of 0.3 g/l (Laurent et al., 2007). Here, the transport of sucrose
was analysed with radiolabelled sucrose using the Caco-2 cell monolayer.
Further studies should be performed to observe the inhibitory mechanism of PFS
extracts for sucrose transport. There are two possible mechanisms for the
inhibition of sucrose transport, but in this study the type of inhibition could not
be observed since radiolabelled sucrose, and its products, all contribute to the
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measured total counts. As the level of sucrose in the apical compartment was not
analysed chemically, the degree of sucrase inhibition could not be observed but it
could be concluded that the overall system were affected by the PFS extracts.
In the literature there are several animal studies regarding the inhibition of
sucrase activity with polyphenols. It is reported that gallic acid and tannic acid
were potent inhibitors of sucrase activity in mice and rats (Welsch et al., 1989;
Gupta et al., 2010; Gupta et al., 2007). Eucalyptus leaf is traditionally used to
treat diabetes in South America and Africa. Sugimoto et al. (2005) observed the
effect of Eucalyptus leaf extract (ELE) in high sucrose diet-fed rats for 5 weeks.
The intestinal sucrase activity was analysed in the presence of ELE using in vitro
tests. The inhibition of sucrase was concentration dependent with IC50 value = 3
mg/ml. The extract was found to inhibit sucrase activity, suggesting the influence
of the isolated polyphenols from the ELE, 1,2,3,4,6-penta-O-galloyl-b-glucose
(hydrolysable tannins). Ishikawa et al. (2007) reported that a leaf from Pakistan
called Nerium Indicum was able to reduce the postprandial glucose level of rats
after they were orally fed with sucrose. Another study analysed acerola fruit and
it was also able to inhibit intestinal sucrase of mice that were orally fed with
sucrose (Hanamura et al., 2006). Hosaka and colleagues (2011) analysed the
effect of buckwheat on diabetes. They found that mice fed with buckwheat bran
extracts (BBE) had a lower blood glucose level compared to control mice after
60 min of oral sucrose administration. However, rutin (one of the major
components of BBE) did not affect the blood glucose level. Therefore, it was
concluded that BBE inhibits sucrase activity but rutin did not have any inhibitory
activity on sucrase.
There are also human studies regarding the effect of polyphenols on the blood
glucose level. Wilson et al. (2008) studied twelve healthy participants fed with
sucrose (35 g) and berries (150 g puree made of bilberries, blackcurrants,
cranberries and strawberries providing nearly 800 mg polyphenols). Berries are a
rich source of anthocyanins, flavonols, proanthocyanidins and phenolic acids.
Participants fed without berries produced a different postprandial glycemic
response compared to the subjects who were fed with berries. Törrönen et al.
(2009) observed the effect of berry puree (containing bilberries, cranberries,
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strawberries and blackcurrant) on the blood glucose level of 12 healthy subjects.
The subjects were fed with 150 g of a berry meal that also contained 35 g
sucrose or a control sucrose load in a randomised, controlled cross-over study.
The blood glucose level was significantly lower at 15 and 30 min after the
consumption of the berry meal and significantly higher at 150 min. The peak
glucose concentration reached was at 45 min in subjects who consumed berry
meal, whereas it was 30 min for subjects who consumed the control meal. They
concluded that berries were able to decrease the postprandial glucose level in
healthy subjects, and the delayed and reduced glycaemic response showed the
decrease of sucrose digestion or absorption from the berry meal. Therefore, they
(bilberries, cranberries, strawberries and blackcurrant) may be used to improve
diabetes (Törrönen et al., 2009). Hoggard et al. (2013) studied 8 male diabetic
subjects. After a 2-week washout period, the subjects were fed with 50 g
bilberries (equal to standardised 0.47 g bilberry extract, 36% (w/w) anthocyanins)
or placebo (75 g glucose drink) in a double-blinded cross-over study design. The
bilberry extract was able to reduce the postprandial glycaemic response and
insulin in type-2 diabetic subjects. They assumed that this effect comes from the
attenuated carbohydrate absorption or digestion.
In conclusion, polyphenol-rich products may help to manage diabetes. PFS
extracts (green tea and German chamomile) reduced the transport of
radiolabelled sucrose to the basolateral compartment. As the sucrose
concentration in the apical compartment was not analysed, the degree of sucrase
inhibition was not observed, but it could be concluded that the transporters were
affected by PFS extracts more than sucrase as half of the transported sucrose was
transported from the basolateral to the apical compartment. Therefore, due to
their inhibitory activity (acarbose-like activity) on liberated glucose transport or
hydrolysis of sucrose by sucrase activity, green tea and German chamomile
extracts have potential for the management of type-2 diabetes.
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CHAPTER 7 DISCUSSION AND FUTURE
WORK
7.1 Method development and novelty
The International Diabetes Federation reported that >371 million people around
the world have diabetes. This is predicted to rise to >550 million by 2030, with
90 % of all people having type-2 diabetes. In the UK, it is assumed that ~750,000
people have type-2 diabetes, but have not been diagnosed, and ~2.7 million have
been diagnosed (Diabetes, UK, 2012). Due to the side effects of some common
drugs (flatulence, diarrhoea, tiredness and upset stomach) in the treatments of
diabetes, use of herbal remedies has increased; 2 to 3.6 million diabetic patients
in the USA use herbal remedies for management of diabetes (Dabaghian et al.,
2012). The World Health Organization (WHO) (2003) reported that 65 to 80 %
of the world population uses traditional medicines for health care.
Glucose is an important carbohydrate that plays a role in the development of
diabetes. Sucrose can lead to an increase of post-prandial blood glucose
(liberated glucose from sucrose) and liberated fructose is utilised in the liver to
generate products such as glucose, glycogen, lactate and pyruvate, and affect
lipid metabolism, which also might affect insulin resistance and type-2 diabetes
(Törrönen et al., 2010; Hansen et al., 2012; Halschou et al., 2012). Type-2
diabetes is caused when there is deficient or ineffective insulin for blood glucose
absorption resulting in a high blood glucose level. To prevent or delay type-2
diabetes, the blood glucose level needs to be controlled. Diabetes increases the
risk of heart disease and complications that damage the kidney, retina and
peripheral nerves (Liu et al., 2000; Liese et al., 2005; Flynn, et al., 2005;
Manzano and Williamson, 2010; Hauner et al., 2012).Another recent study
analysed 3 cohort study (1984-2008 Nurses’ health study I, 1991-2009 Nurses’
health study II and 1986-2008 Health professional follow up study (started with
healthy men and women)) and observed that higher intake of GI and GL
increased the risk of type-2 diabetes. Therefore, controlling the blood glucose
level will decrease the risk of those diseases and may assist in the prevention of
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progression to type-2 diabetes. There are several in vitro and in vivo studies
regarding this.
Polyphenols and their effect on sugar metabolism was first reported ~46 years
ago. A report from 1969 indicated that tannins from ripe and green carobs
inhibited α-amylase activity by ~45 % (Tamir and Alumot, 1969). Another report 
from 1984 observed the effect of polyphenol intake on blood glucose level of
diabetic and non-diabetic patients and observed a negative correlation between
the glycaemic index and the total intake of polyphenols (Thompson and Yoon
1984). Following those studies, Welsch et al. (1989) reported that SGLT1
activity was inhibited by chlorogenic, ferulic, caffeic and tannic acids using rat
intestinal brush border membrane vesicles and indicated an 80 % reduction of
glucose transport with chlorogenic acid and 30-40 % reduction observed in the
presence of ferulic, caffeic and tannic acid.
The aim of this research was to investigate sucrase, maltase, isomaltase and
human salivary α-amylase inhibition by the plant food supplement (PFS) extracts 
and the effect of PFS on sugar transporters (SGLT1, GLUT2 and GLUT5). The
initial steps of the in vitro tests development involved determining the activities
of sucrase, maltase, isomaltase and human salivary α-amylase in an acetone-
extract of rat intestinal tissues, improving a previously published method (for α-
glucosidase: Gao et al., 2007 and for α-amylase: Akkarachiyasit et al., 2010) by
analysing the glucose concentration via the hexokinase assay, and analysing the
effect of PFS on sugar transporters (SGLT1, GLUT2 and GLUT5) using a
previously published method (Manzano and Williamson 2010) using the Caco-2
cell monolayer. Using the Caco-2 cell model, uptake and transport of 14C-
radiolabelled glucose, fructose and sucrose has been investigated in the presence
of PFS and measured with a scintillation counter. The highest concentration of
post-prandial polyphenols is in the gut lumen compared to any other site in the
body (Williamson, 2012). The Caco-2 cell line is the best choice to assess the
inhibition of sugar transport because several morphological and functional
characteristics of the mature enterocyte is able to expressed by Caco-2 cells
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(Sambuy et al., 2005; Angelis and Turco, 2011) and it is thought that glucose
metabolism may be affected in the gut lumen.
In the literature, the effect of polyphenols on glucose transport has been analysed
using brush border membrane vesicles or everted sacs and Caco-2 cells (Welsch
et al., 1989; Kobayashi et al., 2000; Shimizu et al., 2000; Song et al., 2002;
Cermak et al., 2004; Johnston et al., 2005; Li et al., 2006; Manzano and
Williamson 2010; Goto et al., 2012; Farrell et al., 2013). There are some animal
model studies and limited human intervention studies regarding green tea,
chamomile and grape extracts or their active components on glucose metabolism.
However, the literature evidence for the inhibition of cellular glucose uptake and
transport by polyphenols across Caco-2 cells is limited. Also, to the best of our
knowledge, this research is the first report regarding the analysis of cellular
uptake and transport of 14C-sucrose and 14C-fructose using the Caco-2 cell
monolayer with polyphenol-containing extracts. The objective of this research
was to make a preliminary assessment of the capacity of PFS extracts to reduce
glucose, fructose and sucrose transport (acarbose-like activity) across the Caco-2
cell monolayers. Additionally, 14C radioactivity was used due to its easy
detection. Using radiolabelled glucose, fructose and sucrose allowed high
sensitivity. However, there was a limitation regarding the study; the complete
metabolism of the biological intestine does not occur with Caco-2 cells (low
level of sucrase expression), and therefore, only the effect of unmodified
compounds (extracts’ digestion does not occur) on sugar metabolism was
analysed.
Present publications regarding radiolabelled glucose uptake using Caco-2 cells
are limited. Goto et al. (2012) reported that tiliroside inhibited glucose uptake in
Caco-2 cells with an IC50 value of 94 µM (cells were seeded to plates, therefore
there was no monolayer). Johnston et al. (2005) analysed the effect of different
classes of dietary polyphenols on glucose uptake with Caco-2 cells (cells were
seeded to plates, therefore there was no monolayer) and reported that aglycones
inhibited GLUT2 and glycosides inhibited SGLT1. Farrell et al. (2013)
investigated the effect of hydrolysed and unhydrolysed herbal extracts on
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glucose transport and uptake using the Caco-2 cell line and reported that herbal
extract mixtures decreased glucose transport <54 %. Alzaid et al. (2013)
observed that the glucose transport in Caco-2 cells in the presence of berry
extract was significantly decreased (58 % of total glucose uptake). They also
investigated the effect of cyanidin, cyanidin glucoside and cyanidin rutinoside on
glucose uptake (~21, 20 and 21 % of total glucose uptake, respectively) and
found that all these compounds significantly inhibited glucose uptake. In the
current study, using the Caco-2 cell monolayer, the transport and cellular uptake
of glucose was analysed in the presence of PFS. PFS extracts were chosen based
on the list in Annex 1 (the partner’s suggestions) and EFSA.
Previous studies have shown that polyphenols have the potential to inhibit α-
glucosidase and α–amylase enzymes, which in turn would slow down the 
products of sucrose (glucose and fructose α-1,4 glycosidic bonds), maltose 
(glucose and glucose 1-4α linkage), isomaltose (glucose and glucose 1-6α 
linkage) and starch (large number of glucose units linked with glycosidic bonds)
reaching the blood (Kim et al., 2000; Shimizu et al., 2000; Song et al., 2005;
Bhandari et al., 2008; Kamiyama et al., 2010; Boath et al., 2012; Akkarachiyasit
et al., 2013; Posedek et al., 2014; Pantidos et al., 2014). The result of inhibition
of α-glucosidase and human salivary α-amylase enzymes by PFS extracts 
appears to be in agreement with the literature. In the current study, each of the
PFS extracts was analysed for their possible interference with α-glucosidase and 
α–amylase assays and assessed by considering critical parameters affecting the 
final inhibition (maltodextrin content of the extract, polyphenol reduction
potential (the number of OH groups in the chemical structure) causing an
interference with DNS and hexokinase reagent (Rice-Evans et al., 1996) and the
effect of DMSO to enzyme activity). After the enzymatic hydrolysis of
substrates the potential reactive inhibitors were removed by SPE and then DNS
and/or hexokinase reagent was used to assess the product. Therefore, in many
published studies the reducing capacity of polyphenols was ignored and the
results of the inhibition may be inconsistent.
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7.2 Summary of the results
For Caco-2 cells both uptake and transport is important. According to the
analysis of different concentrations of sugars, less fructose was transported to the
basolateral side and glucose transport was higher than sucrose transport.
Therefore, it may be assumed that the transport of glucose is faster than sucrose
and fructose in the intestine. By contrast, cellular uptake of fructose was higher
than glucose and sucrose uptake was the lowest. GLUT5 is a highly specific
transporter for fructose. Cellular uptake of fructose increases with brush border
fructose transport and fructose transport increases only with luminal fructose
(Cui et al., 2004; Suzuki et al., 2011). Cui et al. (2004) reported that cellular
uptake of fructose is higher than glucose after 4 h of perfusion of high glucose
and high fructose in neonatal rat intestine. To create a starvation stress in the
cells, FBS was removed from medium 12 h before the analysis of different
incubation time points. It was observed that basolateral transport of glucose was
not affected in the absence of FBS; however, cellular uptake of glucose
significantly decreased at 30 min. Basolateral transport of fructose was not
affected in the absence of FBS; however, cellular uptake significantly decreased
at 30 and 60 min (p<0.05). Sucrose transport to the basolateral compartment was
significantly decreased under FBS starvation at 30 min but it was not affected at
60 min, and cellular uptake of sucrose was significantly increased at 30 and 60
min under FBS starvation.
Glucose, fructose and sucrose transport across the Caco-2 cell monolayer was
significantly attenuated in the presence of PFS. Green tea, German chamomile
and Vitis Viniferae extracts inhibited the transport of glucose, fructose and
sucrose when tested independently. However, the Vitis Viniferae extracts were
not able to achieve 50 % inhibition for the sucrose and fructose transport. While
the cellular uptake of glucose and fructose was inhibited by the PFS extracts,
they were in effective on the cellular uptake of sucrose. By contrast,
Pelargonium and Echinacea were ineffective for both transport and cellular
uptake of sugars. Glucose transport to the basolateral compartment was analysed
under Na+-containing and Na+-free conditions in the presence of German
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chamomile, and we concluded that the inhibition of GLUT2 was greater than
SGLT1. Accordingly, the results indicate that apical GLUT2 is the primary
target of the compounds from the German chamomile extract. Different
concentrations of sucrose transport were observed from the apical to basolateral
and from the basolateral to apical compartment. It was found that half of the
transported sucrose is transported back to the lumen, which may indicate
paracellular transport of sucrose across the intestine in the absence of sucrase.
The kinetic mechanism of glucose and fructose transport inhibition and cellular
uptake was analysed with 1 mg/ml German chamomile and showed that
basolateral transport of fructose and glucose represented the competitive
inhibition, whereas cellular uptake of fructose was uncompetitive but glucose
uptake was mixed competitive.
To analyse the effect of digestion on the biological activity of the German
chamomile extract, the extract was subjected to enzymatic hydrolysis followed
by extraction as a model of the first step of digestion in the gut. This digestion
affects the biological activity of German chamomile as assessed by glucose
transport across the cell monolayer, which was decreased by ~50%. The cellular
uptake of glucose was significantly decreased by the German chamomile
hydrolysed ACN-treated sample but the cellular uptake of glucose with the
EtAC-extracted sample was significantly increased compared to the control
sample. However, the cellular uptake of glucose with the ACN-control and
ACN-treated samples were the same. Therefore, it was concluded that the
background of the hydrolysis process is affecting the cellular uptake. Also, the
inhibition of glucose transport across the Caco-2 cell monolayer was 32 and 34
% for the ACN-treated and EtAC-extracted samples, and therefore, it may be
concluded that it is mainly aglycones that have a role in inhibiting glucose
transport (while the EtAC-extract sample contains aglycone, the ACN-treated
samples contain glucosides and aglycones). These results suggested that after
ingestion of the PFS, the intact and hydrolysed polyphenols (in the gut lumen)
have an important role in the attenuation of glucose absorption. Some of the
compounds that are present in the German chamomile extract were also tested to
determine their contribution to the inhibition of transport and uptake of glucose
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and fructose. Luteolin was the most effective compound to inhibit glucose
transport; by contrast, luteolin-7-O-glucoside produced the most effective
inhibition of cellular glucose uptake (this data also supports the result for the
German chamomile hydrolysed data). Some of those compounds inhibited both
uptake and transport of fructose. However, none showed high inhibition that
could affect both uptake and transport of fructose.
FBS contains important components such as hormones and growth factors.
Therefore, the addition of FBS to the cell medium promotes cell adhesion and
proliferation (epidermal growth factor, fibronectin and thyroxine). To create
starvation stress in the cells, FBS was removed from the cell culture medium 12
h before the experiment. The response of the Caco-2 cell line to stress (FBS
starvation or glucose, fructose and sucrose load overnight (12 h)) was assessed
after treatment with German chamomile or additional glucose. Both transport
and uptake of sugars were tested. FBS starvation overnight and addition of
German chamomile (1 mg/ml) (12 h) did not have any effect on the cellular
uptake and transport of glucose and fructose. However, transport and cellular
uptake of sucrose increased significantly in both conditions (p<0.05).
Deoxyglucose cannot be further metabolised in the intestine since the 2-hydroxyl
group is replaced by hydrogen; therefore, it is phosphorylated rapidly and
completely and is not effluxed following phosphorylation (Olefsky, 1978, Burant
and Bell, 1992). Transport of deoxyglucose was significantly inhibited by the
same PFS treatments that affected glucose. In contrast to glucose, deoxyglucose
uptake was not changed by any PFS treatments. Inside the cell, glucose is
converted into pyruvate by glycolysis. The first step is phosphorylation of
glucose by hexokinase, which adds a charged phosphate group to glucose
(glucose-6-phosphate). Subsequently, glucose phosphate isomerase converts
glucose-6-phosphate to fructose-6-phosphate, and subsequently by
phosphofructokinase (PFK1) to fructose 1,6 biphosphate and ADP. The latter is
important for glycolysis as it is an irreversible step. This enzyme is an allosteric
enzyme, controlled by some activators (AMP and fructose 2-6 biphosphate) and
inhibitors (ATP, glucagon and low pH). Deoxyglucose is also an inhibitor of
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PFK as there is no signaling involved with deoxyglucose inside the cell while
glucose signals to PFK. It may be concluded that PFS extracts play an important
role in glucose metabolism leading to a decrease in the cellular uptake of
glucose.
Inhibition of sucrose transport was also analysed with TC7 cells (subclone of
Caco-2). It was reported that TC7 cells have a higher sucrase activity than Caco-
2 cells (Caro et al., 1995). Transport of radiolabelled sucrose or its products to
the basolateral side with German chamomile and Vitis viniferae extracts showed
a similar degree of inhibition with the Caco-2 cell transport study; however, the
results for the inhibition activity of green tea extract were different in the two
cell lines. More radiolabelled sucrose or its products were taken up by TC7 cells
compared to Caco-2 cells, which is a result of the higher activity of sucrase. For
the three PFS extracts, cellular uptake of sucrose was reduced significantly
(p<0.01). Acarbose (0.1 mM) also inhibited 48 % of sucrose transport across
TC7 cells.
In this present work, it was also investigated whether the presence of PFS
extracts can inhibit human salivary α-amylase and rat intestinal sucrase, 
isomaltase and maltase (acarbose-like activity). There were some limitations
regarding the study; it was observed that due to the reducing activity of
polyphenols, the measurement of products by DNS and hexokinase reagent could
not be analysed. Therefore, using solid phase extraction, polyphenols were
removed and analysis completed. As maltodextrin was found to be a potent
substrate for α-amylase and α-glucosidase enzymes, the maltodextrin content of 
German chamomile was removed and this purified extract was used for the
analysis. Purified German chamomile and green tea extracts were found to be
moderate inhibitors of α-amylase digestion of amylopectin and α-glucosidase 
enzymes.
7.3 Conclusion
Plant food supplements may influence intestinal glucose transport across the
brush border membrane of enterocytes. Therefore, they can be seen as beneficial
for use by diabetics as part of a nutritional intervention and in combination with
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exercise and drug treatment. Avoiding or blunting postprandial spikes of glucose
in diabetics is regarded as a first-line strategy to amplify determinable effects
related to diabetic complications. This research is a pioneering study regarding
the analysis of cellular uptake and transport of 14C-sucrose and 14C-fructose
using the Caco-2 cell monolayer with polyphenol-containing extracts. However,
the evidence in the literature for the inhibition of cellular glucose uptake and
transport by polyphenols across Caco-2 cells is limited. In this research, sugar
transport was investigated with PFS extracts, using the Caco-2 cell monolayer.
The inhibitory activity of the green tea extract is higher than German chamomile.
Vitis viniferae extracts show the lowest inhibitory effect for the transport of
glucose, fructose and sucrose. Due to the acarbose-like activity of the PFS
extracts, they may have a potential role to play in reducing the risk of diabetes by
inhibiting the hydrolysis of starches and reducing post-prandial blood glucose
spikes. PFS may also be beneficial for use by diabetics due to their effect on
sugar transport and metabolism.
7.4 Future work and overview
In summary, the experimental hypothesis of this thesis is supported by the results.
According to the reported results, plant polyphenols definitely have an influence
on carbohydrate metabolism; however, it is not clear how much difference it will
make to diabetes management. Therefore, human intervention studies are needed
to assess the effect of plant food supplements and to confirm the optimum dose
of the supplement. In some studies postprandial blood glucose level measured
with blood glucose monitor. However, it will be possible to measure the glucose
concentration liberated from sucrose but not specific to glucose transport. The
measurement of 13C-D-glucose could be a more precise and sensitive method for
blood glucose monitoring in the presence of food matrix and it has been
commonly used in the human intervention studies as a metabolic tracer. Using
the stable 13C-D-glucose isotope will enable the specific measurement of 13C
labelled glucose and the calculation of 13C to12C-D-glucose ratio using HPLC
separation and spectrophotometry detection of glucose. Healthy adult volunteers
will be asked not to consume polyphenol-rich food for three days. The subjects
will have fasted for 12 h before the study day. On the day of study, it may be
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asked of them to consume a specific amount of glucose drink (including 13C-D-
glucose) and German chamomile supplement. Then, blood would be collected at
specific time points up to 2 hours and glucose measurement would be analysed
using HPLC-MS.
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ANNEX 1
Priority plants for benefits as identified by partners and SIAG members based on analytical challenges, market share and market prospects
(www.plantlibra.eu)
Latin name Common
name
Used portion Active compounds Main reported benefits Origin
Abies alba Mill.
Aloe ferox Mill.
Silver fir
Bitter aloe/tap
aloe
Buds, barks, leaves, resin
Leaves/Leaves Juice
Essential oils
Anthroquinones
Balsamic expectorant,
antimicrobial, rubefacient Helps
to promote intestinal regularity.
Ease intestinal transit
Western Europe
S. Africa,
Central/S.
America
Artemisia abrotanum L.
Calendula officinalis L.
Carica papaya L. Carum
carvi L.
Southernwood
Pot marigold
Papaya
Caraway
Herb and young shoots
Leaves and flowers
Fruits, leaves, latex Seeds,
roots, leaves
Essential oils
Carotenoids and essential oil
Enzymes, phenolyc compounds
Essential oils, sennosides
Antiseptic, cholagogue
Antiphlogistic, vulnerary and
soothing of the skin and mucosae
Digestive, antimicrobial,
Antispasmodic, digestive,
carminative, expectorant Helps to
promote intestinal regularity.
Southern Europe
Europe, Asia,
North Africa
Central/South
America
Europe, Asia,
North Africa
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Chrysanthemum
balsamita Desf.
Cichorium intybus L.
Citrus aurantium L. var.
dulcis
Costmary
Chicory
Sweet orange
Leaves and flowers
Flowers, leaves, roots
Skin of fruits
Essential oils
Inulin
Essential oils
Spasmolitic, balsamic, cholagogue
Tonic affect upon the liver and
digestive tract
Ansiolitic, stomachic, carminative,
antimicrobial (E.O.)
Europe, Africa
Wide distribution
Mediterranean
Citrus limon Burm.
Crataegus monogyna
Jacq.
Lemon
Hawthorn
Skin of fruits
Flowers, fruits, leaves
Essential oils
Flavonoids
Ansiolitic, antimicrobial (E.O.)
Mild cardiotonic, hypotensive,
antioxidant
Mediterranean
Wide distribution
Mediterranean
Cuminum cyminum L. Cumin Seeds Essential oils Carminative, spasmolitic
Europe, Asia,
North Africa
Echinacea pallida Britton
Eschscholtzia californica
Ch.
Pale purple
coneflower
California
poppy
Herb, roots
Herb tops
Echinacosides
Eschscholtzine and
californidine
Adaptogen, antiseptic,
immunostimulant
Mild sedative, ansiolitic,
antispasmodic
North America,
Europe
North America,
Europe
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Foenicolum vulgare Mill.
Ginkgo biloba L.
Glycyrrhiza glabra L.
Fennel
Maidenhair
tree
Licorice
Seeds, leaves and roots
Leaves
Roots
Essential oils
Ginkgolides
Glycyrrhetic acid
Carminative, spasmolitic
Memory and concentration
enhancer
Antiphlogistic, emollient, mildly
ease intestinal transit. Adrenergic
tonic
Europe, Asia,
South America,
China
Asia,
Mediterranean
Grindelia Robusta Nutt.
Harpagophytum
procumbens DC
Helichrysum italicum G.
Don.
Great valley
gumweed
Devil's claw
Curry plant
Leaves and flowering top
Roots
Flowering tops
Total phenols, grindelic acid
Iridoid glycoside, harpagosid
Flavonoids, caffeol quinic acid
Expectorant, broncospasmolitic
Antiphlogistic, antirheumatic,
bitter tonic
Antispasmodic, antiphlogistic,
mild choleretic
North America
South Africa
South Europe
Hibiscus sabdariffa L.
Hippophae rhamnoides L.
Lavandula angustifolia
Mill.
Roselle
Sea buckthorn
Lavender
Flowers
Leaves, flowers, fruits
Flowers, flowering tops
Antioxidants
Carotenoids and essential oil
Essential oils
Antioxidant, mildly ease the
intestinal transit.
Antibacterial and soothing agent of
the skin and gastric mucosa. Tonic
Tropical areas
Europe
East Europe,
Mediterranean
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Matricaria recutita L.
Melissa officinalis L.
Myrtus communis L.
Chamomile
Lemon balm
Myrtle
Flowers and flowering tops
Leaves and flowering shoots
Leaves and fruits
Bisabolols, flavonoids,
coumarins
Rosmarinic acid
Essential olis
Antimicrobial, mild ansiolitic,
tonic Antiphlogistic, spasmolitic,
vulnerary, mild ansiolitic
Mild sedative, spasmolitic,
carminative Antiphlogistic,
expectorant, antimicrobial,
diuretic, tonic
Wide
distribution
Europe, Asia,
North Africa
Europe and Asia
Olea Europea L.
Panax ginseng C.A. Meyer
Olive
Ginseng
Oil and leaves
Roots
Oleuperine
Ginsenosides
Antispasmodic, hypotensive
Adaptogen, tonic,
immunomodulant, cardiotonic,
enhance mental faculties
Mediterranean
China, Korea
Passiflora incarnata L. Passion flower Herb and leaves Flavonoids Ansiolitic Europe, North
America
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Pelargonium sidoides DC Umckaloab Roots Coumarins, flavonoid and
catechins
Mucolitic, immunostimulant,
antimicrobial, antispasmodic
South Africa
Peumus boldus Molina
Plantago lanceolata L.
Plantago ovata Forsk.
Boldo
Ribwort
Plantain
Hispagula
Leaves
Herb and leaves
Seeds and seed husks
Boldine
Aucubine
Mucillage
Cholagogue, choleretic
Antiphlogistic, ease the intestinal
transit, helps to promote intestinal
regularity
Helps to promote intestinal
regularity. Ease intestinal transit
Chile
Europa Europe,
Asia
Pseudowintera colorata
Dandy Serenoa serrulata
Hook f.
Silybum marianum
Gaertn.
Mountain
Horopito
Saw palmetto
Milk thistle
Leaves
Fruits
Herb and seeds
Sesquiterpene dialdehyde
polygodiali
Phytosterols, fatty acid
Sylimarin
Antimicotic, gastric spasmolitic
Help reducing benign prostatic
hyperplasia
Epatoprotective, choleretic,
antioxidant, bitter tonic
New Zealand
Florida
Wide distribution
Taraxacum officinale
Weber
Dandelion Herb and roots Terpenes, sterols Diuretic, choleretic
Digestive, antimicrobial,
Wide distribution
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Thymus serpillum L. s.l. Wild Thyme Herb and leaves Essential oils spasmolitic, carminative,
expectorant.
Europe, Asia
Trifolium pratense L. Red clover Flowers, leaves Isoflavonoids, Mild estrogenic Europe,
America, Asia
Vaccinium myrtillus L. Bilberry Leaves, fruits Tannins and anthocyanosides Astringent, enhance vascular tone,
antioxidant, antiphlogistic
Europe, North
America
Valeriana officinalis L. Valerian Roots Monoterpenes, Sesquiterpene,
etc
Mild ansiolitic, spasmolitic Anti-
inflammatory, antioxidant
Wide distribution
Europa, America
Vitis vinifera L. Grape Fruits, leaves, seeds Favonoids Laxative, Africa
